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ABSTRACT 
 
Protein interactions play major roles in many biological processes. This thesis is composed of 
three projects. Using five datasets, we explored the characteristics and composition of 
overlapping protein-protein (PP) and protein-ligand (PL) interfaces. Overall, characteristics of 
PP contacts and overlapping PL contacts are highly similar. Second study was designed to 
identify transcription factor binding site motifs in promoter regions of STIM and ORAI genes, 
to gain knowledge of their regulation and relation with breast cancer. Our findings form an 
important basis of predictive interactions between transcription factors targeting STIM and 
ORAI genes and underline roles of these genes in breast cancer. Thirdly, we evaluated the 
performance of seven protein prediction tools on a dataset of protein-ligand complexes. 
Although the tools predicted pockets of various sizes and shapes, we found comparable 
performance amongst the predictions of five tools. We trained a random forest model to output 
a list of suitable tools for a given protein structure. This classifier should be useful for 
prioritizing the tools to be used for unknown proteins. 
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ZUSAMMENFASSUNG 
 
Wechselwirkungen zwischen Proteinen spielen in biologischen Prozessen eine wesentliche 
Rolle. Diese Dissertation ist in drei Projekte aufgegliedert. Unter Zuhilfenahme von fünf 
Datensätzen aus drei unterschiedlichen Datenbanken wurden die Eigenschaften und die 
Zusammensetzung von überlappenden Protein-Protein (PP) und Protein-Ligand (PL) 
Bindestellen untersucht. Statistisch gesehen sind sich die Eigenschaften von PP Kontakten und 
überlappenden PL Kontakten sehr ähnlich. Die zweite Studie diente dazu Motive von 
Transkriptionsfaktor-Bindestellen in bestimmten Promotor-Regionen der STIM und ORAI 
Gene zu identifizieren als auch Erkenntnisse über deren Regulation und Zusammenhang mit 
Brustkrebs zu gewinnen. Unsere Ergebnisse stellen eine wichtige Grundlage für die 
Vorhersage der Wechselwirkungen zwischen Transkriptionsfaktoren, welche an die beiden 
Gene STIM und ORAI binden, dar. Darüber hinaus konnten wir die Rolle dieser Gene in 
Zusammenhang mit Brustkrebs herausstellen. Im dritten Teil werteten wir die Performance von 
sieben verschiedenen Tools anhand eines Datensatzes von PL Komplexen aus. Obwohl die 
Tools von der Größe und Form her unterschiedliche Bindetaschen vorhersagten, konnten wir 
dennoch ein vergleichbares Verhalten zwischen fünf Tools feststellen. Wir trainierten ein 
Random-Forest Modell, welches, gegeben eine Proteinstruktur, eine Reihe von geeigneten 
Tools vorhersagt. Dieses Modell kann dazu dienen Vorhersagemodelle anhand unbekannter 
Proteine zu priorisieren. 
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Chapter 1 
 
Introduction 
 
1.1  Introduction  
Protein interactions play a major role in many biological processes. Numerous important 
applications benefit from the identification of protein-protein and protein-ligand interactions 
such as drug design, protein mimetics engineering, elucidation of molecular pathways, and 
understanding of disease mechanisms. Nowadays, a wide range of high-throughput 
experimental approaches are available for identification of protein-protein and protein-ligand 
interactions. For that reasons, many publicly accessible databases stores the high-quality 
information about protein-protein and protein-ligand complexes. Moreover, for almost three 
decades, gene expression was recognized to be mainly regulated at the transcriptional level and 
protein known as transcription factors functions in regulating the expression of a gene. Any 
changes of protein interactions can lead to mutations and diseases by affecting the functions of 
protein complexes or by affecting gene regulations.  
 
1.2 Motivation 
This thesis addresses three problems which related mostly to protein interactions and gene 
regulation. Nowadays, many efforts and studies have analyzed protein-protein and protein-
ligand interactions, however a detailed of protein interfaces composition is remain elusive as 
targeting protein-protein interactions is challenging because usually no convenient natural 
substrates are available as starting point for small-molecule design. Hence, by using five 
datasets from three different databases, our aim was to explore the characteristics and 
composition of overlapping protein-protein and protein-ligand interfaces.  
On the other hand, many studies have been done on STIM and ORAI genes as they play 
important roles in calcium signals and involved in store-operated Ca2+ entry (SOCE) in cells. 
STIM1 and STIM2 are needed for the development and functioning of various cell types such 
as lymphocytes, skeletal and smooth muscle myoblast, adipocytes and neurons [1,2]. In 
addition, previous studies stated that STIM and ORAI genes are associated with differentiation 
processes and linked to several diseases such as Alzheimers, Parkinsons diseases and cancer 
(e.g. breast cancer and prostate cancer) [3–6]. Today, cancer is a major public health problem 
worldwide which breast cancer is one of the most common and predominant cancer types that 
affects 1.3 million people and causes thousands of death annually [7,8]. In the United States of 
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America, 30.4% of women are diagnosed with breast cancer yearly [7]. However, only few 
studies addressed the involvements of STIM and ORAI genes to breast cancer. In addition, the 
discovery of transcription factor binding sites (TFBS) motifs in specific locations in the 
promoter regions of STIM and ORAI genes is remain elusive. Our aim was to find the 
interacting transcription factors bound to the particular promoter regions of STIM1, STIM2, 
ORAI1, ORAI2, and ORAI3 and their regulation and relation with normal and breast invasive 
carcinoma (BRCA) samples.  
Identification of binding pockets is often a prerequisite step for structure-based drug 
design. However, the characterization of these sites is a main challenge in computational 
biology. Defining the correct pockets on protein surfaces is not an easy task. Recently, many 
protein pocket identification tools have been developed by using different strategies and 
approaches. So far apparently, none of the existing approaches performed in a way which can 
set as a standard or that is widely accepted as benchmarking method to identify protein pockets 
accurately. Hence, it is great of interest to evaluate and compare the performances of these 
tools. By using seven different protein pocket identification tools and tested on a dataset of 
protein-ligand complexes, our aim was to evaluate and compare their performances and suggest 
a set of the best tool which can identify protein pockets accurately. 
 
1.3 Contributions 
Most of the results chapters of this thesis are based on manuscripts that either published or 
ready for submissions as follow: 
 
Chapter 3: Ruzianisra Mohamed, Jennifer Degac, and Volkhard Helms. Composition of 
Overlapping Protein-Protein and Protein-Ligand Interfaces. PloS One. 2015 Oct 
30;10(10):e0140965. doi: 10.1371/journal.pone.0140965. 
 
Chapter 4: Ruzianisra Mohamed, Riccha Sethi, Mohamed Hamed, and Volkhard Helms. STIM 
and ORAI Genes, Interactions with Transcription Factors, Differential Gene Expression and 
Co-expression Analysis on Breast Invasive Carcinoma Dataset (In preparation for submission 
to peer reviewed journal). 
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Chapter 5: Zhao Yuan, Rahmad Akbar, Volkhard Helms, and Ruzianisra Mohamed. Evaluation 
of Protein Pocket Identification Tools on Protein-Ligand Complexes (In preparation for 
submission to peer reviewed journal). 
 
1.4 Thesis Organization 
The structure of the thesis is as follows: 
 Chapter 2 provides general introduction to biological background and computational 
methods such as proteins, protein-protein and protein-ligand interactions, protein pocket 
identification algorithms, transcription factors, promoters, gene expressions, differential 
gene expression analysis and co-expression analysis. 
 Chapter 3 will discuss the topic on compositions of overlapping protein-protein and 
protein-ligand interfaces. 
 Chapter 4 will show the study on STIM and ORAI genes, interactions with transcription 
factors and differential gene expression and co-expression analysis on a dataset of breast 
invasive carcinoma. 
 Chapter 5 will discuss the topic of evaluation of seven protein pocket identification tools 
on a dataset of 167 protein-ligand complexes. 
 Chapter 6 summarizes the results of the projects and provides conclusions with regard to 
the aims of the studies and contributions made and present the future works. 
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Chapter 2 
 
Biological Background and Computational Methods 
 
In this chapter, we present the background on the biological concepts and computational 
methods relevant to this thesis. We also briefly describe the publicly accessible biological 
databases, tools, and packages that were used in this thesis. 
 
2.1 The Nature of Protein  
Proteins rarely act by themselves and in most cases in order to function in biological systems, 
they work in groups which known as protein complexes. Protein complexes perform many 
important tasks within biological cells such as catalyzing metabolic reactions, replicating DNA, 
and transporting molecules from one place to another. Being workhorses that assist many 
biological processes, their detection is needed to increase our knowledge about cellular 
organizing and function. Generally, a protein consists of a sequence of 20 amino acids (also 
known as residues) which are linked together through peptide bonds, forming a polypeptide 
chain known as the primary structure. The primary structure forms secondary structural 
elements, for example alpha helices and beta sheets through hydrogen bonds, which interact to 
form the tertiary structure via protein folding. The tertiary structure may combine with another 
to construct a quaternary structure. 
 
2.2 Protein-Protein Interactions, Protein-Ligand Interactions, and Protein Interfaces 
As mentioned above, proteins play major roles in almost all biological functions. Most of the 
molecular processes are based on molecular machines which are composed of a large number 
of proteins and bind to each other through protein-protein interactions. The interactions of 
proteins are determined and usually mediated by their interfaces [9]. Protein interfaces are 
defined as binding sites of certain patches on each of the two protein’s surface, which enables 
the interaction between two proteins. The characteristics of the protein-protein and protein-
ligand interfaces are important to describe binding principles and provide clues about 
algorithms for binding site prediction. One of the most important aims in interface studies is to 
identify properties which may distinguish residues at binding sites from the rest of the protein 
surfaces. A few studies showed that interfaces are rather large, planar or well packed depending 
on the type of the interactions [10,11]. 
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Due to the importance of protein interfaces in mediating protein-protein and protein-
ligand interactions, various studies have analyzed protein interfaces. The analysis of three 
dimensional (3D) protein structures revealed that protein interfaces are composed of buried 
cores which are surrounded by partially accessible rims [12,13]. Additionally, the size of the 
interface patches ranges between 400 and 1600Å2 [12]. 
Interestingly, PPI interfaces contain small regions called “hot spots” that contribute the 
most to the total binding energy [10,14,15]. A powerful experimental approach named alanine 
scanning mutagenesis is used to identify hot spot regions by successively mutating each 
interface residue to alanine. Those residues are termed hot spots where mutation into alanine 
leads to a decrease in binding free energy by more than 2.0 kcal/mol [16]. Since hot spots by 
definition make up the largest contribution to the binding energy, the ability to predict hot spots 
is important to identify, analyze and lead to targets for drug binding sites. To circumvent the 
required time and costs and the experimental uncertainty whether protein mutants will properly 
express and purify, several computational methods have been designed and used to predict hot 
spots. They typically either use energy based methods to calculate the energetic contributions 
of residues [17,18], solvent accessible surface area (SASA) [19], and sequence conservation 
based approaches [20].  
 
2.3 Types of Protein Interactions 
Studies  showed that many factors are influencing the classification of protein interactions into 
different types of interactions [10,21]. The most basic classification of interactions is based on 
the composition of the protein complex. For example a complex consisting of identical proteins 
is termed homo-oligomer (e.g. homodimer complex). Usually, homo-oligomers are very stable 
permanent protein structures such as in the case of homodimer (two proteins) complexes [10]. 
On the other hand, a complex made of non-identical proteins is defined as hetero-oligomers 
(e.g. heterodimer complex) [22]. Then, protein interactions can be further grouped into obligate 
or non-obligate depending on the lifetime of the interactions [22,23]. Obligate complexes only 
exist in the bound form. Components of non-obligate complexes such as antibodies are also 
stable in the unbound form. Based on their binding affinity, the interaction can be considered 
to be permanent or transient. Generally, all obligate interactions are permanent, however not 
all permanent interactions are obligate. Non-obligate and transient protein interactions usually 
have lower binding affinities. The transient interactions are subdivided into weak and strong 
transient. The strong transient ones include protein interactions that shift from an unbound or 
weakly bound state to a strongly bound state. This is frequently stimulated by an effector 
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molecule. Figure 2.1 shows the classification of protein interactions. The protein interaction 
types depend on the situation and cellular process. Therefore, it is importance to understand 
protein-protein interaction types and the effects they have on certain biological processes.  
 
 
Figure 2.1 Classification of different types of protein interactions.  
 
2.4 The Protein Data Bank (PDB) 
The 3D coordinates of protein structures are generally deposited in The Protein Data Bank 
(PDB) [24], the globally recognized primary depository for experimentally determined 
atomistic structure of 3D biological macromolecules. The PDB was developed in 1971 at the 
Brookhaven National Laboratories containing a set of seven protein structures. Then, in 1998, 
the PDB moved under management of the Research Collaboratory for Structural 
Bioinformatics (RCSB) at the Rutgers University, New Jersey (http://www.rcsb.org/pdb/). 
Since early 1990’s, the number of 3D structures deposited in the PDB has been increasing 
exponentially. As for 16 May 2016, the PDB stores 118748 structure of biological 
macromolecules of which more than 92% are proteins, 2% nucleic acid complexes, 4% protein-
nucleic acid complexes and 0.02% other complexes. 99% of the structures were determined by 
X-ray crystallography (89%) and by Nuclear Magnetic Resonance (NMR) Spectroscopy 
(10%). 1022 structures were solved with electron microscopy, 95 hybrid and 196 by other 
methods.  The PDB also stores 20955 ligands which interact with the proteins (protein-ligand 
complexes).  
The PDB is the primary resource to study the diversity of protein-protein (PP) and 
protein-ligand (PL) interactions. Thus,  some secondary databases have been developed to 
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assist the research on  PP interactions such as the Biological General Repository for Interaction 
Datasets BioGRID (thebiogrid.org) [25,26] which stores data of small molecules modulating 
protein–protein complexes, the Molecular INTeraction database (MINT) 
(mint.bio.uniroma2.it/mint/Welcome.do) [27], the Biomolecular Interaction Network Database 
(BIND) (http://bind.ca) [28], the Database of Interacting Proteins (DIP: http://dip.doe-
mbi.ucla.edu) [29], the IntAct molecular interaction (IntAct) database (www.ebi.ac.uk/intact/) 
[30], the ABC database (http://service.bioinformatik.uni-saarland.de/ABCSquareWeb/) [31], 
and the database of structurally defined protein interfaces named PIBASE 
(http://pibase.janelia.org/pibase2010/queries.html) [32].  
On the other hand, the high-quality databases of PL interactions can assist the field of 
structure-based drug design to develop the best computational tools. There are several publicly 
available databases such as the Timbal database (http://mordred.bioc.cam.ac.uk/timbal) [33], 
the Mother of All Database (MOAD) (http://bindingmoad.org) [34,35], the 2P2I database 
(http://2p2idb.cnrs-mrs.fr) [36], the PDBbind 
(http://sw16.im.med.umich.edu/databases/pdbbind/index.jsp) [37], the BindingDB database 
(www.bindingdb.org) [38,39], and Relibase 
(http://relibase.ccdc.cam.ac.uk/account_utilities/login_form.php) [40]. The ABC and PIBASE 
databases also stored data on PL interactions. 
 
2.5 Protein Pockets 
The accurate prediction of protein pockets from a 3D protein structure is an important issue for 
structure-based drug design [41,42] which can elucidate protein functions [43]. The basic 
principle of molecular interactions was proposed by Emil Fischer in 1894, who stated that 
ligand binding to proteins follows a “lock and key” mechanism [44]. These interactions often 
occur in particular sites on protein surfaces (binding sites). These binding sites can be 
distinguished from other parts of the protein surface by their unique characteristics as such the 
electrostatic properties and the size of a cavity on the protein surface [45]. Additionally, in a 
single protein there can be many pockets and the sizes of ligands are varying. They can be as 
small as ions or large polymers. Figure 2.2 shows an example of a pocket identified by the 
protein pocket identification tool GHECOM, that overlap with the ligand dysiherbaine bound 
to human glutamate receptor, GluR5 (PDB ID: 3FV1). 
Generally, clinically approved drugs are classified into two broad classes (i) small 
molecules which typically comprise of <100 atoms with a molecular mass of <1,000 Da and 
(ii) biologics such as antibodies, modified nucleic acids, peptides, and vaccines [46]. The small 
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molecules usually traverse cellular membranes before they can reach intracellular target 
molecules and work on a relatively limited surface area. On the other hand, biologics generally 
interact with a large surface area that contains multiple interaction sites. They are also larger in 
sizes which restrict their mode of delivery and pose more challenges in drug design.  
 
Figure 2.2 Pocket (orange sphere) identified by the protein pocket identification tool 
GHECOM that overlaps with the ligand dysiherbaine (red sticks) bound to human glutamate 
receptor, GluR5 (PDB ID: 3FV1). The figure was generated using PyMOL Molecular Graphics 
System [47].  
 
2.6 Computational Methods for Identification of Protein Pockets 
As the experimental identification of a binding site is not always feasible, as alternative 
computational protein pocket identification methods are required. Nowadays, many 
computational approaches for protein pocket identification have been developed which greatly 
accelerate drug discovery and protein designs. These protein pocket identification tools and 
algorithms fall into five different categories according to the methods applied (i) geometry 
based, (ii) energy based, (iii) evolution based, (iv) blind docking, and (v) combined approaches 
[48]. Geometry based methods can be grouped into three subcategories (i) grid system 
scanning, (ii) probe sphere filling, and (iii) based on the alpha shape theory [49,50]. In the 
following sections these methods are introduced in more details.  
 
2.6.1 Geometry based Methods 
Geometry based methods aim to identify solvent accessible regions that are located in surface 
cavities and clefts by the analysis of geometric criteria [48]. These approaches have been 
popular for years because they appear to exhibit good performance in the identification protein 
pockets. They were reported to predict almost 95% of the known binding sites. At a fast 
computational speed and they are robust in handling cases of structural variations or missing 
atoms/residues in the protein complexes [51]. Generally, geometry based methods are based 
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on the hypothesis that the ligand binding site are represented by the largest pocket [52–54]. 
Although these methods only considered the largest pocket, in reality this is not always the 
cases. Therefore, these methods have been further improved and new algorithms of prediction 
have been developed. In the following subsections the subcategories of geometry based 
methods are introduced in more detail. 
 
2.6.1.1 Grid System Scanning  
Grid based methods are a subcategory of geometry based methods that use a grid to define the 
molecular surface. These methods typically focus on the buriedness of grid points and the 
protein surface [54,55]. For example, DogSiteScorer is a grid based method. When tested on a 
dataset of 1069 structures, it achieved prediction accuracies more than 80% [56]. Generally, 
the initial step in the DoGSiteScorer process is the prediction of pockets on the protein surface 
based on the coordinates of the protein heavy atoms. A grid is spanned around the protein and 
grid points are labelled according to their spatial overlap with protein atoms. Then, the 
difference of Gaussian (DoG) filter is applied to the grid to identify the position of a cavity on 
the protein surface. Next, these positions are clustered to potential subpockets based on a 
density threshold. Finally, pockets are identified as the collection of merged neighbouring 
subpockets [48,56]. On the other hand, DEPTH [57,58], GHECOM [49], PocketDepth [59], 
and PocketPicker [55] also implement grid system scanning methods.  
 
2.6.1.2 Probe Sphere Filling Methods 
Probe sphere filling methods identify protein pockets by generating a set of probe spheres to 
fill cavities in a protein. Those regions containing the largest number of spheres are defined as 
pockets. In addition, these approaches use different types of probes such as (i) gap sphere [60], 
(ii) rotating probe, (iii) multiscale probe [49], (iv) the combination of big and small probes 
[61], and (v) probes placed tangential to triplets of protein atoms [62]. For example, SURFNET 
[60] and IsoMif [63] are representatives of these methods.  
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2.6.1.3 Alpha Shape Methods 
In the1990s, the studies by Edelsbrunner and co-workers led to the development of new 
methods based on the alpha-shape theory [64,65]. The accuracy of the alpha-shape methods is 
influenced by the alpha values. The Automatic Protein Pocket Search (APROPOS) [66], the 
Computed Atlas of Surface Topology (CAST) [67], and Fpocket [68] are tools that implement 
alpha shape methods. For instance, CAST applied alpha shape methods to compute a 
triangulation of the protein surface atoms. This tool uses the discrete flow concept by allowing 
the small triangle flow to the neighbouring bigger triangles which act as “sinks” that later 
collect excess flow from neighbouring empty triangles. The collection of empty triangles is 
defined as the protein pocket [67].  
 
2.6.2 Energy based Methods 
Energy based methods rely on the assumption that the potential binding sites are characterized 
by binding energies which are different from the rest of the protein surface. Usually, these 
methods uses simple van der Waals (vdW) probes to locate the grid points around the protein 
surfaces and calculate interaction energies between the probe and a protein. The protein pockets 
are defined only by the energetic features. For examples, ProACT2 [69,70] and Q-SiteFinder 
[71] are tools that apply energy based methods to predict protein pockets. 
 
2.6.3 Evolution based Methods 
Evolution based methods also known as sequence based evolutionary conservation methods, 
are based on the assumption that functionally important residues of proteins are typically 
conserved during the evolution because of natural selection and these functional areas are 
mainly the protein pockets. Generally, the degree of conservation at each amino acid site is 
divided into two categories (i) slowly evolving sites which refer to evolutionarily conserved 
and (ii) rapidly evolving sites [72]. Based on this, several tools have been developed such as 
ConSeq [73], ConSurf [72], and a new version of ConSurf called Consurf 2010 [74] to identify 
the functional areas of unknown proteins by comparing their amino acid sequences to the 
already known amino acid sequences of proteins. These methods are fast, robust, and require 
only a protein sequence to predict the binding sites. Exceptions to this are the methods by de 
Rinaldis et al. 1998 [75] and siteFINDER|3D [76]. 
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2.6.4 Blind Docking and Molecular Dynamic Methods 
In addition to methods mentioned above, molecular dynamics (MD) and blind docking 
algorithms are also considered as useful methods to identify protein pockets. These approaches 
are most practical in cases where the ligand that binds in the target protein is known, but the 
binding site is unknown and requires the 3D-structure of the protein. Generally, MD 
calculations use two different approaches which are based on two situations (i) mobility of 
water molecules and (ii) long scale MD simulations to find the correct binding site of an already 
known active ligand. For example, a representative for this methods is molecular-docking 
binding site finding (MolSite) [77]. On the other hand, blind docking methods work by 
scanning the entire surface of the protein target to identify binding sites and modes of peptide 
ligands [78]. AnchorDock [79] is a representative of blind docking methods. 
 
2.6.5 Combined Approaches 
So far, apparently none of the methods described above performed in a way which can set as a 
standard or that is widely accepted as benchmarking method to identify protein pockets 
accurately. Several of the existing methods are often unsuccessful in certain types of cases, in 
which the algorithms are not able to take into account correctly or adequately all properties of 
the target site and did not work for all the entries in the dataset [80,81]. Furthermore, improving 
the existing algorithms does not necessarily can produce better predictions results. Thus the 
idea of extending the methods in other ways which aim to reduce the weaknesses of other 
algorithm appears promising. Consequently, the combination of two or more methods seems 
to be a good solution to improve the identification of protein pockets. 
The first attempt of combined approaches was started by a study of Del Sol Mesa and 
co-workers (2003) [82]. They combined three separate evolution based methods but did not 
combine different types of approaches. Later, a study by Huang B et al., 2009 [83] introduced 
the MetaPocket tool which uses and combines the four methods LIGSITEcs [84], PASS [62], 
Q-SiteFinder [71], and SURFNET [60] to predict protein pocket binding sites. The method was 
tested on two different datasets of 48 unbound/bound structures and 210 bound structures. The 
results showed a success rate of 70 to 75%. Two years later, Zhang et al. and co-workers 
introduced MetaPocket2.0 [85].  By applying these combined approaches to the same datasets, 
the results increased by 5% compared to the previous study.  
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2.7 Transcription Factors, Promoters, Motifs, and Position Weight Matrix (PWM) 
2.7.1 Transcription Factors and Promoters  
The information within a gene is expressed by the cellular processes of transcription and 
translation. Transcription factors are regulatory DNA-binding proteins which play major roles 
in the regulation of gene expression. Previous studies noted that the larger total number of 
transcription factors reflects the larger number of genes in the genome of an organism which 
results in a larger size of the genome [86,87]. Single transcription factor or transcription factor 
complexes bind to the promoter region of the coding sequence which influencing RNA 
transcription. In addition, transcription factors can regulate gene expression by either activating 
or repressing gene transcription.  
On the other hand, promoters are defined as the genomic regions that are located 
5’upstream of the transcription start site (TSS) of genes. Promoters are the important element 
of expression vectors as they control the attachment of RNA polymerase and required to recruit 
the transcription initiation complexes and initiate transcription. There is no accurate definition 
of promoter length. Promoter binding is different in bacteria compared to eukaryotes as in 
bacteria RNA polymerase only needs the association of protein sigma factor to bind to the 
promoter. In contrast, eukaryotes require several transcription factors for the binding of RNA 
polymerase II to the promoter. Usually the complex consists of specific TFs, general TFs, co-
factors, and RNA polymerase II [88]. Transcription does not only depend on co-factors and 
TFs and their ability to work together, but also on the structure of the chromatin. Additional 
mechanisms that also control gene expression are RNA interference, methylation and 
acetylation. The EPDnew database is one of the several publicly available resources of species-
specific databases of experimentally validated promoters [89].  
 
2.7.2 Motifs and position weight matrix (PWM)  
Transcription factor binding sites (TFBSs) are the specific recognition sites in the DNA 
sequence for a given transcription factor. These binding sites are often referred to as 
occurrences of the motif for the corresponding TF. Nowadays, there are several approaches for 
the genome-wide detection of TFBSs such as (i) computational approaches which are based on 
the DNA sequence-based analysis and (ii) experimental approaches, which are nowadays based 
on chromatin immunoprecipitation (ChIP) and DNaseI HS-based technologies.  
A position weight matrix (PWM) is a common way of representing patterns in 
biological sequences. It consists of a stack of letters representing each nucleotide at each 
position and the height of each letter is proportional to its value in the PWM. In addition, the 
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sequence logos are regularly used to visualize count or frequency matrices. Figure 2.2 shows 
an example formation of PWM and the resulting sequence motif for eight known genomic 
binding sites in three genes HEM13, ANB1 and ROX1 from Saccharomyces cerevisiae. PWMs 
and sequence logos are available in several databases such as the JASPAR [90], HOCOMOCO 
[91], and TRANSFAC [92]. In this thesis, we identified the putative TFBS in the promoter 
regions of human STIM and ORAI genes. The description of STIM and ORAI genes are 
discussed in the Introduction section (4.1) of Chapter 4.   
 
Figure 2.3 Example of formation of position weight matrix (PWM) and sequence motif. (A) 
Shown are eight known genomic binding sites in three Saccharomyces cerevisiae genes 
(HEM13, ANB1 and ROX1). (B) Frequencies matrix of nucleotides at each position. (C) 
Sequence logo used to visualize count at each position. (D) Sequence logo to represent the 
frequencies scaled relative using the information content at each position. (E) Energy 
normalized logo using relative entropy to adjust the GC content in S.cerevisiae. The figures 
were taken from [93,94]. 
GC content, guanine-cytosine content.  
 
2.8 Gene Expression, Differential Gene Expression, and Co-expression Analysis 
2.8.1 Gene Expression 
The high-throughput sequencing technologies (HTS) are the most common approaches used in 
genomic studies which later involve statistical analysis to measure quantitative differences 
between experiments. It is important to analyze RNA expression levels (also known as RNA-
seq data) to detect which genes that are differentially expressed across a group of samples. 
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Nowadays, there have been active efforts due to the advent of sequencing technologies with 
reduced costs that produce detailed profiling of gene expression levels, which are  important in 
life sciences fields and clinical use [95]. Furthermore, the RNA-seq technology has been used 
to study complex transcriptomes and has assisted identification of levels of transcripts and 
isoforms, translocation events, sequence variations (for example SNPs) in the transcribed 
regions and post-transcriptional base modification.  
Hence, various statistical approaches and tools have been developed such as differential 
expression analysis, random effects, gene set enrichment, gene set testing, and co-expression 
analysis to analyze the large datasets of genome-wide gene expression experiments. In this 
thesis, the differential gene expression analysis, co-expression analysis and differential 
interactions networks was performed using a dataset of breast invasive carcinoma (BRCA) 
obtained from the online data portal, The Cancer Genome Research (TCGA) (see Chapter 4).   
 
2.8.2 Differential Gene Expression Analysis 
The rapid growth of high-throughput technologies and publicly available datasets of RNA 
expression levels has motivated many studies to develop statistical algorithms that implement 
various approaches for normalization and differential gene expression analysis such as edgeR 
[96], DESeq [97], DESeq2 [98], PoisssonSeq, baySeq, and linear models for microarray data 
(limma). Generally, differential gene expression analysis of RNA-Seq data consists of three 
steps such as normalization of counts, parameter estimation of the statistical model and 
statistical tests for different expression.  
 
2.8.2.1 DESeq, DESeq2, and edgeR Packages  
DESeq, DESeq2 the extendable version of successful DESeq method and digital gene 
expression in R (EdgeR) are widely used Bioconductor packages for differential expression 
analysis of RNA-Seq and ChIP-Seq count data. These packages are very popular among user 
with biological background because they are easy to use, well documented and perform the 
best in replicated experiments. Generally, these statistical methods are based on the negative 
binomial distribution. Moreover, these packages have similar steps to perform differential 
analysis for count data. However they differ in several aspects such as (i) their look and feel, 
(ii) default normalization for example, edgeR applies the trimmed mean of M values and 
DESeq applies a relative log expression approach, and (iii) the application of dispersion 
estimate [99]. Typically, edgeR uses moderates individual dispersion estimates toward a 
trended-by-mean estimation [96]. A study by Dillies et al. 2013 [100] showed that the 
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normalization methods of edgeR and DESeq2 packages outperforms other approaches either 
in the case of expressed RNA repertoires that vary across biological conditions or in the 
presence of highly expressed genes. On the other hand, for the quality control step, clustering 
and Principal Component Analysis (PCA) can be used to assess the structure of the dataset.  
In differential gene expression analysis, the False Discovery Rate (FDR) was used as a 
multiple testing correction approach. This was introduced by Benjamini and Hochberg (BH) in 
1995 [101]. Multiple testing corrections adjust the p-values obtained from a large number of 
hypotheses testing to correct the occurrence of false positives. The FDR is defined as the 
expected proportion of falsely rejected null hypotheses among all rejected null hypotheses.  
   𝐹𝐷𝑅 = 𝐸 (
number of falsely rejected null hypotheses
number of rejected null hypotheses
)                              (2.1) 
 
For example, a threshold of 0.02 FDR indicates that only two false positives are expected in 
100 predictions. DESeq2 computes a q-value (FDR adjusted p-value) for each gene and uses it 
as the threshold to identify differentially expressed genes.  
 
2.8.3 Co-expression Analysis 
Generally, gene co-expression analysis is used to detect gene pairs that are coordinated in their 
expression profiles and to explore network characteristics of complex traits. In addition, gene 
co-expression network differential analysis is designed to assist biologists in many applications 
such as discovering protein-protein interaction relationships, predicting new gene functions, 
pathways, and identifying disease biomarkers or genes. In this network nodes represent genes 
and edges link two genes to show to what degree this pair of genes is co-expressed across 
several samples. The edges are based on correlation coefficients between each gene pair, where 
higher correlation means a higher probability of existing co-functionality between them. 
Recently, several computational approaches have been developed for the co-expression 
analysis and networks such as the Average Specific Connection, Differential Coexpression 
profile (DCp) [102], Differential Coexpression enrichment (DCe) [102], Differential 
Correlation in Expression for meta-module Recovery (DICER) [103], DiffCoEx [104], Log 
Ratio of Connections [105], and the Weighted Gene Co-Expression Network Analysis 
(WGCNA) [106]. For example, the popular R-package WGCNA has been used to analyze high 
dimensional data, distinct biological states and complex diseases. This approach identifies 
candidate genes relevant to a particular process of interest, construction of networks, module 
identifications, calculation of topological properties and visualizations [106]. The WGCNA 
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package does not only concentrate on the individual gene expression, but it also focuses on 
modules of the genes which provide the relationships between modules [107]. In this thesis, 
we applied the WGCNA package for our co-expression analysis and differential interaction 
networks analysis. 
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Chapter 3 
Composition of Overlapping Protein-Protein  
and Protein-Ligand Interfaces 
 
This chapter is based on the following publication: 
Ruzianisra Mohamed, Jennifer Degac, and Volkhard Helms. Composition of Overlapping 
Protein-Protein and Protein-Ligand Interfaces. PloS One. 2015 Oct 30;10 (10):e0140965. doi: 
10.1371/journal.pone.0140965 [108]. 
 
My contribution was to write the manuscript, designed the research project and analyzed the 
results together with the co-authors Jennifer Degac and Volkhard Helms. The calculations were 
performed by me and Jennifer Degac.   
 
Abstract 
Protein-protein interactions (PPIs) play a major role in many biological processes and they 
represent an important class of targets for therapeutic intervention. However, targeting PPIs is 
challenging because often no convenient natural substrates are available as starting point for 
small-molecule design. Here, we explored the characteristics of protein interfaces in five non-
redundant datasets of 174 protein-protein (PP) complexes, and 161 protein-ligand (PL) 
complexes from the ABC database, 436 PP complexes, and 196 PL complexes from the 
PIBASE database and a dataset of 89 PL complexes from the Timbal database. In all cases, the 
small molecule ligands must bind at the respective PP interface. We observed similar amino 
acid frequencies in all three datasets. Remarkably, also the characteristics of PP contacts and 
overlapping PL contacts are highly similar. 
 
Keywords: Atomic contact, protein interface, protein-ligand interaction, protein-protein 
interaction, and amino acid composition. 
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3.1 Introduction  
Protein-protein interactions (PPIs) play major roles in many biological processes such 
as bioenergetics, immune response, signal transduction, structural organization, and apoptosis 
[10,109]. Recently, PPIs also became a promising new target for therapeutic intervention. 
Unlike established pharmaceutical efforts that are directed, for example, at enzymes, G-protein 
coupled receptors (GPCR), or ion-channels, PPIs are challenging subjects because there are 
usually no convenient natural substrates that can be exploited as starting points for small-
molecule design. Moreover, the lack of information about particular interface residues 
determining the affinities and specificities at such interfaces makes it quite hard to design 
compounds that are capable of interfering with PPIs. Hence, there is a strong need to 
characterize the properties of protein interfaces that may also bind small-molecule ligands and 
the underlying molecular principles of contacts they are involved in.  
The Protein Data Bank (PDB) [24] is the primary resource for elucidating the diversity 
of atomic contacts in protein-protein (PP) and protein-ligand (PL) interactions. Many statistical 
analyses of molecular interactions have been done based on this resource [1, 4–6]. Furthermore, 
some secondary databases that are derived from the PDB have been created to assist the 
integrated research on PP and PL interactions. Examples for this are the Timbal database 
(http://mordred.bioc.cam.ac.uk/timbal) which stores data of small molecules modulating 
protein–protein complexes [33], the Mother of All Database (MOAD) which contains data on 
ligand-protein binding (http://bindingmoad.org) [8-9], the 2P2I database of structures of PP 
complexes with known small molecule inhibitors (http://2p2idb.cnrs-mrs.fr) [36], the 
Analysing Biomolecular Contacts (ABC) database (http://service.bioinformatik.uni-
saarland.de/ABCSquareWeb/) [31], and the database of structurally defined protein interfaces 
named PIBASE (http://pibase.janelia.org/pibase2010/queries.html) [32]. One important aim in 
interface analysis is to identify properties which may distinguish binding residues from the rest 
of the protein surfaces.  
Although protein-protein interfaces are rather large, planar and well packed depending 
[10,11], some parts of these interfaces termed overlap or bifunctional regions may bind both to 
small-molecule ligands and to proteins. The remaining regions of the interface which bind only 
to either protein or ligand are called non-overlap or monofunctional regions. Davis and Sali 
[113] found that bifunctional regions were enriched in tyrosine and tryptophan residues and 
depleted from alanine, isoleucine, leucine and valine when compared to monofunctional 
positions. Walter et al. [114] found for a different dataset that the overlap regions were mostly 
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found in pockets and some of their surfaces were exposed to the solvent. Koes and Camacho 
[115] used Small Molecular Inhibitor Starting Points (SMISPs) from PL and PP complexes in 
the PDB to train statistical classifiers for predicting such SMISPs.  
In this study, we analyzed the residue-residue and atomic contact frequencies and 
propensities of five non-redundant datasets i) 174 protein-protein and ii) 161 protein-ligand 
complexes from Walter [114], iii) 436 protein-protein and iv) 196 protein-ligand complexes 
from the PIBASE database [32], and v) a dataset of 89 protein-ligand complexes from the 
Timbal database [33]. Our main research question was to find out whether small molecule 
ligands have similar physio-chemical features as protein binding interfaces when they bind at 
overlapping PP/PL binding interfaces and this was indeed found to be the case. 
 
3.2 Material and Methods 
3.2.1 Datasets 
Non-redundant datasets from three different databases were used to investigate the composition 
of protein interfaces. The first pair of datasets consists of 174 PP complexes and 161 PL 
complexes compiled by Walter et al. [114] from the ABC database [31] (see Tables A and B in 
Supplementary Information Table 3.1). 25 entries of this PL dataset had been updated in the 
PDB in the meantime. We changed 22 previous ligand names to the current ligand names in 
the PDB files and removed 14 PDB files because they contain modified residues that were 
wrongly recognized as ligands before [114]. As described by Walter et al. [114], these 
complementary PP and PL datasets fulfill the following criteria: (i) PP: PL pairs represent pairs 
of complexes, where one protein may bind either a second protein or a small molecule ligand 
at the same interface, (ii) every pair of the dataset is represented as (Pi1, Pi2): (Pi3, Lj), where 
Pi1, Pi2 and Pi3 are three proteins and Lj is a small molecule ligand, (iii) Pi1 and Pi3 share at 
least 40% sequence identity, and (iv) the aligned positions in the binding interfaces of Pi1–Pi2 
and Pi3 – Lj have at least two residues in common.  
The same criteria of (Pi1, Pi2):( Pi3, Lj) pairs of PP and PL complexes from Walter et 
al., were then applied to the datasets of PP and PL complexes from the PIBASE database [32]. 
To avoid redundancy among these complexes, we clustered the PL complexes using the CD-
Hit program [116,117] with the same sequence identity cut-off of 40%. Within a cluster, we 
selected the representative PP:PL pair with the highest identity score of the interface residues. 
Additionally, we discarded clusters which contained only sequences with fewer than 40 amino 
acids. The final pair of datasets comprises 436 PP complexes (Table C in Supplementary 
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Information Table 3.1) and 196 PL complexes (Table D in Supplementary Information Table 
3.1).  
Interactions where both interacting chains have > 90% sequence identity are defined as 
homodimer complexes and the remainder as heterodimer complexes. As a result, the PP 
complexes from the ABC dataset comprised 94 homodimer complexes and 80 heterodimer 
complexes (see Tables A and B in Supplementary Information Table 3.2). The PP complexes 
from the PIBASE dataset were grouped into 335 homodimer complexes and 101 heterodimer 
complexes (see Tables A and B in Supplementary Information Table 3.3). 
The fifth dataset was extracted from the table of PDB entries in the Timbal database 
(see Table E in Supplementary Information Table 3.1). First, the 1695 entries in the current 
version of the Timbal database were filtered by removing complexes containing ligands that 
are annotated to act as stabilizers. Then, the CD-Hit program was applied to remove 
redundancy among the protein chains of the complexes with the sequence identity cut-off of 
40%. We also eliminated clusters of proteins with fewer than 40 amino acids. This gave a final 
dataset of 89 protein-small molecule complexes.  
Data from the ABC, PIBASE, and Timbal databases was retrieved by using MySQL 
queries, Java, Biojava [118] and analyzed with the R software (http://www.R-project.org).  
 
3.2.2 Surface and Interface Residues 
The solvent accessible surface area (SASA) was calculated using the NACCESS program 
[119]. As surface residues we considered those residues with a SASA value larger than zero. 
Labeled as interface residues were those residues that are within a radius of either 3 Å, 4 Å or 
5 Å of any residue of the binding partner. Figure 3.1 shows a schematic diagram how we 
determined the interface and the remaining surface of PL complexes.  
 
 
Figure 3.1 Schematic illustration of a PL complex illustrating the interface (black border) and 
the remaining surface regions. PL, protein-ligand. 
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3.2.3 Classification of the Amino Acids 
The standard classification according to the Eisenberg hydrophobicity scale [120] was used to 
classify amino acids into four categories: hydrophobic (Ala, Ile, Leu, Met, Phe, Pro, Val), 
charged (Arg, Asp, Glu, Lys), polar (Cys, Asn, Gln, His, Ser, Thr, Trp, Tyr), and Gly. 
 
3.2.4 Interface Residue Propensities 
Residue interface propensities were calculated for the homodimeric and heterodimeric protein-
protein complexes of the ABC and PIBASE datasets and for the protein-ligand complexes of 
the ABC, PIBASE and Timbal datasets. These propensities give a measure of the relative 
importance of different amino acid residues in the interface, compared with the surface as a 
whole. The propensities were calculated with the following formula: 
 
𝐼𝑛𝑡𝑒𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑝𝑟𝑜𝑝𝑒𝑛𝑠𝑖𝑡𝑦 𝐴𝐴𝑗 = (
∑ 𝑖𝑛𝑡𝑒𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 𝑜𝑓 𝑡𝑦𝑝𝑒 𝑗
∑ 𝑎𝑙𝑙 𝑖𝑛𝑡𝑒𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠
) (
∑ 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 𝑜𝑓 𝑡𝑦𝑝𝑒 𝑗
∑ 𝑎𝑙𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠
)⁄          (3.1) 
 
An interface residue propensity of >1.0 indicates that a residue type occurs more frequently in 
interfaces than on the protein surface in general.  
 
3.2.5 Contacts between Amino Acids of the Two Proteins  
For every PP complex, we counted the observed number of contacts between amino acids of 
the first protein and amino acids of the second protein. A contact exists between two residues 
of these proteins if any residue of the first protein is within a distance threshold of 5.0 Å from 
the other protein. This was represented in a 20 x 20 table. From the 400 observed counts of 
amino acid pairs in the two datasets of protein-protein complexes, we derived normalized pair 
frequencies with the following formula:  
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 =
(
∑ 𝑐𝑜𝑛𝑡𝑎𝑐𝑡𝑠 𝑜𝑓 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑝𝑎𝑖𝑟 𝑋𝑌
∑ 𝑎𝑙𝑙 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑐𝑜𝑛𝑡𝑎𝑐𝑡𝑠
)
(
∑ 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑋 𝑜𝑛 𝑠𝑢𝑟𝑓𝑎𝑐𝑒
∑ 𝑎𝑙𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 𝑜𝑓 𝑓𝑖𝑟𝑠𝑡 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
)(
∑ 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑌 𝑜𝑛 𝑠𝑢𝑟𝑓𝑎𝑐𝑒
∑ 𝑎𝑙𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 𝑜𝑓 𝑠𝑒𝑐𝑜𝑛𝑑 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
)
       (3.2) 
 
Here, XY is the number of observed contact pairs between residues X and Y across the 
interface, X is the count of amino acid X in the first protein and Y is the count of amino acid Y 
in the second protein.  
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3.2.6 Atom Contacts in Protein-protein and Protein-ligand Complexes 
In protein-protein and protein-ligand complexes, we considered two surface atoms belonging 
to separate molecules to be in contact and labeled them as interface atoms if the distance 
between them is less than 5.0 Å. We counted contacts between all pairs of carbon (C), fluorine 
(F), nitrogen (N), oxygen (O), phosphorus (P), and sulfur (S) atoms resulting in 36 contact 
pairs. Then, the absolute counts were normalized as follows: 
 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 =
(
∑ 𝑐𝑜𝑛𝑡𝑎𝑐𝑡𝑠 𝑜𝑓 𝑎𝑡𝑜𝑚 𝑝𝑎𝑖𝑟 𝐴𝐵
∑ 𝑎𝑙𝑙 𝑎𝑡𝑜𝑚 𝑐𝑜𝑛𝑡𝑎𝑐𝑡𝑠
)
(
∑ 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝐴 𝑜𝑛 𝑠𝑢𝑟𝑓𝑎𝑐𝑒
∑ 𝑎𝑙𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑡𝑜𝑚 𝑜𝑓 𝑙𝑖𝑔𝑎𝑛𝑑 𝑜𝑟 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
)(
∑ 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝐵 𝑜𝑛 𝑠𝑢𝑟𝑓𝑎𝑐𝑒
∑ 𝑎𝑙𝑙 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑡𝑜𝑚 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
)
              (3.3) 
 
where A is the count of atom type A in the first protein (PP complexes) or protein (PL 
complexes), B is the count of atom type B in the second protein (PP complexes) or ligand (PL 
complexes) and, AB is the number of observed contact pairs between atom types A and B across 
the interface.  
According to Higueruelo et al. [121], atom type contacts were grouped into polar and 
apolar contacts as follows: For protein-protein complexes, apolar contacts exist between C…C, 
C…S and S…S (not in Cys-Cys bridges). Polar contacts involve the pairs N…O, O…O, N…N, 
O…S and N…S (from Cys). For protein-ligand complexes, apolar contacts are C…C, and 
C…S pairs whereas polar contacts are formed by the pairs N…O, O…O, N…N, O…S, N…S, 
N…F, O…F, and S…F (from Cys). 
 
3.2.7 Calculation of Polarity Ratio and Interface Atom Ratio 
The polarity ratio (PR) is a simple measure of the polarity of the interface [122]. It was defined 
as the ratio of the number of polar atoms N, O, S at the interface to the sum of all C, N, O, S at 
the interface. 
The interface atom ratio (IR) is a measure for the fraction of surface atoms that are 
located at the interface. It was calculated for the interfaces of protein-protein and protein-ligand 
complexes. Only the six heavy atom types C, N, O, S, P and F were considered in the 
calculation. IR is the ratio of the sum of all atoms at the interface to the sum of all atoms at the 
surface. 
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3.3 Results and Discussion  
PPI interfaces are known to possess particular geometric and physicochemical characteristics, 
see e.g. [10,123–125]. Comparing these features of protein interfaces to those of overlapping 
protein-ligand interfaces should aid in targeting protein-protein interaction sites. Here, we used 
the ABC, PIBASE and Timbal databases as data sources for protein interfaces and surfaces. All 
three databases are secondary database that are derived from the PDB. However, due to the 
different way of identifying overlapping PP/PL pairs, the direct overlap between the three non-
redundant datasets derived from them is fairly small. We believe that this may have resulted 
from the clustering with the CD-Hit program that selected different cluster representatives in 
each case. We found only the following redundant PP complexes 1AB8 (B-A), 1AZZ (A-C), 
1BMF (F-B), 1EYS (H-M), 1RQ8 (A-E), 1SGF (G-B) from the ABC dataset and 1AB8 (A-B), 
1AZZ (C-A), 1BMF (C-D), 1EYS (M-C), 1RQ8 (E-A), 1SGF (G-Z) from the PIBASE dataset. 
Furthermore, both datasets share the following lists of PDB IDs with same chain interactions 
1DPJ (A-B), 1P0S (H-E), and 2G2U (A-B). Similarly, there are few redundancies between 
datasets of PL complexes from ABC and PIBASE, namely 1C50 (A-CHI), 1KYN (A-KTP), 
1LBC (A-CYZ) and 1M2Z (A-BOG), respectively. There is also one overlapping member 
between the datasets of PL complexes from PIBASE and Timbal, namely the PDB ID 1AB8 
(A-FOK). Figure 3.2 summarizes the workflow of the analysis of the five datasets. The fraction 
of homodimers and heterodimers in the datasets derived from ABC and PIBASE are 54%: 46% 
and 77%: 23%, respectively. 
 
Figure 3.2 Flow chart summarizing the compilation of contacts between amino acids of the 
first protein (Pi1) and amino acids of the second protein (Pi2), atom contacts in PP and PL 
complexes, and the calculation of PR and IR.  
PP, protein-protein; PL, protein-ligand; PR, polarity ratio; IR, interface atom ratio. 
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3.3.1 Amino Acid Composition and Protein Interfaces Propensity 
Figures 3.3 and 3.4 show the percentage frequencies and propensities of amino acids at the 
interfaces of homodimeric and heterodimeric PP complexes from the ABC and PIBASE 
datasets, respectively. Figure 3.5 shows the percentage frequencies and propensities of amino 
acids at the protein interfaces of the PL complexes from the ABC, PIBASE and Timbal 
datasets, respectively. Previous studies showed that protein-protein interfaces have unique 
characteristics that distinguish them from non-interface portions of protein surfaces 
[123,126,127].  
By grouping the amino acids according to the Eisenberg hydrophobicity scale (see 
methods) we found that, hydrophobic amino acids account for 38.06% (ABC-P1-homo), 
38.87% (ABC-P2-homo), 38.81% (PIB-P1-homo) and 38.75% (PIB-P2-homo) at interfaces of 
homodimeric PP complexes compared to 35.60% (ABC-P1-hetero), 36.11% (ABC-P2-hetero), 
37.94% (PIB-P1-hetero) and 36.38% (PIB-P2-hetero) at interfaces of heterodimeric PP 
complexes (Figures 3.3A and 3.4A). This matches the general finding e.g. of Jones and 
Thornton who stated that homodimer complexes are more hydrophobic [10].  
At interfaces of both homodimeric and heterodimeric PP complexes from the ABC and 
PIBASE datasets, alanine, valine, and lysine residues are underrepresented with propensities 
lower than 1.0 (Figures 3B and 4B). One hydrophobic amino acid (leucine), one charged amino 
acid (lysine) and two polar amino acids (glutamine and threonine) have higher propensities at 
interfaces of homodimer complexes than at interfaces of heterodimer complexes of the ABC 
dataset. In the PIBASE dataset, four hydrophobic amino acids (alanine, leucine, proline and 
valine), one polar amino acid (threonine) and glycine have higher propensities in homodimer 
complexes than in heterodimer complexes.  
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Figure 3.3 Percentage frequencies and propensities of amino acid residues at protein interfaces 
of PP complexes from the ABC dataset. (A) Percentage frequencies of amino acid residues at 
protein interfaces. (B) Propensities of amino acid residues at protein interfaces.  
PP, protein-protein; ABC, ABC dataset; homo, homodimeric PP interface; hetero, 
heterodimeric PP interfaces; P1, protein interface of the first protein (Pi1); P2, protein interface 
of the second protein (Pi2).  
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Figure 3.4 Percentage frequencies and propensities of amino acid residues at protein interfaces 
of PP complexes from the PIBASE dataset. (A) Percentage frequencies of amino acid residues 
at protein interfaces. (B) Propensities of amino acid residues at protein interfaces.  
PP, protein-protein; PIB, PIBASE dataset; homo, homodimeric PP interface; hetero, 
heterodimeric PP interfaces; P1, protein interface of the first protein (Pi1); P2, protein interface 
of the second protein (Pi2).  
 
As expected, hydrophobic and polar residues make up the largest portion of protein 
interfaces. In fact, this is one of the challenges for targeting PPIs with small molecules as the 
contact surfaces between proteins typically involve many hydrophobic and polar interactions 
distributed over a large interface with buried area of ~1500 – 3000 Å2 [128]. According to the 
classification by Eisenberg, the fractions of hydrophobic, polar, charged and glycine residues 
are 36.95%, 33.38%, 22.11%, 7.56% for the first protein (Pi1), 37.70%, 32.48%, 22.35%, 
7.46% for the second protein (Pi2) of the PP complexes from the ABC dataset, 38.60%, 
30.93%, 24.09%, 6.38% for the first protein (Pi1), and 38.20%, 31.35%, 24.22%, 6.23% for 
the second protein (Pi2) of the PP complexes from the PIBASE dataset. Although there are 
minor differences between the two datasets (slightly more charged and fewer glycine residues 
in the PIBASE dataset), we found the composition to be overall remarkably similar.  
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 At the interfaces of both homodimeric and heterodimeric PP complexes from the ABC 
and PIBASE datasets, the frequencies of methionine and tryptophan at protein interfaces are at 
most 3.07%. However, both amino acids have normalized interface propensities clearly larger 
than one, suggesting that these residues play important roles and thus occur more frequently at 
protein interfaces rather than elsewhere on the protein surface. Overall, tryptophan, tyrosine 
and arginine each have propensities above 1.0 at both protein interfaces of homodimeric and 
heterodimeric PP complexes from the ABC and PIBASE datasets. This reflects that aromatic 
amino acids and arginine play important roles in protein interfaces, which is a well-known fact. 
For example, Bogan and Thorn [129] reported that hotspot regions at protein interfaces are 
enriched in tryptophan, tyrosine and arginine. Also, Jones, Marin and Thornton [130] found 
that hydrophobic residues including tryptophan and tyrosine as well as arginine are moderately 
enriched at protein interfaces compared to the whole surface. Jones and Thornton [10] reported 
that with the exception of methionine, all hydrophobic residues show a greater preference for 
the interfaces of homodimers than for those of heterocomplexes. Based on our analysis, only 
leucine is clearly enriched at homodimer interfaces. Janin, Bahadur and Chakrabarti [125] 
wrote that relative to the accessible protein surface, the interfaces are depleted in glutamic acid, 
aspartic acid, and lysine, and enriched in methionine, tyrosine and tryptophan. Our findings are 
in good agreement with this. In our case, the enriched category also includes phenylalanine, 
histidine and arginine. The underrepresented category also includes alanine, proline and valine. 
Talavera et al. [131] provided a rather recent compilation of amino acid frequencies and 
propensities, separately for homomeric and heterodimeric PP complexes. A possible concern 
about their work is that they applied a rather generous homology threshold of 80% identity. 
They found tyrosine, tryptophan, methionine, cysteine, phenylalanine, leucine, valine and 
isoleucine to be enriched at the interfaces of homo-complexes. In the case of hetero-complexes, 
cysteine fell out from this list. On the other hand, lysine, asparagine, aspartic acid and glutamic 
acid were underrepresented in homo-complexes. The same ones plus serine and glycine were 
found for hetero-complexes. 
 The distributions of the percentage frequencies and propensities of amino acids at the 
protein interfaces of the PP datasets derived from ABC and PIBASE were compared with the 
non-parametrical Friedman test as the datasets do not have a normal distribution. As suggested 
by the graphical representation of Figures 3.3 and 3.4, the ABC and PIBASE datasets do not 
differ significantly (percentage frequencies, p-value = 0.99 and propensities, p-value = 0.97).  
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 The fractions of hydrophobic, polar, charged and glycine residues at protein binding 
interfaces of PL complexes are 34.08%, 36.97%, 20.31%, 8.64% (ABC dataset), 38.25%, 
35.39%, 18.12%, 8.24% (PIBASE dataset) and 42.32%, 32.61%, 18.60%, 6.47% (Timbal 
dataset), see Figure 3.5A. Compared to PP interfaces, the ligand-contacting protein interfaces 
of the Timbal dataset contain about 5% more hydrophobic residues, and about 5% fewer 
charged residues. In contrast, the ligand-contacting protein interfaces from the ABC and 
PIBASE datasets contain 3-4% more polar residues than PP interfaces and 3-4% less charged 
residues. 
In the PL complexes of the ABC dataset, the five amino acids with the highest 
propensities found at protein interfaces are cysteine (2.20), tryptophan (2.18), histidine (1.75), 
tyrosine (1.74), and phenylalanine (1.47). In the PL complexes of the PIBASE dataset, the most 
enriched ones are tryptophan (2.25), tyrosine (1.93), phenylalanine (1.92), histidine (1.89), and 
methionine (1.66). In the PL complexes of the Timbal dataset, methione has the highest 
propensity of 1.85, followed by phenylalanine (1.78), tryptophan (1.78), histidine (1.54) and 
tyrosine (1.53), respectively. In all datasets of PL complexes, tryptophan, phenylalanine, 
histidine, and tyrosine are found most often at the protein interfaces (Figure 3.5B) 
complemented by either cysteine (ABC) or methionine (PIBASE, Timbal).  
The distributions of percentage frequencies and propensities of amino acids acids at the 
protein interfaces in the datasets derived from ABC, PIBASE and Timbal did not differ 
significantly (percentage frequencies, p-value = 0.86 and propensities, p-value = 0.96, 
Friedman rank sum test).  
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Figure 3.5 Percentage frequencies and propensities of amino acids residues at protein 
interfaces of PL complexes from the ABC, PIBASE and Timbal datasets. (A) Percentage 
frequencies of amino acids residues at protein interfaces. (B) Propensities of amino acids 
residues at protein interfaces. PL, protein-ligand; PL-ABC, PL complexes from the ABC 
dataset; PL-PIBASE, PL complexes from the PIBASE dataset; PL-Timbal, PL complexes from 
the Timbal dataset. 
 
3.3.2 Amino Acid Contacts 
The propensities of amino acid contacts in PP complexes between amino acids of the first 
protein (Pi1) and amino acids of the second protein (Pi2) were obtained by counting the 
absolute number of contacts and normalizing this number against the appearance probability 
of the two involved residues at the surface. In Figures 3.6 and 3.7, the propensity values were 
log2 transformed to ensure a balanced view of over- and under-representation. Contacts with 
high propensities were observed among residues pairs of different polarity types. In PP 
complexes from the ABC dataset, the five most over-represented interactions were found 
between the pairs of tryptophan (6.32), cysteine (4.66), phenylalanine (3.61) and histidine 
(3.50) as well as between tryptophan and phenylalanine (3.36), see Figure 3.6. In PP complexes 
from the PIBASE dataset, the five most over-represented interactions were pairs of tryptophan 
(7.50), methionine (4.34), phenylalanine (3.96), tyrosine (3.57), and cysteine (3.43), see Figure 
3.7. These results are consistent with previous studies of protein-protein interfaces that reported 
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an enrichment of contacts between cysteine, hydrophobic contacts and aromatic contacts [123, 
126, 132-134]. Further studies noticed that besides disulfide bonds and hydrophobic 
interactions, also salt-bridges contribute to stabilizing protein-protein interactions [126,132–
134]. In our analysis, contacts between lysine and negatively charged amino acids (Asp, Glu) 
are only mildly enriched (propensity 1.23 on average), whereas those between arginine and 
either Asp or Glu are about two-fold enriched (2.06), see Tables A and B in S5 File, what 
reflects the enriched of arginine at protein interfaces. The propensities of amino acid contacts 
between amino acids of the first protein (Pi1) and amino acids of the second protein (Pi2) in 
PP complexes between datasets from the ABC and the PIBASE did not differ statistically 
significantly (p-value = 0.76, Wilcoxon signed rank test).  
 
 
Figure 3.6 Amino acid pairing propensities (in log2-format) for interfaces of PP complexes 
from the ABC dataset.  
PP, protein-protein. 
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Figure 3.7 Amino acid pairing propensities (in log2-format) for interfaces of PP complexes 
from the PIBASE dataset.  
PP, protein-protein. 
 
Based on the counts of amino acids, we computed the average number of amino acid 
residues at the interfaces of the two proteins Pi1 and Pi2 of PP complexes and the Pi3 protein 
of PL complexes using three different atom distances (3Å, 4Å and 5Å). At the distance 
threshold of 3Å, both interfaces at Pi1 and Pi2 contain less than 10 amino acids on average. 
For thresholds of 4Å and 5Å, the average size of the protein interfaces is 26.22 (ABC dataset) 
and 38.69 amino acids (PIBASE dataset) (Table 3.1).  
Table 3.1 The average number with standard deviation of amino acid residues at the interfaces 
of PP complexes in the ABC and PIBASE datasets. 
 PP complexes 
 ABC dataset PIBASE dataset 
Atom distance Pi1 Pi2 Pi1 Pi2 
3 Å 7.67 ± 6.68 7.49 ± 6.85 9.61 ± 15.62 9.53 ± 15.52 
4 Å 27.17 ± 19.18 26.22 ±19.7 31.13 ± 24.53 30.76 ± 24.61 
5 Å 34.52 ± 23.31 32.8 ± 24.11 38.69 ± 27.97 38.09 ± 27.94 
PP, protein-protein; Pi1, first protein; Pi2, second protein. 
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Table 3.2 shows the average number of residues at the interfaces of Pi3 in PL complexes 
from the ABC, PIBASE and Timbal datasets. At the distance threshold of 3 Å, the average size 
of the interfaces is less than 3 amino acids for all datasets. At 4 Å and 5 Å atom distances, the 
average sizes of the interfaces are between 6.31 amino acids (ABC dataset) and 13.54 amino 
acids (Timbal dataset). Although the PL interfaces from the ABC dataset are clearly smaller 
than those from the PIBASE and Timbal datasets, the average ligand size in the ABC dataset 
(20.48 atoms without hydrogen atoms) is only slightly smaller than the average ligand size in 
the Timbal dataset (21.53 atoms) and in the PIBASE dataset (21.42 atoms), respectively. 
Table 3.2 The average number with standard deviation of amino acid residues at the interfaces 
of PL complexes in the ABC, PIBASE and Timbal datasets. 
 PL complexes 
Atom distance ABC dataset PIBASE dataset Timbal dataset 
3 Å 1.64 ± 1.93 2.58 ± 2.08 2.54 ± 2.52 
4 Å 6.31 ± 4.66 10.04 ± 4.39 9.99 ± 6.32 
5 Å 8.84 ± 5.79 13.43 ± 5.63 13.54 ± 8.06 
PL, protein-ligand. 
 
3.3.3 Atomic Contacts in Protein-protein and Protein-ligand Complexes 
In this section, we analyzed the atomic contacts in the datasets of PP and PL complexes. For 
atom pairs between the first and second proteins (Pi1–Pi2) in PP complexes and between 
protein and ligand (Pi3 – Lj) in PL complexes, we counted contacts of less or equal to 5 Å 
between six types of heavy atoms, namely carbon (C), flourine (F), nitrogen (N), oxygen (O), 
phosphorus (P) and sulfur (S). This resulted in 36 atomic pair contacts. Table 3.3 lists the 
appearance frequency of these 36 atomic contact types in PP and PL complexes from the ABC, 
PIBASE and Timbal datasets. In all datasets, the most frequent contacts are C…C (> 41%), 
O…C (> 10%), C…O (> 8%), and C…N (>7%).  
Chen and Kurgan [135] previously characterized the binding interfaces of proteins with 
small molecules, irrespective of whether they also bind to other proteins. As expected, 
interactions with organic molecules are dominated by van der Waals contacts, hydrogen bonds, 
and covalent contacts, whereas those with charged species also involve electrostatic 
interactions. Hakulinen et al. [136] argued that small molecules frequently contact 
phenylalinine, histidine, tyrosine and tryptophan residues of proteins because their aromatic 
ring carbons prefer other aromatic carbons. Both findings match well with the results of this 
analysis. The atomic contacts in PP complexes of the ABC and PIBASE datasets did not differ 
33 
 
significantly (p-value = 0.76, Wilcoxon signed rank test). Also the frequencies of the atomic 
contacts between the PL complexes of the ABC, PIBASE and Timbal datasets did not differ 
significantly (p-value = 0.11, Friedman rank sum test). 
Tables 3.4 and 3.5 list the percentage frequencies and normalized propensities of apolar, 
polar and other atomic contacts in PP complexes and PL complexes, respectively. The content 
of apolar contacts (45.52% for the PP complexes in the ABC dataset and 45.25% for the 
PIBASE dataset) and of polar contacts (13.85% vs 13.70%) is highly similar between the two 
PP datasets. In contrast, the PL complexes of the PIBASE dataset (46.45%) contained more 
apolar contacts than the Timbal dataset (44.84%) and the ABC dataset (43.04%). Concerning 
polar contacts in PL complexes, the Timbal dataset (14.71%) and the ABC dataset (14.48%) 
contain more such contacts than the PIBASE dataset (12.95%). Overall, the differences of the 
normalized propensities seem minor, among the PP and PL datasets, as well as between PP and 
PL datasets, which agrees with the findings of [135]. In all datasets, C-C contacts are slightly 
overrepresented (1.04 to 1.11 times the randomly expected number of contacts). N-N contacts 
are always more frequent (1.07 to 1.32) than O-O contacts (0.70 to 0.95). 
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Table 3.3 The percentage frequencies of the 36 atomic contact types in PP and PL complexes.  
  PP complexes PL complexes 
  
ABC 
dataset 
PIBASE 
dataset 
ABC 
dataset 
PIBASE 
dataset 
Timbal 
dataset 
Atom1a Atom2b %  %  %  %  %  
C C 44.08 44.20 41.24 44.57 43.49 
C N 10.82 10.95 8.50 9.03 7.05 
C O 10.42 10.68 12.63 11.85 8.88 
C S 0.85 0.57 0.90 0.88 1.00 
C P 0.00 0.00 0.00 0.00 0.00 
C F 0.00 0.00 0.00 0.00 0.00 
N C 8.29 8.12 5.81 5.16 5.51 
N N 2.76 2.70 1.58 1.25 1.30 
N O 2.85 2.83 2.18 1.77 1.57 
N S 0.14 0.08 0.17 0.09 0.13 
N P 0.00 0.00 0.00 0.00 0.00 
N F 0.00 0.00 0.00 0.00 0.00 
O C 10.93 11.17 13.87 12.78 15.03 
O N 4.48 4.40 4.89 4.38 6.58 
O O 3.37 3.45 4.79 4.43 4.60 
O S 0.17 0.14 0.18 0.25 0.22 
O P 0.00 0.00 0.00 0.00 0.00 
O F 0.00 0.00 0.00 0.00 0.00 
S C 0.56 0.47 0.90 1.00 0.35 
S N 0.14 0.10 0.26 0.26 0.08 
S O 0.11 0.12 0.31 0.23 0.04 
S S 0.03 0.02 0.04 0.04 0.01 
S P 0.00 0.00 0.00 0.00 0.00 
S F 0.00 0.00 0.00 0.00 0.00 
P C 0.00 0.00 0.59 0.45 1.64 
P N 0.00 0.00 0.50 0.28 1.18 
P O 0.00 0.00 0.19 0.22 0.40 
P S 0.00 0.00 0.02 0.01 0.00 
P P 0.00 0.00 0.00 0.00 0.00 
P F 0.00 0.00 0.00 0.00 0.00 
F C 0.00 0.00 0.32 0.77 0.75 
F N 0.00 0.00 0.04 0.11 0.09 
F O 0.00 0.00 0.08 0.15 0.10 
F S 0.00 0.00 0.01 0.04 0.00 
F P 0.00 0.00 0.00 0.00 0.00 
F F 0.00 0.00 0.00 0.00 0.00 
Total 100.00 100.00 100.00 100.00 100.00 
PP, protein-protein; PL, protein-ligand.  
aFor PP complexes, atom1 belongs to the first protein and for PL complexes, atom1 belongs to 
the protein. 
bFor PP complexes, atom2 belongs to the second protein and for PL complexes, atom2 belongs 
to the ligand. 
35 
 
Table 3.4 Percentage frequencies (with normalized propensity values in parentheses) of apolar, 
polar and other atomic contacts of PP complexes from the ABC and PIBASE datasets. 
 
    PP complexes 
  
  
ABC 
dataset 
PIBASE dataset 
Apolar 
contacts: 
C…C 
44.08 
(1.10) 
44.20 (1.10) 
  C…S 0.85 (2.53) 0.57 (1.91) 
  S...C 0.56 (1.82) 0.47 (1.63) 
  
S…S (not in Cys-Cys bridge) 
0.03 
(10.94) 
0.01 (6.60) 
  Total 45.52 45.25 
Polar 
contacts: 
N…O 2.85 (0.91) 2.83 (0.90) 
  O…N 4.48 (1.40) 4.40 (1.40) 
  O…O 3.37 (0.70) 3.45 (0.73) 
  N…N 2.76 (1.31) 2.70 (1.29) 
  O…S 0.16 (1.40) 0.14 (1.38) 
  S…O 0.11 (1.05) 0.12 (1.24) 
  N…S (from Cys) 0.05 (0.68) 0.02 (0.35) 
  S…N (from Cys) 0.07 (0.93) 0.03 (0.50) 
  Total 13.85 13.7 
Other 
contacts: 
C…N 
10.83 
(1.19) 
10.95 (1.20) 
  N…C 8.28 (0.91) 8.12 (0.88) 
  
C…O 
10.42 
(0.76) 
10.68 (0.78) 
  
O…C 
10.93 
(0.78) 
11.17 (0.81) 
  N…S (S not from Cys) 0.09 (1.14) 0.06 (0.86) 
  S…N (S not from Cys) 0.08 (1.08) 0.07 (1.05) 
  
S…S (in Cys-Cys bridge) 
0.002 
(0.84) 
0.003 (1.39) 
  C…P/P…C 0.00 (0.00) 0.00 (0.00) 
  C…F/F…C 0.00 (0.00) 0.00 (0.00) 
  N…P/P…N 0.00 (0.00) 0.00 (0.00) 
  N…F/F…N 0.00 (0.00) 0.00 (0.00) 
  O…P/P…O 0.00 (0.00) 0.00 (0.00) 
  O…F/F…O 0.00 (0.00) 0.00 (0.00) 
  S…P/P…S 0.00 (0.00) 0.00 (0.00) 
  S…F/F…S 0.00 (0.00) 0.00 (0.00) 
  P…P 0.00 (0.00) 0.00 (0.00) 
  P…F/F…P 0.00 (0.00) 0.00 (0.00) 
  F…F 0.00 (0.00) 0.00 (0.00) 
  Total 40.63 41.05 
  Grand Total 100 100 
PP, protein-protein. 
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Table 3.5 Percentage frequencies (with normalized propensity values in parentheses) of apolar, 
polar, and other atomic contacts of PL complexes from the ABC, PIBASE, and Timbal 
datasets. 
    PL complexes 
    ABC dataset PIBASE dataset Timbal dataset 
Apolar 
contacts: 
C…C 41.24 (1.04) 44.57 (1.04) 43.49 (1.11) 
  C…S 0.90 (2.86) 0.88 (2.82) 1.00 (2.60) 
  S…C 0.90 (1.26) 1.00 (1.14) 0.35 (0.99) 
  Total 43.04 46.45 44.84 
Polar 
contacts: 
N...O 2.18 (1.20) 1.77 (1.02) 1.57 (0.94) 
  O…N 4.89 (1.31) 4.38 (1.39) 6.58 (1.68) 
  O…O 4.79 (0.85) 4.43 (0.95) 4.6 (0.80) 
  N…N 1.58 (1.32) 1.25 (1.07) 1.30 (1.14) 
  O…S 0.18 (1.45) 0.25 (2.50) 0.22 (1.33) 
  S…O 0.31 (1.22) 0.23 (0.77) 0.04 (0.36) 
  N…S 0.17 (4.07) 0.09 (1.24) 0.13 (2.75) 
  S…N 0.26 (1.59) 0.26 (1.30) 0.08 (0.97) 
  N…F 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  F…N 0.04 (0.56) 0.11 (0.46) 0.09 (0.88) 
  O…F 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  F…O 0.08 (0.80) 0.15 (0.43) 0.10 (0.70) 
  S…F (S from Cys) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  F…S (S from Cys) 0.00 (0.00) 0.02 (3.21) 0.00 (0.00) 
  Total 14.48 12.95 14.71 
Other 
contacts: 
C…N 8.50 (0.93) 9.03 (0.91) 7.05 (0.77) 
  N…C 5.81 (1.12) 5.16 (1.03) 5.51 (1.13) 
  C…O 12.63 (0.91) 11.85 (0.81) 8.88 (0.66) 
  O…C 13.87 (0.86) 12.78 (0.94) 15.03 (0.90) 
  C…P 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  P…C 0.59 (0.57) 0.45 (0.94) 1.64 (1.07) 
  C…F 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  F…C 0.32 (1.14) 0.77 (0.77) 0.75 (1.77) 
  N…P 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  P…N 0.50 (2.08) 0.28 (2.52) 1.18 (3.30) 
  O…P 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  P…O 0.19 (0.51) 0.22 (1.33) 0.40 (0.77) 
  S…S 0.04 (6.30) 0.04 (6.34) 0.01 (2.09) 
  S…P 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  P…S 0.02 (2.18) 0.01 (2.90) 0.00 (0.00) 
  S…F (S not from Cys) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  F…S (S not from Cys) 0.01 (5.40) 0.01 (1.84) 0.00 (0.00) 
  P…P, P…F/F…P and F...F 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 
  Total 42.48 40.6 40.45 
  Grand Total 100 100 100 
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3.3.4 Polarity Ratio and Interface Atom Ratio  
Then, we analyzed the polarity ratio (PR), namely the fraction of polar N, O, S atoms at the 
interface areas of both PP and PL complexes. The interface atom ratio (IR) indicates the fraction 
of surface atoms that are involved in protein contacts at the interface. As mention before, the 
interface areas were defined as those residues that are closer than 3 Å (or 4 Å and 5 Å) to at 
least one residue from the binding partner. Both IR and PR were computed for the datasets of 
PP and PL complexes from the ABC, PIBASE, and Timbal datasets. 
At 3 Å distance threshold, the differences in IR and PR ratios are not representative 
because only the shortest-distance contacts are considered. For example, when a 3 Å cut-off is 
used, most carbon atoms are not considered as part of the interfaces as this short distance is 
shorter than twice the van der Waals radius of carbon (1.7 Å) [137]. Table 3.6 shows that, as 
expected, only very small differences were observed when computing PR and IR of PP 
complexes between the first protein (Pi1) and the second protein (Pi2), as both of them exhibit 
similar characteristics at binding interfaces. For the larger cut-off distances (4 Å and 5 Å), the 
polarity ratio (PR) decreases quickly because now all carbon atoms at the surface are included. 
On the other hand, the interface atom ratio (IR) of 8.0% (4 Å) and 14.0% (5 Å) shows that, 
expectedly, only a small fraction of the protein surface atoms are included in the interface.  
 
Table 3.6 Interface atom ratio (IR) and polarity ratio (PR) (with standard deviations in 
parentheses) for interfaces of PP complexes from the ABC and PIBASE datasets.  
        
  PP complexes from the PP complexes from the 
  ABC dataset PIBASE dataset 
  Atom distance Atom distance 
  3 Å 4 Å 5 Å 3 Å 4 Å 5 Å 
IR        
 Pi1 0.01 (±0.01) 0.08 (±0.05) 0.14 (±0.08) 0.01 (±0.07) 0.08 (±0.08) 0.13 (±0.09) 
 Pi2 0.01 (±0.01) 0.09 (±0.08) 0.15 (±0.13) 0.01 (±0.07) 0.08 (±0.08) 0.13 (±0.10) 
PR        
 Pi1 0.87 (±0.22) 0.38 (±0.07) 0.34 (±0.06) 0.72 (±0.20) 0.37 (±0.06) 0.34 (±0.05) 
 Pi2 0.85 (±0.22) 0.37 (±0.06) 0.34 (±0.05) 0.71 (±0.20) 0.37 (±0.06) 0.34 (±0.05) 
IR, interface atom ratio; PR, polarity ratio; PP, protein-protein; Pi1, first protein; Pi2, second 
protein. 
Table 3.7 lists the IR and PR ratios of 161 PL complexes from the ABC dataset, 196 
PL complexes from the PIBASE dataset, and 89 PL complexes from the Timbal dataset. At the 
distance threshold of 3 Å, almost no ligands atoms are considered as interfacial atoms whereas 
the opposite is the case for 5 Å where 93% (PIBASE) and 94% (Timbal) of the ligand atoms 
are considered as interfacial atoms compared to 78% for ABC. This is suggesting that the 
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PIBASE and Timbal ligands bind more flat on the protein surfaces and/or bind deeper into 
pockets on the protein surface than the ABC ligands. Finally, the polarity ratios of the proteins 
in the PL dataset are comparable to the proteins in the PP dataset.  
 
Table 3.7 Interface atom ratio (IR) and polarity ratio (PR) (with standard deviations in 
parentheses) for interfaces of PL complexes from the ABC, PIBASE, and Timbal datasets.  
 
  PL complexes from the PL complexes from the PL complexes from the 
  ABC dataset PIBASE dataset Timbal dataset 
  Atom distance Atom distance Atom distance 
  3 Å 4 Å 5 Å 3 Å 4 Å 5 Å 3 Å 4 Å 5 Å 
IR Pi3 
0.002 
(±0.004) 
0.01 
(±0.02) 
0.03 
(±0.03) 
0.003 
(±0.003) 
0.02 
(±0.01) 
0.03 
(±0.02) 
0.003 
(±0.003) 
0.02 
(±0.02) 
0.03 
(±0.03) 
 Lj 
0.11 
(±0.14) 
0.55 
(±0.27) 
0.78 
(±0.25) 
0.13 
(±0.17) 
0.74 
(±0.25) 
0.93 
(±0.20) 
0.16 
(±0.14) 
0.75 
(±0.21) 
0.94 
(±0.19) 
PR Pi3 
0.83 
(±0.45) 
0.38 
(±0.20) 
0.35 
(±0.14) 
0.85 
(±0.36) 
0.38 
(±0.14) 
0.34 
(±0.12) 
0.86 
(±0.38) 
0.36 
(±0.16) 
0.32 
(±0.12) 
 Lj 
0.76 
(±0.45) 
0.38 
(±0.23) 
0.35 
(±0.18) 
0.79 
(±0.38) 
0.33 
(±0.17) 
0.31 
(±0.18) 
0.84 
(±0.41) 
0.38 
(±0.25) 
0.36 
(±0.20) 
IR, interface atom ratio; PR, polarity ratio; PL, protein-ligand; Pi3, protein; Lj, ligand. 
3.4 Conclusions 
In this study, we characterized the residue and atom composition of overlapping protein-protein 
and protein-ligand interfaces from the ABC and PIBASE databases and compared these to a 
dataset derived from the Timbal database. According to the statistics, both interface types have, 
in general, a very similar composition. Among the three datasets of PL complexes, the protein 
interfaces of the Timbal dataset contain more hydrophobic residues and fewer polar residues 
than the two other datasets. The ligands in the PIBASE and Timbal datasets bind more flat on 
the protein surfaces or bind deeper into pockets on the protein surface than ABC ligands. 
Depending on the respective application in a ligand design project, researchers may consider 
to bias their principal dataset in one or the other direction. Selecting the appropriate set of 
reference data may slightly affect the physiochemical characteristics of designed ligands.  
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Chapter 4 
STIM and ORAI Genes, Interactions with Transcription 
Factors, Differential Gene Expression and Co-expression 
Analysis on Breast Invasive Carcinoma Dataset 
 
My contribution was to design the research project together with the co-authors Riccha Sethi, 
Mohamed Hamed, and Volkhard Helms. The analysis of transcription factors and STIM and 
ORAI genes was done by me and the differential gene expression, and co-expression analysis 
was done by Riccha Sethi. I and Volkhard Helms wrote the manuscript. 
 
Abstract 
Store-operated calcium (Ca2+) entry (SOCE) is ubiquitous mechanism for Ca2+ entry in 
eukaryotic cells, which regulates diverse cellular functions.  SOCE is achieved primarily by 
the gating of the plasma membrane (PM)-localized-channel, ORAI, by the ER-localized Ca2+-
sensing protein, STIM. The discovery of transcription factor binding site (TFBS) motifs in 
specific locations on the STIM and ORAI promoters remains elusive. Moreover, the knowledge 
of the defects of STIM and ORAI genes expression and/or function linked to disease such as 
breast cancer is still obscured. Here, we used the HOCOMOCO and EPDnew databases to 
obtain a set of position weight matrix (PWM) and promoter sequences of STIM and ORAI, 
respectively, and mapped the possible binding motifs proteins using the FIMO tool. The results 
were then mapped with the set of transcription factors (TFs) targeting STIM and ORAI gene 
which were retrieved from the CheA database. We found ten predictive interactions between 
transcription factors bound to promoter regions of STIM and ORAI genes based on predictions 
using the STRING, prePPI, and mentha databases. Then, the collection of 63 TFs was used as 
gene of interest for co-expression and differential expression analysis on breast invasive 
carcinoma (BRCA) dataset. There, we found ORAI genes to be up-regulated, in contrast 
STIM1 and STIM2 were down-regulated. Unveiling the predicted transcription factors bound 
to the promoter regions of STIM and ORAI genes, the regulations of these genes and 
differential networks properties may suggest putative interactions for experimental studies and 
allows us to gain knowledge relation with breast cancer. 
 
Keywords: STIM, ORAI, breast invasive carcinoma, promoters, transcription factors. 
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4.1 Introduction 
Calcium (Ca2+) signals control many cellular functions ranging from short-term responses such 
as muscle contraction, impulse transmission and secretion to longer-term regulation of 
transcription, growth, and cell division. Store-operated Ca2+ entry (SOCE), the main Ca2+ 
influx mechanism in non-excitable cells, typically is activated in response to depletion of 
endoplasmic reticulum (ER)-Ca2+ stores [138,139]. SOCE is controlled by the ER-localized 
Ca2+ sensing proteins, STIM1 and STIM2 [140–142]. Recently, SOCE and the function of Ca2+ 
released-activated Ca2+ (CRAC) channels were shown to involve the ORAI1 or CRACM1 
[143,144] and two homologs, ORAI2 and ORAI3 [145,146]. 
In mammals, the stromal interaction molecule (STIM) family has two members STIM1 
(Figure 4.1) and STIM2 (Figure 4.2). They share a sequence identity almost 65%, they have 
diverse properties what results in different functions [147]. Both STIM are single spanning 
transmembrane (TM) proteins containing an N-terminal EF-hand domain responsible for 
calcium store sensing and a COOH terminal cytoplasmic domain [141,148–151]. STIM1 is a 
ubiquitously expressed, protein of 77 kDa and consists of 13 exons, located at chromosome 11, 
in 11p15.5. The STIM2 gene contains 148 amino acids residues (aa) longer than STIM1 (105-
115 kDa) and also consists of 13 exons located at chromosome 4, in 4p15.1 [148].  
The human ORAI family includes three members: ORAI1, ORAI2 and ORAI3 (Figure 
4.3). They share a high sequence similarity of almost 89% and are broadly expressed with 
different expression levels depending on the cell type. These ORAI members are localized on 
the plasma membrane (PM) and consists of four transmembrane domains that are flanked by 
cytosolic NH2 and COOH termini [152–155]. Many studies have shown that ORAI1 functions 
together with STIM1 to initiate CRAC currents [156,157]. On the other hand, previous studies 
showed that STIM1 and STIM2, are linked to several diseases such as Alzheimers disease 
(AD), Parkinson’s and autoimmune diseases, brain and breast cancer, ischemia and, 
neurodegeneration diseases [158–164]. Moreover, a few studies found that ORAI1 and ORAI3 
are linked to breast cancer migration and metastasis [165–168]. However, only few studies 
addressed the relation of STIM and ORAI genes to breast cancer. 
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Figure 4.1 Molecular structure of STIM1 (A) STIM1 domain organization. (B) Cartoon 
depicting a possible model of the STIM1 monomer in the resting state. The figure 4.1(B) was 
taken from [147]. 
N, N terminus; Ca2+ , calcium; cEF, canonical EF-hand motif; nEF, non-canonical EF-hand 
motif; SAM, steril alpha motif; CC, coiled-coil domain; CAD, CRAC activation domain also 
called SOAR or CCb9; ER, endoplasmic reticulum; TM, transmembrane domain; S, serine-
rich domain; S/P, serine- and proline-rich domain; K, poly-K and C, C terminus. 
 
 
 
 
Figure 4.2 Molecular structure of STIM2 (A) STIM2 domain organization. (B) Cartoon 
depicting a possible model of the STIM2 monomer in the resting state. The figure 4.2(B) was 
taken from [147].  
N, N terminus; Ca2+ , calcium; cEF, canonical EF-hand motif; nEF, non-canonical EF-hand 
motif; SAM, steril alpha motif; CC, coiled-coil domain; CAD, CRAC activation domain also 
called SOAR or CCb9; ER, endoplasmic reticulum; TM, transmembrane domain; S, serine-
rich domain; S/P, serine- and proline-rich domain; K, poly-K and C, C terminus. 
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Figure 4.3 Molecular structure of ORAI1, ORAI2, and ORAI3 (A) Domain organization of 
ORAI genes. (B) Cartoon depicting a possible model of ORAI in the resting state and sequence 
alignments. The figure 4.3(B) was taken from [169]. 
N, N terminus; P, Proline-rich; R, Arginine-rich; R/K, Arginine/Lysine-rich; TM, 
transmembrane domain; CC, coiled-coil domain and C, C terminus. 
 
The binding of transcription factors (TFs) to specific locations in the genome is 
important for the coordination of transcriptional regulation in cells. Hence, the identification 
and accurate predictions of TF binding sites (TFBS) throughout genomes is a prerequisite to 
understanding of gene regulation and their networks [170]. Often, TFBSs are identified by 
using a set of target promoter sequences to characterize the binding properties for a particular 
TF that is known or assumed to bind these sequences. The position weight matrix (PWM) are 
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computed from an alignment of these DNA sequences. Various databases are available which 
store TF targets such as the TRANSFAC [92] which contains experimentally verified TF target. 
There are also CheA [171] and Factorbook.org [172] which includes the resources of ChIP-seq 
and ChIP-chip data from the ENcyclopedia of DNA Element (ENCODE) project [173], 
HOCOMOCO [91], and JASPAR [90,174] databases. On the other hand, a number of online 
databases that store physical protein-protein interactions (PPIs) and networks have been 
developed such as the IntNetDB [175], mentha [176], OPHID [177], prePPI [178], Predictome 
[179], PIPs [180], and STRING [181,182]. Note that STRING also contains functional protein-
protein (PP) interactions in additional to physical PPIs. These databases are the main resources 
of currently used for integrated research on PP interactions. 
Here, by using publicly available databases and computational tools, we perform 
predict the transcription factors (TFs) responsible for the regulation of human STIM and ORAI 
genes, and perform differential gene expression and co-expression analysis for breast invasive 
carcinoma (BRCA) datasets. First, we created a dataset of transcription factors targeting 
STIM1, STIM2, ORAI1, ORAI2, and ORAI3 genes from the ChEA database and mapped them 
to the promoter regions of STIM and ORAI genes. Next, we searched for the predicted physical 
protein-protein interactions of TFs using the STRING, prePPI, and mentha databases. Then, 
the interacting TFs and bridge proteins were used for differential gene expression and co-
expression analysis on datasets of level 3 RNASeqV2 breast invasive carcinoma (BRCA) from 
the TCGA database. Our main research question was to find the interacting transcription factors 
bound to the promoter regions of STIM1, STIM2, ORAI1, ORAI2, and ORAI3 and to assess 
how the regulation by these transcription factors may affect differential expression and co-
expression analysis for breast invasive carcinoma datasets. The acquired knowledge should 
enhance our understanding of STIM and ORAI genes binding sites on promoters, their TF 
interactions and their regulations in differential expression gene and co-expression analysis.  
 
4.2 Material and Methods 
4.2.1 Transcription Factors Targeting STIM and ORAI Genes 
We used the ChIP Enrichment Analysis (ChEA) database (amp.pharm.mssm.edu/chea) version 
1 [171] to obtain the list of transcription factors (TF) targeted to STIM1, STIM2, and ORAI1-
ORAI3 genes. We focused on transcription factors in human (Homo sapiens) only. The 
network of transcription factors targeting STIM1, STIM2, and ORAI1-ORAI3 genes was 
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visualized using the open-source platform for network analysis and visualization, Cytoscape 
(http://www.cytoscape.org/) [183].   
 
4.2.2 Transcription Factors Binding Models 
The dataset of transcription factor binding site (TFBS) models was obtained from the Homo 
sapiens Comprehensive Model Collection (HOCOMOCO) database version 9 
(autosome.ru/HOCOMOCO/) [91]. We downloaded the probability matrices of AD curated 
collection in MEME text format (HOCOMOCOv9_AD_MEME.txt) which are derived against 
a uniform nucleotide background. 
 
4.2.3 Sequence of Promoter Regions 
A set of promoter regions of the STIM1, STIM2, ORAI1, ORAI2, and ORAI3 genes was 
downloaded on April 2016 from The Eukaryotic Promoter Database (EPDnew, epd.vital-
it.ch/EPDnew_database.php) [89,184]. The EPDnew is a database of species-specific 
databases of experimentally validated promoters. The searched was filtered to Homo sapiens, 
and the default setting for the range from -499 to 100 bp relative to the transcription start site 
(TSS).  
 
4.2.4 Motif Over-representation Analysis 
A dataset of known binding motifs was obtained from the Find Individual Motif Occurrences 
(FIMO, meme-suite.org/tools/fimo) tool [185]. The FIMO tool is part of the Motif-Based 
Sequence Analysis Tools, the MEME Suite version 4.11.2 [186]. This tool searches a database 
of sequences for occurrences of known motifs and treats the motifs independently.  The motif 
input from the HOCOMOCO database (HOCOMOCOv9_AD_MEME.txt) was uploaded in 
the “input the motifs” section of the FIMO tool. On the other hand, the promoter sequences of 
STIM1, STIM2, ORAI1, ORAI2, and ORAI3 were uploaded respectively each time in the 
“input the sequences” option.   
 
4.2.5 Transcription Factors Predicted by CheA Mapped with the FIMO Results 
We mapped 426 models from the HOCOMOCO database to our results of transcription factors 
targeted to STIM1, STIM2, and ORAI1-ORAI3 genes obtained from the ChEA database. Then 
the results were mapped according to their base pair (bp) location to each of the corresponding 
promoter regions.  
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4.2.6 Prediction of Physical Interactions of Protein-protein Complexes 
Three different databases were used to obtain predicted physical interactions of protein-protein 
complexes, (i) the Search Tool for the Retrieval of Interacting Genes (STRING) database 
(http://string-db.org) downloaded in April 2016  [181,182], (ii) the prePPI database version 
1.2.0 (https://bhapp.c2b2.columbia.edu./PrePPI) [178], and (iii) the mentha database 
(mentha.uniroma2.it/about.php) downloaded in April 2016 [176]. For the STRING database, 
the minimum required interaction score was set to the default cut-off of medium confidence 
(0.4).  For the prePPI database, the probability ≥0.5 indicates true interaction. Next, we grouped 
the interactions according to (i) direct interactions which contain no bridge protein and (ii) 
indirect interactions which require bridge protein/s. 
 
4.2.7 TCGA BRCA Dataset 
Publicly accessible RNA-Seq datasets version 2, level 3 of breast invasive carcinoma (BRCA) 
was downloaded in May 2016 from the online data portal, The Cancer Genome Atlas (TCGA; 
http://tcga-data.nci.nih.gov) [8]. We downloaded two separate datasets of 113 normal samples 
(n= 113) and 1102 tumor samples (n=1102), respectively. Each of them contains gene 
expression profiles. The datasets were pre-processed using python programming language and 
R software (http://www.R-project.org).  
 
4.2.8 Computing Differential Gene Expression 
We applied the widely used Bioconductor package DESeq2 version 1.12.3 [187] to identify 
genes showing differential expression in the TCGA dataset of breast invasive carcinoma. A 
false discovery rate (FDR) threshold of 0.1 after Benjamini and Hochberg multiple hypothesis 
correction was used for statistical significance genes. We used the pheatmap package to create 
a heatmap of the differentially expressed genes which used the normalized counts as the input.  
 
4.2.9 Weighted Gene Co-expression Network Analysis 
The co-expression analysis network was performed using the Weighted Gene Expression 
Network Analysis (WGCNA) [106] package version 1.51 for R version 3.2.0. We analyzed the 
results separately for normal and tumor samples. The clustering and principal-components 
analysis (PCA) was performed to identify outliers. In normal samples, 39 outlier samples were 
omitted. The cut-height was set to 8 and the soft-thresholding power parameter was set to 7. In 
tumor samples, 455 outlier samples were removed and the cut-height was set to 12 and the soft-
thresholding power parameter was set to 4. 
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The significant modules obtained from normal and tumor samples were used to identify 
the differential interactions for all selected genes. The differential interactions were computed 
as following: 
 
𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡𝑖𝑎𝑙 𝐼𝑛𝑡𝑒𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑠 = (𝑛𝑜𝑟𝑚𝑎𝑙 − 𝑡𝑢𝑚𝑜𝑟) + (𝑡𝑢𝑚𝑜𝑟 − 𝑛𝑜𝑟𝑚𝑎𝑙)                (4.1) 
 
where (normal-tumor) are the interactions that are (edges) included in modules of the normal 
network which are not present in the tumor network modules and (tumor-normal) is vice versa. 
The edge weights greater than 0.02 obtained from the WGCNA were visualized by Cytoscape 
[183]. Edges with higher score are represented by thicker lines.  
  
4.2.10 Flowchart 
Figure 4.4 summarizes the workflow of the analysis of this study. 
 
 
Figure 4.4 Flowchart summarizing the workflow of the analysis. 
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4.3 Results and Discussion 
4.3.1 Transcription Factors Targeting STIM and ORAI Genes 
Generally, high-throughput ChIP-seq data was used together with PWMs to identify the 
putative TF binding sites in the promoter regions of human STIM and ORAI genes. Thus, 
firstly we created a dataset of TFs targeting STIM and ORAI genes. These were downloaded 
from the ChEA database which contains gene lists of TFs obtained from ChIP-seq and ChIP-
chip studies. We found a set of 23 TFs targeting STIM1, 29 (STIM2), 15 (ORAI1), 11 
(ORAI2), and 13 (ORAI3), respectively. Overall, there are 48 non-redundant TFs targeting 
STIM and ORAI genes (Figure 4.5). Supplementary Information Table 4.1 lists the 
transcription factors targeted to STIM1, STIM2, and ORAI1-ORAI3, together with Pubmed 
ID (PMID), technique of experiments and cell types.  
 
 
Figure 4.5 Dynamic graphical representations of 48 transcription factors targeting STIM and 
ORAI genes. The figure drawn using Cytoscape [183]. 
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4.3.2 Promoter Sequences of STIM and ORAI Genes from the EPDnew Database  
Two sets of promoter sequences each of STIM1 (named STIM1_1 and STIM1_2), and STIM2 
(STIM2_1 and STIM2_2), and one promoter sequence for each ORAI1, ORAI2, and ORAI3 
were retrieved from the EPDnew database. Supplementary Information Table 4.2 lists the 
promoter sequences for STIM1, STIM2, ORAI1, ORAI2, and ORAI3 genes. We used rather 
short promoter sequence region from -499 to 100 bp relative to the transcription start site (TSS) 
to focus on putative physical interactions between TFs targeted to these selected regions rather 
than longer promoter regions which may contain many unreliable interactions.  
 
4.3.3 HOCOMOCO and FIMO Results 
The STIM and ORAI promoter sequences were searched for occurrences of known motifs 
using the FIMO tool. This tool scans a sequence database for individual matches to each of the 
motifs provided in the HOCOMOCO dataset (HOCOMOCOv9_AD_MEME.txt) which 
contains 426 non-redundant curated binding models for 401 human TFs. In total, we found 411 
known motifs in the promoter of STIM1_1, 79 for (STIM1_2), 276 for (STIM2_1), 83 for 
(STIM2_2), 304 for (ORAI1), 571 for (ORAI2), and 262 for (ORAI3), respectively.   
Then, the respective motifs were mapped to the 91 transcription factors targeting STIM 
and ORAI genes obtained from the ChEA database. In total, there are 13 non-redundant 
transcription factors (E2F1, E2F4, EGR1, ELF1, ELK3, GATA1, HNF4A, MITF, MYC, 
PPARD, RUNX1, SOX2, and SPI1) that were found targeted STIM and ORAI genes. Table 
4.1 lists the motifs found targeting STIM and ORAI genes. On the other hand, only one 
transcription factor was found in the promoters of STIM1_1, STIM1_2, and STIM2_2, 
respectively. Moreover, 12 TFs were found in the promoter of STIM2_1, 4 TFs in the 
promoters ORAI1 and ORAI2, and 5 TFs in the promoter ORAI3. 
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Table 4.1 Motifs found targeting STIM and ORAI genes based on the CheA database and 
FIMO tool. 
 
Promoter 
Name Motif Strand Start End p-value q-value Matched Sequence 
STIM1_1 
ELK3_f1 + 494 505 4.05e-05 0.0361 GCCTGGAAGCCG 
STIM1_2 
SOX2_f1 + 443 458 2.14e-05 0.0238 CTATGCATCAGAAAAG 
STIM2_1 
ELK3_f1 + 154 165 5.54e-05 0.0528 CTCAGGATGTGG 
E2F1_f2 - 256 269 5.86e-06 0.00441 AGGAGGCGGGGAAG 
E2F4_do - 256 269 4.41e-05 0.0372 AGGAGGCGGGGAAG 
GATA1_si - 290 299 7.73e-05 0.0914 GCTGATAACG 
EGR1_f2 + 339 349 9.25e-05 0.0115 GGCGGGGCTGG 
EGR1_f2 - 354 364 8.56e-06 0.00306 CGCGTGCGCGG 
E2F1_f2 + 404 417 8.14e-05 0.0204 GGGAGGCGGGGGAT 
EGR1_f2 + 489 499 5.1e-06 0.00306 GGAGGGGGCGG 
E2F1_f2 + 491 504 3.92e-05 0.0147 AGGGGGCGGGGGGA 
EGR1_f2 + 510 520 1.94e-05 0.00361 CGCGGCGGCGG 
EGR1_f2 + 513 523 1.23e-05 0.00306 GGCGGCGGCGG 
EGR1_f2 + 516 526 7.86e-05 0.0115 GGCGGCGGCGC 
STIM2_2 
SOX2_f1 - 304 319 5.86e-05 0.0544 TTTTACAAAATAATGA 
ORAI1 
E2F4_do + 67 80 2.48E-005 0.0183 AGTGGGCGCCAAAT 
E2F4_do + 280 291 6.29E-005 0.0231 GGTGGGCGGGGAGC 
ELK3_f1 - 387 400 3.68E-005 0.0338 TCCTGGAAGCGC 
PPARD_f1 + 396 409 3.91E-005 0.0446 CGGGGCACAGGTGG 
ORAI2 
RUNX1_f1 + 121 130 8.89E-005 0.101 TCTGTGGGTA 
PPARD_f1 + 519 532 1.41E-005 0.0161 TGGGCCACAGGCCA 
MYC_f1 + 528 538 2.47E-005 0.0114 GGCCACGCGGC 
MYC_f1 - 529 539 5.66E-005 0.0131 GGCCGCGTGGC 
ORAI3 
HNF4A_f1 + 38 50 5.71e-06 0.0063 GGACCAAAGGCCG 
MITF_f1 + 466 475 6.78e-05 0.0589 ATCATGTGGC 
SPI1_si - 496 512 5.55e-07 0.000628 CAAAACAGGAACTGGGA 
ELF1_f1 - 499 508 8.68e-05 0.0473 ACAGGAACTG 
ELF1_f1 - 583 592 5.74e-05 0.0473 CCAGGAAGAG 
 
We prepared two diagrams to illustrate the transcription factors targeting STIM and 
ORAI on their promoter regions within the range of -499 to 100 bp, where 0 bp defines as the 
transcription start site (TSS) (Figure 4.6). We are assuming that possible physical interactions 
may occur between overlapping and neighbouring or adjacent transcription factors within ≤ 
50bp in the promoter regions. We identified nine such possible physical protein-protein 
interactions E2F1:E2F4, E2F1:EGR1, E2F1:GATA1, and E2F4:GATA1 in the promoter 
region of STIM2_1 and PPARD: E2F4 in the promoter region of ORAI1, PPARD: MYC 
(promoter region of ORAI2), MITF: SPI1, MITF: ELF1, and SPI1:ELF1 (promoter region of 
ORAI3) (Table 4.2). However, no putative interaction was found on promoter regions of 
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STIM1_1, STIM1_2 and STIM2_2 because only one transcription factor bound at each of 
them. In addition, an experimental study by Eylenstein et al. 2012 [188], found that NFKB1 
are related to STIM1 and ORAI1. The FIMO tool predicted NFKB1 to targeted STIM1 and 
ORAI2, but these were not found in the CheA database. Though, we considered the interactions 
between NFKB1 and RUNX1 in the promoter region of ORA12. 
 
 
 
Figure 4.6 Schematic illustration of transcription factors binding motifs in the promoters of 
the genes STIM1, STIM2, ORAI1, ORAI2, and ORAI3. (A) Transcription factor binding 
motifs in the promoters of genes STIM1 and STIM2. (B) Transcription factors binding motifs 
in the promoters of genes ORAI1, ORAI2, and ORAI3. 
TSS, transcription start site; Promoter STIM1_1, first promoter of STIM1; Promoter STIM1_2, 
second promoter of STIM1; Promoter STIM2_1, first promoter of STIM2; Promoter STIM2_2, 
second promoter of STIM2; Promoter ORAI1, promoter of ORAI1; Promoter ORAI2, 
promoter of ORAI2; Promoter ORAI3, promoter of ORAI3.  
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Table 4.2 List of ten predicted physical transcription factor interactions, location in the 
promoter and their overlap or gap by base pair. 
 
   Location on promoter  
Promoter Name TF1 TF2 TF1 TF2 Overlap/gap by bp 
STIM2_1 E2F1 E2F4 -245 to -230 overlap by 15bp 
  EGR1 E2F1 -145 to -135 -95 to -82 gap by 40bp 
    -10 to 0 -8 to 5 overlap by 8bp 
  *E2F1 EGR1 -8 to 5 11 to 21 gap by 6bp 
    -8 to 5 14 to 24 gap by 9bp 
    -8 to 5 17 to 27 gap by 12bp 
  E2F1 GATA1 -245 to -230 -209 to -200 gap by 21bp 
  E2F4 GATA1 -245 to -230 -209 to -200 gap by 21bp 
ORAI1 PPARD E2F4 -112 to -99 -103 to -90 overlap by 4bp 
ORAI2 NFKB1 RUNX1 -430 to -420 -378 to -369 overlap by 42bp 
    -397 to -387 -378 to -369 overlap by 9bp 
  PPARD MYC 20 to 30 29 to 40 overlap by 1bp 
      20 to 30 30 to 40 gap by 0bp 
ORAI3 MITF SPI1 -33 to -24 -3 to 13 gap by 21bp 
  MITF ELF1 -33 to -24 0 to 9 gap by 24bp 
  SPI1 ELF1 -3 to 13 0 to 9 overlap by 9bp 
*The interaction between EGR1:E2F1 is assumed to be the same as interaction between 
E2F1:EGR1. 
bp, base pair; TF1, first transcription factor and TF2, second transcription factor. 
 
4.3.4 Physical Protein-protein Interactions 
We used three well known databases STRING, prePPI, and mentha, to search for putative 
physical protein-protein interactions between transcription factors targeting STIM and ORAI 
genes on their promoter regions. Generally, these databases will search for possible physical 
protein-protein interactions either as direct or indirect interactions involving further bridge 
protein/s. Every database presented different results, scores, outputs, and networks.  
Table 4.3 lists the results obtained from the STRING database. Figure 4.7 shows the 
network of interactions between 13 TFs targeting STIM and ORAI genes generated by the 
STRING database. The STRING database predicted eight possible protein-protein interactions 
either direct or involving bridge protein/s. The interactions of node1 and node2 which have a 
score of ≥0.5 suggest true interactions (Supplementary Information Table 4.3). In total, three 
direct interactions were observed between E2F1:E2F4, E2F4:GATA1 in the promoter of 
STIM2_1, and MITF:SPI1 in the promoter of ORAI3. Additionally, besides being direct 
interactions, E2F1:E2F4 was also connected by the bridge protein MYC and E2F4:GATA1 by 
MYC and EGR1.  
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Table 4.3 List of the predicted interactions between transcription factors obtained from the 
STRING database. 
 
Promoter 
name 
Putative 
Interactions 
Type of 
interaction 
Bridge 
Proteins Interactions 
STIM2_1 E2F1:E2F4 Direct   
  E2F1:E2F4 Bridge protein MYC E2F1>MYC>E2F4 
STIM2_1 E2F1:EGR1 Bridge protein SPI1 E2F1>SPI1>EGR1 
  E2F1:EGR1 Bridge protein E2F4 E2F1>E2F4>EGR1 
  E2F1:EGR1 Bridge protein MYC E2F1>MYC>EGR1 
STIM2_1 E2F1:GATA1 Bridge protein ELF1 E2F1>ELF1>GATA1 
  E2F1:GATA1 Bridge protein SPI1 E2F1>SPI1>GATA1 
  E2F1:GATA1 Bridge protein MYC E2F1>MYC>GATA1 
STIM2_1 E2F4:GATA1 Direct   
  E2F4:GATA1 Bridge protein MYC E2F4>MYC>GATA1 
  E2F4:GATA1 Bridge protein EGR1 E2F4>EGR1>GATA1 
ORAI1 PPARD:E2F4 Bridge protein EGR1 PPARD>EGR1>E2F4 
ORAI2 NFKB1:RUNX1 Bridge protein EGR1 NFKB1>EGR1>RUNX1 
  NFKB1:RUNX1 Bridge protein MYC NFKB1>MYC>RUNX1 
  NFKB1:RUNX1 Bridge protein SPI1 NFKB1>SPI1>RUNX1 
ORAI2 PPARD:MYC Bridge protein EGR1 PPARD>EGR1>MYC 
  PPARD:MYC Bridge protein HNF4A PPARD>HNF4A>MYC 
ORAI3 MITF:ELF1 Bridge proteins SPI1, E2F1 MITF>SPI1>E2F1>ELF1 
  MITF:ELF1 Bridge proteins SPI1, 
GATA1 
MITF>SPI1>GATA1>ELF1 
ORAI3 MITF:SPI1 Direct   
ORAI3 SPI1:ELF1 Bridge protein GATA1 ELF1>GATA1>SPI1 
  SPI1:ELF1 Bridge protein E2F1 ELF1>E2F1>SPI1 
 
 
Figure 4.7 Network of 14 transcription factors targeting STIM and ORAI genes. Evidence 
view of the STRING database output depicting the transcription factors targeting STIM and 
ORAI genes obtained from http://string-db.org/. 
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The prePPI database results include prePPI LR, database LR, final probability and 
prediction code. The prediction code was labelled as S, T, G, E, M, C, and P to represent their 
sources of evidence used in the prediction. In our cases, the code of S was found which referred 
to structural modelling between the interactions of E2F1:E2F4, E2F1:GATA1, and 
NFKB1:RUNX1, T represents protein-peptide modelling (PPARD:E2F2 and PPARD:MYC) 
and G means GO term similarity (function similarity) (E2F1:EGR1 and MITF:SPI1). 
Generally, the prePPI database predicts only direct interactions. In total, four putative physical 
protein-protein interactions are predicted true by the prePPI database with a final probability 
≥0.5. This includes the interactions between E2F1:E2F4 (final probability of 1.00), E2F:EGR1 
(final probability of 0.68), MITF:SPI1 (final probability of 1.00), and SPI1:ELF1 (final 
probability of 0.99), respectively (Table 4.4).  
 
Table 4.4 List of predicted interactions between transcription factors obtained from the prePPI 
database. 
 
Promoter 
name 
Predicted 
Interactions 
prePPI 
LR 
Database LR 
Final 
Probability 
Prediction 
Code 
STIM2_1 E2F1:E2F4 109392.00 957.82 1.00 S 
STIM2_1 E2F1:EGR1 1268.49 Not available 0.68 G 
STIM2_1 E2F1:GATA1 31.17 Not available 0.05 S 
STIM2_1 E2F4:GATA1 Not found Not found Not found Not found 
ORAI1 PPARD:E2F4 23.76 Not available 0.04 T 
ORAI2 NFKB1:RUNX1 388.29 Not available 0.39 S 
ORAI2 PPARD:MYC 61.64 Not available 0.09 T 
ORAI3 MITF:ELF1 Not found Not found Not found Not found 
ORAI3 MITF:SPI1 47.73 4625.64 1.00 G 
ORAI3 SPI1:ELF1 60755.6 Not available 0.99 S 
LR, likelihood ratio; G, GO term similarity; S, structural modelling and T, protein-peptide 
modelling. 
 
Generally, the mentha database can predict direct and indirect interactions. Table 4.5 
lists the predicted interactions obtained from the mentha database. In total, three interactions 
with bridge proteins are predicted between E2F1:EGR1, PPARD:E2F4, PPARD:MYC, and 
one direct interaction between E2F1:E2F4. We identified one bridge protein (HDAC1) in the 
NFKB1:RUNX1 interaction, three bridge proteins (HDAC1, HDAC3, and NCOR2) in 
PPARD:E2F4 interactions, four bridge proteins (CDKN2A, CREBBP, EP300, and SP1) 
associate with E2F1:EGR1 interactions, and five bridge proteins (EP300, HDAC1, HDAC2, 
HDAC3, and KDM1A) with PPARD:MYC interactions, respectively. However, interactions 
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between E2F1:GATA1, E2F4:GATA1, MITF:SPI1, MITF:ELF1, and SPI1:ELF1 were not 
found in mentha. 
 
Table 4.5 List of the predicted interactions between transcription factors obtained from the 
mentha database. 
Promoter 
name 
Putative 
Interactions 
Type of 
interaction 
Bridge 
Proteins TF1 TF2 Score PMID 
STIM2_1 E2F1:E2F4 Direct NULL E2F4 E2F1 0.126 16357170 
STIM2_1 E2F1:EGR1 Bridge protein CDKN2A CDKN2A E2F1 0.507 11314038 
     CDKN2A EGR1 0.623 19057511 
  E2F1:EGR1 Bridge protein SP1 E2F1 SP1 0.902 
10547281, 8657141, 
10409740, 8657142 
     EGR1 SP1 0.523 20121949 
  E2F1:EGR1 Bridge protein CREBBP CREBBP E2F1 0.523 12748276, 8932363 
     CREBBP EGR1 0.623 9806899 
  E2F1:EGR1 Bridge protein EP300 EP300 E2F1 0.507 
24112038, 15123636, 
23001041 
     EP300 EGR1 0.93 
9806899, 15225550, 
20089040, 20018936 
STIM2_1 E2F1:GATA1             
  Not found        
STIM2_1 E2F4:GATA1             
  Not found        
ORAI1 PPARD:E2F4 Bridge protein NCOR2 NCOR2 PPARD 0.454 11867749 
     NCOR2 E2F4 0.376 22508987 
  PPARD:E2F4 Bridge protein HDAC1 HDAC1 PPARD 0.569 18037904, 11867749 
     E2F4 HDAC1 0.523 
9724731, 23060449, 
9858615 
  PPARD:E2F4 Bridge protein HDAC3 PPARD HDAC3 0.454 11867749,12943985 
     E2F4 HDAC3 0.376 22508987 
ORAI2 NFKB1:RUNX1 Bridge protein HDAC1 NFKB1 HDAC1 0.91 
25241761 16319923 
24448807 12972430 
17827154 11931769 
17962807  
     HDAC1 RUNX1 0.73 
22498736, 16652147, 
21059642 
ORAI2 PPARD:MYC Bridge protein HDAC3 PPARD HDAC3 0.454 11867749, 12943985 
     MYC HDAC3 0.692 
22002311,18483244, 
23079660 
  PPARD:MYC Bridge protein KDM1A PPARD KDM1A 0.49 23455924 
     MYC KDM1A 0.332 23455924 
  PPARD:MYC Bridge protein HDAC2 HDAC2 PPARD 0.309 25241761, 11867749 
     HDAC2 MYC 0.472 
17314511, 20195357, 
22286234 
  PPARD:MYC Bridge protein HDAC1 HDAC1 PPARD 0.569 18037904, 11867749 
     HDAC1 MYC 0.911 
22286234, 18003922, 
26496610, 17314511, 
18271930, 24951594 
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  PPARD:MYC Bridge protein EP300 EP300 PPARD 0.309 16930961 
     EP300 MYC 0.911 
17157259, 15616592, 
16287840, 16126174 
ORAI3 MITF:SPI1             
  Not found        
ORAI3 MITF:ELF1             
  Not found             
ORAI3 SPI1:ELF1             
  Not found             
PMID, Pub Med ID. 
 
Table 4.6 summarizes the type of interactions either as direct interaction or using bridge 
protein/s predicted from the STRING, prePPI, and mentha databases. If one of these databases 
predicts any interaction; which the first TF (TF1) interact with the second TF (TF2), we labelled 
“YES” in “Consider as TFs pair?” column. Overall, 14 non-redundant TFs are found to act as 
bridge proteins predicted by the STRING and mentha databases. Next, we used these 63 non-
redundant genes (including 48 TFs predicted by the ChEA database and STIM1, STIM2, 
ORAI1, ORAI2, and ORAI3 genes itself) as genes of interest for differential expression gene 
analysis and co-expression analysis of the breast invasive carcinoma dataset (Table 4.7).  
 
Table 4.6 List of predicted interactions between transcription factors obtained from the 
STRING, prePPI, and mentha databases. 
Promoter 
name TF1 TF2 
Type of 
Interaction STRING prePPI mentha 
Consider 
as TF pair? 
STIM2_1 E2F1 E2F4 Direct YES YES YES YES 
    Bridge Protein YES    
  E2F1 EGR1 Direct  YES   YES 
    Bridge Protein YES  YES   
  E2F1 GATA1 Direct      
    Bridge Protein YES   YES 
  E2F4 GATA1 Direct YES    YES 
      Bridge Protein YES       
ORAI1 PPARD E2F4 Direct         
      Bridge Protein YES   YES YES 
ORAI2 NFKB1 RUNX1 Direct         
    Bridge Protein YES  YES YES 
  PPARD MYC Direct      
      Bridge Protein YES   YES YES 
ORAI3 MITF ELF1 Direct      
    Bridge Protein YES   YES 
  MITF SPI1 Direct YES YES  YES 
    Bridge Protein      
  SPI1 ELF1 Direct  YES  YES 
      Bridge Protein YES       
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Table 4.7 List of 63 non-redundant genes of interest obtained from the CheA, STRING, 
prePPI, and mentha databases.  
 
AR FOXA1 HNF4A PAX3-FKHR STIM1 
BCL6 FOXA2 HOXB7 PHF8 STIM2 
CDKN2A FOXP1 KDM1A POU3F2 TFAP2C 
CREBBP FOXP2 KLF5 PPARD TFEB 
CUX1 GABP MITF RBPJ TOP2B 
E2F1 GATA1 MYC RUNX1 TP63 
E2F4 GATA2 MYCN RUNX2 TRIM28 
EBNA2 GATA3 NCOR1 SCL TTF2 
EGR1 GATA4 NCOR2 SMAD4 VDR 
ELF1 GATA6 *NFKB1 SOX11 WT1 
ELK3 HDAC1 ORAI1 SOX2 ZNF217 
EP300 HDAC2 ORAI2 SP1  
FLI1 HDAC3 ORAI3 SPI1   
* NFKB1 was found to be related to STIM and ORAI genes by experimental study and was 
predicted by the FIMO tool. 
 
4.3.5 Differential Gene Expression Analysis 
To identify specific genes that were differentially expressed in breast invasive carcinoma 
dataset, we used DESeq2 packages. This dataset contains 113 normal and 1102 tumor samples. 
Aforementioned, we used a set of 63 genes of interest (Table 4.7) for differentially expressed 
analysis with STIM and ORAI genes as the main focus. By setting the p-value ≤0.05 and FDR 
value of 0.1, DESeq2 analysis identified 45 out of 63 genes that were differentially expressed 
with 26 genes being significantly up-regulated and 19 genes are down-regulated (Table 4.8). 
The ten most significantly differentially up-regulated genes were E2F1, ORAI2, CDKN2A, 
SOXII, GATA3, TRIM28, RUNX2, FOXA1, HDAC1, and KDM1A. On the other hand, the 
ten most significantly down-regulated genes were EGR1, FLI1, FOXP2, BCL6, TP63, MITF, 
SMAD4, STIM2, RBPJ, and ELK3. The ORAI1, ORAI2, and ORAI3 genes were found up-
regulated. This agrees with the results of several studies stating that the expression of ORAI1 
[167,189,190] and ORAI3 [168,190] genes increased in primary human breast cancer cells or 
tissues. On the other hand, we found STIM1 and STIM2 to be down-regulated genes.  
Following data pre-processing, a total of 59 genes were identified. Four genes EBNA2, 
GABP, PAX3-FKHR, and SCL were not found in both normal and tumor samples of the breast 
invasive carcinoma dataset. Based on principal component analysis (PCA) for the gene 
expression profile data, it was found that the gene expression level in tumor (breast invasive 
carcinoma) samples was dissimilar to that in normal samples, thus the two groups were 
distinguished absolutely at the gene expression level (Figure 4.8). 
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Table 4.8 List of differentially expressed genes in the dataset of breast invasive carcinoma 
(BRCA). 
 
  
Log fold 
change p-value 
FDR-
adjusted   
Log fold 
change p-value 
FDR-
adjusted 
(a) Up-regulated genes (b) Down-regulated genes 
E2F1 2.81 5.29E-132 2.81E-130 EGR1 -2.68 7.75E-84 2.05E-82 
ORAI2 1.05 2.78E-63 4.92E-62 FLI1 -1.22 3.04E-55 3.22E-54 
CDKN2A 2.95 8.34E-63 1.10E-61 FOXP2 -2.38 5.07E-50 4.48E-49 
SOX11 3.06 2.24E-43 1.19E-42 BCL6 -1.12 2.54E-49 1.92E-48 
GATA3 1.87 5.02E-42 2.42E-41 TP63 -2.56 6.32E-45 4.19E-44 
TRIM28 0.83 3.19E-40 1.41E-39 MITF -1.21 1.55E-44 9.12E-44 
RUNX2 1.28 6.42E-38 2.62E-37 SMAD4 -0.53 1.13E-28 4.00E-28 
FOXA1 1.86 3.20E-33 1.21E-32 STIM2 -0.50 1.56E-28 5.16E-28 
HDAC1 0.59 1.51E-27 4.70E-27 RBPJ -0.49 2.32E-25 6.83E-25 
KDM1A 0.52 1.80E-22 5.02E-22 ELK3 -0.69 2.40E-21 6.07E-21 
MYCN 1.75 8.31E-22 2.20E-21 MYC -0.90 7.03E-16 1.49E-15 
ZNF217 0.72 1.02E-18 2.45E-18 SP1 -0.25 4.66E-12 9.14E-12 
HDAC2 0.61 6.77E-17 1.56E-16 KLF5 -0.82 4.02E-08 6.45E-08 
TTF2 0.57 2.97E-16 6.55E-16 NCOR1 -0.31 1.637E-06 2.55E-06 
ORAI1 0.55 4.46E-13 9.10E-13 TFAP2C -0.47 2.00E-05 2.87E-05 
SPI1 0.67 7.14E-12 1.35E-11 STIM1 -0.26 3.01E-05 4.10E-05 
VDR 0.47 2.44E-11 4.45E-11 EP300 -0.18 0.0009369 0.0011822 
PHF8 0.36 3.40E-11 6.01E-11 GATA6 -0.33 0.006 0.007 
PPARD 0.39 1.52E-10 2.59E-10 FOXP1 -0.17 0.013 0.015 
ORAI3 0.46 1E-09 1.69E-09      
CUX1 0.30 3.87E-06 5.86E-06      
GATA2 0.68 5.90E-06 8.69E-06      
NCOR2 0.22 2.66E-05 3.71E-05      
HDAC3 0.17 3.45E-05 4.57E-05      
RUNX1 0.25 0.0004872 0.0006298      
TOP2B 0.11 0.023 0.027         
FDR, False Discovery Rate. 
 
 
58 
 
 
Figure 4.8 Plot of principal component analysis of 113 normal samples and 1102 tumor 
samples.  
PC, principal component. 
 
4.3.6 Results of Gene Co-expression Analysis 
The analysis of gene co-expression of 113 normal samples and 1102 tumor samples was done 
separately using the WGCNA program.  
 
4.3.6.1 Normal Samples 
By observing the result obtained from the clustering dendogram and the topological overlap 
matrix (TOM) heatmap for all genes in normal samples (Figure 4.9), we found two significant 
modules. The blue module contains 15 genes (including ORAI2) and the turquoise module 
contains 18 genes (Table 4.9).  
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Figure 4.9 Topological overlap matrix (TOM) heatmap corresponding to the two co-
expression modules in normal samples. Each row and column of the heatmap represents a 
single gene. Red indicates high levels of co-expression genes. The dendograms on the upper 
and left sides show the hierarchical clustering tree of genes. 
 
4.3.6.2 Tumor Samples 
In the tumor samples, we identified three significant modules. The brown module contains 
eight genes, the blue module 11 genes, and the turquoise module 13 genes, respectively (Figure 
4.10). On the other hand, we found STM2 in brown module and ORAI1 in blue module. Table 
4.9 summarizes all genes found in normal and tumor samples. The expression patterns of the 
individual modules will provide some clue about their functions. 
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Figure 4.10 Topological overlap matrix (TOM) heatmap corresponding to the three co-
expression modules in tumor samples. Each row and column of the heatmap represents a single 
gene. Red indicates high levels of co-expression genes. The dendograms on the upper and left 
sides show the hierarchical clustering tree of genes. 
 
Table 4.9 Number of genes and gene name of the significant modules obtained from the normal 
and tumor samples identified by the WGCNA program. 
 
Module 
No. of 
genes Gene Name Module 
No. of 
genes Gene Name 
(a) Normal samples (b) Tumor samples 
Blue 15 FOXP1 TOP2B CUX1 Blue 11 SMAD4 PHF8 CREBBP 
  SMAD4 ORAI2 AR    ELF1 SP1  
  FOXA1 PHF8 EP300    NCOR1 CDKN2A  
  TTF2 SP1 GATA3    TOP2B AR  
    NCOR1 CDKN2A CREBBP     ORAI1 EP300   
Turquoise 18 FOXP2 NCOR2 HOXB7 Turquoise 13 FOXP2 NFKB1 RUNX1 
  HDAC1 TP63 VDR    HDAC1 TRIM28  
  HDAC3 RBPJ GATA6    MITF GATA6  
  KDM1A KLF5 GATA2    TP63 E2F1  
  MITF TRIM28 ELK3    EGR1 RUNX2  
    HDAC2 FLI1 TFAP2C     KLF5 ELK3   
     Brown 8 FOXA1 ZNF217 GATA3 
        STIM2 FLI1 E2F4 
              SPI1 TFEB   
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4.3.7 Differential Interaction Networks 
Following the analysis with the WGCNA package, we extracted all the genes differentially 
expressed from the significant modules of the TOM plot to construct networks of differential 
interactions using the Cytoscape [183]. The differential interactions were computed to observe 
which interactions are not in normal samples (labelled as normal-tumor) and vice versa for 
tumor samples (tumor-normal).  We used the edges scores of the threshold ≥0.02. This resulted 
in 83 differential interactions in normal-tumor samples and 61 interactions in tumor-normal 
samples (Supplementary Information Table 4.4). The differential interactions networks 
suggesting that one of our focus genes, ORAI2 interacts with the SP1 and SMAD4 genes in 
normal-tumor, while STIM2 interacts with the ELK3, FOXP2 and FLI1 in tumor-normal 
(Figure 4.11). In the normal-tumor network, the three highest scored edges are the interactions 
between EP300:CREBPP (0.2822), NCOR1:EP300 (0.2343), and SP1:EP300 (0.2093), 
respectively. In the tumor-normal network, the three highest scored edges are the interactions 
between FOXP2:ELK3 (0.1546), MITF:RUNX2 (0.1528), and FOXA1:GATA3 (0.1112), 
respectively. On the other hand, genes with the highest number of edges which known as hubs 
play centred roles in the analysis of the networks. Thus, we identified two genes CREBBP and 
ELK3 as hub genes in the normal-tumor network which contains eight edges (Figure 4.11 (A)) 
while in the tumor-normal network, ELK3 is the hub gene which contains 12 edges (Figure 
4.11 (B)).  
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Figure 4.11 Differential Interaction Networks (A) Differential interactions network of normal-
tumor. (B) Differential interactions network of tumor-normal. 
Red edges indicate interactions that found in differential interactions and black edges indicate 
the interactions which were not found in differential interactions. Blue nodes indicate the genes 
found in the blue module, brown (blue module), and turquoise (turquoise module), 
respectively. 
 
 
 
A 
B 
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4.3.8 Regulation of STIM and ORAI Genes on Normal and Tumor Breast Cancer Tissue 
As mentioned above, we identified ten putative interactions of transcription factors bound to 
promoter region of STIM and ORAI. There, five of the interactions involving E2F1 and E2F4 
on promoter regions of STIM2 and ORAI1 (Table 4.6). Previous studies showed that the 
transcription factors of E2F family (E2F1-8) is recognized to regulate many important genes 
and involved in many biological processes such as apoptosis, cell proliferation, differentiation, 
and DNA damage response [191,192]. Furthermore, we identified E2F1 was up-regulated gene 
in tumor samples and interact with RUNX1 in differential interaction of tumor-normal network. 
Moreover, our results show that E2F1 and E2F4 are found co-expressed in tumor samples. We 
speculate that E2F1 and E2F4 are regulating STIM2 and ORAI1 genes which also show 
relation to breast cancer. In addition, we identified an interaction of NFKB1:RUNX1 on the 
promoter region of ORAI2 which also found co-expressed in turquoise module of tumor 
samples. NFKB1 is one of the family members of NFKB1 transcription factors [193]. Several 
studies noted that NFKB among the Ca2+ sensitive transcription factors which are associate 
with STIM1 and ORAI1 to stimulate cell proliferation and differentiation [194–196]. On the 
other hand, two interactions are found involving the micophthalmia-associated transcription 
factor (MITF) on promoter region of ORAI3 (MITF:ELF1 and MITF:SPI1). We found that 
MITF are co-expression in both turquoise modules of normal and tumor samples. A study by 
Carmit and co-workers noted that MITF functions as master regulatory of melanocytes 
development and melanoma oncogene [197]. Furthermore, Stanisz and co-workers stated the 
role of STIM and ORAI in melanocytes and melanoma which significantly correlates with the 
expression of MITF [163,198]. Generally, our findings suggest several roles of STIM and 
ORAI genes in normal and breast cancer tissues.  
 
4.4 Conclusions 
In this work, we identified 13 non-redundant transcription factors targeting STIM and ORAI 
genes.  We then found ten putative TFs interactions bound on promoter regions of STIM and 
ORAI genes predicted by the STRING, prePPI, and mentha databases. According to these 
interactions, we found 14 non-redundant TFs act as bridge proteins. Then, we identified 63 
non-redundant genes as genes of interest for differential expression gene analysis and co-
expression analysis of breast invasive carcinoma dataset. In the differential expression analysis, 
we found 26 up-regulated genes including ORAI1, ORAI2, and ORAI3, while the 19 down-
regulated genes include STIM1 and STIM2. On the other hand, in the co-expression analysis, 
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we found two significant modules (blue and turquoise modules) in normal samples and three 
significant modules (brown, blue, and turquoise modules) in tumor samples which the 
expression patterns of the individual modules tend to provide clues about their functions. Next, 
we identified 83 differential interactions in normal-tumor samples and 61 interactions in tumor-
normal samples. Finally, we identified CREBBP and ELK3 as hubs genes in the normal-tumor 
network, and ELK3 in the tumor-normal network. Overall, our findings form an important basis 
for identifying TFs targeting STIM and ORAI genes and demonstrate the significant 
involvements of STIM and ORAI genes in breast cancer. In ongoing work, we are extending 
the gene enrichment analysis and applying the framework to datasets of diseases reported 
linked to STIM and ORAI genes such as Alzheimers disease (AD) and prostate cancer. 
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Chapter 5 
 
Evaluation of the Protein Pocket Identification Tools on 
Protein-Ligand Complexes 
 
My contribution was to write the manuscript, designed the research project, and analyzed the 
results together with the co-authors Zhao Yuan, Rahmad Akbar, and Volkhard Helms. I and 
Rahmad Akbar co-supervised Zhao Yuan. Zhao Yuan performed the calculations. 
 
Abstract 
Binding pockets are regions on protein surfaces where substrates of enzymatic reactions or 
effector molecules and co-factors may bind. Thus, identifying these cavities is often a 
prerequisite step for structure-based drug design. Various computational methods have been 
developed to identify such sites on protein surfaces. In this work, we evaluated the seven tools 
DEPTH, DoGSiteScorer, Fpocket, GHECOM, IsoMif, PocketPicker, and ProACT2 on a 
dataset of 167 non-redundant protein-ligand complexes. We analyzed how well the predicted 
pocket-lining residues overlap with the residues that contact the ligand. We used the residue 
overlap to define a score as a measure of the predictive capabilities of the tools.  Even though 
the tools predicted pockets of various sizes and shapes we found comparable performance 
amongst the predictions of five tools (DEPTH, GHECOM, DoGSiteScorer, Fpocket, and 
IsoMif) in terms of average score. Using always the most suitable tool improved the average 
score by 28% over randomly selecting a tool. To support users in a pocket prediction scenario, 
we trained a random forest model (classifier) to output a list of suitable tools for a given protein 
structure. This classifier should be useful for prioritizing the tools to be used for unknown 
proteins or proteins that are not contained in our dataset. 
 
Keywords: classifier, protein-ligand complexes, protein pockets, and random forest. 
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5.1 Introduction 
Proteins play major roles in practically all cellular processes. They typically interact with small 
molecules (ligands), nucleic acids or other proteins to perform a certain function. These 
interactions often occur in a particular site on the protein surface (binding site). As binding 
sites are thus often related directly to protein function, it is important to advance our 
understanding on these sites. The large collection of experimentally determined three-
dimensional structures of protein-ligand complexes stored in the protein data bank (PDB) 
allows us to study these binding sites.  For instance, it has been shown that binding sites for 
small molecule ligands tend to be rather hydrophobic with few selected polar and charged 
residues [199–201] and tend to be found in deep pockets on the proteins surface [53,202]. 
Based on this data, one can develop algorithms to identify cavities that may 
accommodate bound ligands on protein surfaces. The current batch of such algorithms fall into 
five categories (i) geometric methods that can be further grouped into the three subcategories 
grid system scanning, probe sphere filling, and alpha shape [49,50], (ii) energy based methods, 
(iii) evolution based methods, (iv) blind docking and molecular dynamics and, (v) combined 
approaches [48]. Grid system scanning basically projects a protein structure onto a three-
dimensional grid of points and examines spatial overlaps on this grid. DEPTH [57,58], 
DoGSiteScorer [56], GHECOM [49], and PocketPicker [55] are tools that implement a grid 
system scanning approach.  Probe sphere filling methods generate a set of probe spheres to fill 
cavities on protein surfaces. Pockets are then defined as those regions containing the highest 
amount of spheres, e.g. by the tool IsoMif [63].  Alpha shape methods rely on the alpha-shape 
theory and Voronoi tessellation to identify a pocket. Fpocket [68] is a representative of alpha 
shape methods. Energy based methods identify pockets using energetic criteria. Cavities with 
the largest total interaction energies are defined as pockets. For instance, ProACT2 [69,70] is 
a representative of energy based method. Other tools employ further strategies. For example, 
Rate4Site [203] uses an evolution based approach and MolSite [77] utilizes blind docking. As 
a wide range of different strategies and approaches are employed by current pocket 
identification tools, it is of interest to compare and contrast the performance of these tools.  
Defining the correct pockets on protein surfaces is not an easy task [68,204]. 
Schematically, Figure 5.1 sketches three possible ways to define the pocket volume of a 
pacman-shape surface cavity that is shown in two dimensions. It is unclear what definition is 
correct and most useful. Here we analyzed how well the constructed pockets overlap with the 
protein contacts made by small molecule ligands in their X-ray conformations. One should add, 
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as a word of caution, that native or synthetic ligands may either be smaller than surface pockets 
or exceed the volume of the pocket into the solution. Figure 5.2 shows for a case system that 
these tools predict pockets of various sizes and shapes. Indeed, in some cases the ligand is not 
fully enclosed by the detected pocket whereas other tools generated rather large pockets.  
 
Figure 5.1 Two dimensional illustrations of three possible ways to define the pocket volume 
of a pacman-shape surface cavity. 
 
 
Figure 5.2 Pockets (blue) identified by DEPTH (lining residues) (top panel left), GHECOM 
(top panel middle), Fpocket (top panel right), DoGSiteScorer (middle panel left), PocketPicker 
(middle panel middle), IsoMif (middle panel right), and ProACT2 (bottom panel) that overlap 
with the ligand HNT (red sticks) bound to human phenylethanolamine N-methyltransferase, 
PNMT (PDB ID: 2G70). The figures were generated using PyMOL Molecular Graphics 
System [47].  
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Here, we compared the performance of seven tools using a set of quality metrics on a 
set of 167 protein-ligand complexes. We then computed a set of physico-chemical and 
geometric features for each ligand-bound pocket in the dataset. Correlation analysis of pocket 
features and the quality metrics revealed only weak correlation between pocket features and 
the predictive performance of the tools. In general, we found comparable performance in the 
predictions of five tools DEPTH [57,58], GHECOM [49], DoGSiteScorer [56], Fpocket [68], 
and IsoMif [63]. 
 
5.2 Material and Methods 
5.2.1 Dataset 
We used a non-redundant dataset of 195 protein-ligand complexes retrieved by Degac et. al. 
[205] from the PDBbind [37,206] database version 2014. Beside the protein, these complexes 
contain a single ligand with weight less than 1000 Da and the resolution of the X-ray structure 
must be equal to or better than 2.5 Å. Additionally, the ligand molecules must contain only 
common organic elements and the protein molecules include only the standard 20 amino acid 
residues in the area of the binding sites. Complexes with insertions and/or residues numbered 
with special characters (20 complexes), or that could not be processed with Fpocket [68] (five 
complexes) or with DoGSiteScorer [56] (three complexes) were removed. This yielded a final 
dataset of 167 complexes (Supplementary Information Table 5.1). Only a single chain was 
considered if a complex contains more than one homomer. 
 
5.2.2 Tools 
Initially, we considered a total of 25 pocket identification tools. However, among these, we 
were only able to automate the use of seven tools due to various limitations. Table 1 lists the 
tools used in this work. The complete set of tools and the respective limitations are listed in 
Supplementary Information Table 5.2.   
 
Table 5.1 Names, URLs and year of creation of the seven protein pocket prediction tools. 
Program URL Year 
DEPTH http://mspc.bii.a-star.edu.sg/tankp/help.html 2011 
DoGSiteScorer http://dogsite.zbh.uni-hamburg.de/ 2012 
Fpocket http://Fpocket.sourceforge.net/ 2009 
GHECOM http://strcomp.protein.osaka-u.ac.jp/GHECOM/ 2010 
IsoMif http://bcb.med.usherbrooke.ca/imfi.php 2015 
PocketPicker http://gecco.org.chemie.uni-frankfurt.de/pocketpicker/index.html 2007 
ProACT2 http://people.cryst.bbk.ac.uk/~ubcg66a/proact2_summary.html 2010 
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5.2.3 Binding Site Definition 
A binding site is defined as the set of residues which are located within 5.0 Å from the ligand 
surface (actual positive class in the X-ray structure of the protein-ligand complexes). The 
remaining residues in the protein are defined as non-binding site residues (actual negative 
class). 
 
5.2.4 Model Evaluations 
Predicted pockets were evaluated by comparing their pocket lining residues with the residues 
of the corresponding binding site of the respective protein-ligand complexes using a confusion 
matrix. Each column of the confusion matrix represents the predicted class, whereas each row 
represents the actual class. We used this matrix to quantify the correct and incorrect predictions 
of each tool. In our case, TP (true positive) is the overlap between residues in the binding site 
and the lining residues of the predicted pockets, FN (false negative) are the residues in the 
binding site that were predicted as non-binding site. FP (false positive) are the non-binding site 
residues that were predicted as binding sites and TN (true negative) are the non-binding site 
residues that were correctly predicted as non-binding site. From the confusion matrix we 
computed the following quality metrics. 
 
5.2.5 MCC 
The Matthews correlation coefficient (MCC) [207] quantifies the degree of correlation between 
the actual and predicted classes of the residues. An MCC value of 1 indicates that all predictions 
are correct, -1 for completely incorrect predictions [208], and a value of zero indicates a random 
prediction [209]. MCC is defined in equation 5.1: 
 
𝑀𝐶𝐶 =
𝑇𝑃 ×𝑇𝑁−𝐹𝑃 ×𝐹𝑁
√(𝑇𝑃+𝐹𝑁)(𝑇𝑃+𝐹𝑃)(𝑇𝑁+𝐹𝑃)(𝑇𝑁+𝐹𝑁)
                                   (5.1) 
5.2.6 Precision 
Precision (P) is the proportion of correct predictions (TP) among all positive predictions (TP 
and FP). The precision value ranges from 0 to 1. 
 
𝑃 =
𝑇𝑃
𝑇𝑃+𝐹𝑃
                                                             (5.2) 
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5.2.7 Recall 
Recall (R) is the proportion of correct predictions (TP) in condition positive (TP and FN). 
The recall value ranges from 0 to 1. 
𝑅 =
𝑇𝑃
𝑇𝑃+𝐹𝑁
                                                               (5.3) 
5.2.8 Overlap 
Overlap measures the fraction of overlapping residues in a binding site for every tool (high 
probability residues, HPR). The values range from 0 to 1. An overlap value of 1 indicates that 
all residues in the binding site predicted by one tool are high probability residues that are found 
by the majority of the tools. 
 
𝑜𝑣𝑒𝑟𝑙𝑎𝑝 𝑠𝑐𝑜𝑟𝑒 =
𝐻𝑃𝑅 𝑖𝑛 𝑎 𝑡𝑜𝑜𝑙
𝑡𝑜𝑡𝑎𝑙 𝐻𝑃𝑅
                                                       (5.4) 
 
5.2.9 Correlation between Features and Quality Metrics 
The correlation between features (chemical descriptors) and quality metrics was computed 
using the Pearson Correlation Coefficient (PCC). 
𝑃𝐶𝐶 =
∑ 𝑋𝑌−
(∑ X)(∑ Y)
n
√(∑ 𝑋
2
−
(∑ X)2
n
)(∑ 𝑌
2
−
(∑ Y)2
n
)
                                             (5.5) 
 
where X is the value of a descriptor, Y is the value of the corresponding quality metrics and n 
is the total number of samples. 
 
5.2.10 TScore 
A tool score (TScore) was defined as the sum of the quality metrics (MCC, precision, recall, 
and overlap) normalized by the count of this metrics. Higher scores, in general, indicate better 
performance. 
𝑇𝑆𝑐𝑜𝑟𝑒 =
𝑀𝐶𝐶+𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛+𝑟𝑒𝑐𝑎𝑙𝑙+𝑜𝑣𝑒𝑟𝑙𝑎𝑝
4
                            (5.6) 
 
5.2.11 TRatio 
The tool ratio (TRatio) was used to approximate the distance between a predicted TScore and 
the reference score. The reference score was defined separately for each protein-ligand 
complex as the maximum score obtained from any of the tools (maxTScore). TRatio is defined 
as: 
 
𝑇𝑅𝑎𝑡𝑖𝑜 =
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛 𝑠𝑐𝑜𝑟𝑒
𝑚𝑎𝑥𝑇𝑆𝑐𝑜𝑟𝑒
                                                (5.7)                                
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5.2.12 Classifiers 
Scikit-learn [210] was used to evaluate five classification methods Bayes [211,212], decision 
tree [213,214], random forest [215], support vector machine with radial kernel (svm_c_rbf), 
and support vector machine with linear kernel (svm_linear) [216,217]. These methods were 
trained on 75% of the dataset and tested on the remaining samples. As the training and test data 
were randomly split, we iterated the training and testing procedures 100 times to obtain more 
objective results. 
 
5.3 Results  
5.3.1 Pocket Distributions 
The pocket tools output various quantities of pockets and formats for a given protein. DEPTH 
and ProACT2 output predicted pockets as a single file making it difficult to extract individual 
pockets for further analysis. GHECOM and PocketPicker output a predetermined number of 
five pockets per protein. In contrast, Fpocket, DoGSiteScorer, and IsoMif output all predicted 
pockets on the protein surface without limiting the number of predicted pockets to a fixed 
quantity.  For the latter three tools, as they output all predicted pockets for a given protein, 
Figure 5.3 shows the distribution of the number of predicted pockets. Fpocket, DoGSiteScorer, 
and IsoMif predicted 1 to 43, 3 to 112, and 13 to 147 pockets, respectively. IsoMif predicted, 
on average, the largest number of pockets per protein (52.1) followed by DoGSiteScorer (18.4), 
and Fpocket (11.7). 
 
72 
 
 
Figure 5.3 Distribution of the number of predicted pockets per protein for Fpocket, 
DoGSiteScorer, and IsoMif, respectively.   
 
5.3.2 Size Distributions 
Beside predicting different numbers of pockets, the tools also predict pockets of different sizes. 
For tools which provide individual pockets (Fpocket, DoGSiteScorer, IsoMif, GHECOM, and 
PocketPicker), we approximated the size of the predicted pockets by counting the number of 
residues that constitute a predicted pocket. As GHECOM and PocketPicker only output five 
pockets per protein, we always considered the top five pockets in each case. DoGSiteScorer, 
PocketPicker, and IsoMif predicted a similar number of residues for the top five pockets of 
26.7, 26.5, and 23.6, respectively. Fpocket predicted 17.4 residues per pocket and GHECOM 
predicted the smallest number of residues per pocket, 9.0. Figure 5.4 shows the distribution of 
the number of residues per pocket for the tools. 
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Figure 5.4 Distribution of the number of pocket lining residues per pocket (top five) for 
Fpocket, DoGSiteScorer, IsoMif, GHECOM, and PocketPicker, respectively. 
 
5.3.3 Prediction versus Reality 
Then, we measured how well the identified pockets match the positions of bound ligands (see 
also discussion section). We used four quality metrics to assess the performance of each tool 
against a reference binding site namely Matthews correlation coefficient (MCC), precision 
(pre), recall (recall), and residue overlap (overlap). The Methods section provides 
comprehensive definitions of these metrics. Reference binding sites encompass residues within 
5.0 Å distance from any atom of the small-molecule ligand bound to the protein. Figure 5.5 
shows the cumulative density of each metric for each tool. In general a tool would perform well 
if its corresponding quality metrics are shifted to the right of the density plots. 
ProACT2 and PocketPicker consistently yielded lower performance compared to the 
other tools. ProACT2 is on the leftmost portion of the density plots (Figure 5.5) for MCC, 
precision, and overlap. Similarly, PocketPicker is near or at the leftmost portion of the density 
plot for MCC, precision, and recall. On the other hand, GHECOM performed best (on the 
rightmost of the plots) in three metrics (MCC, precision, and overlap) followed by 
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DoGSiteScorer in recall, and DEPTH was on the rightmost of the MCC plot. On the other hand, 
IsoMif was placed always in the middle range. 
 
 
Figure 5.5 Cumulative density of Matthews correlation coefficient (MCC), precision (pre), 
recall, and residues overlap (overlap). 
 
5.3.4 Features and Quality Metrics 
Next we asked whether the pocket tools work better for certain types of pockets and worse for 
other. Several of the tools used in this work can compute features for the predicted pockets. 
DoGSiteScorer, Fpocket, GHECOM, PocketPicker, and ProACT2 provide 64, 19, 5, 420, and 
23 descriptors for a protein, respectively. PocketPicker [55] generates the largest number of 
features. However, its features focus only on shapes and buriedness of a pocket neglecting 
physico-chemical properties entirely. In contrast, DoGSiteScorer [56] outputs both shapes and 
physico-chemical descriptors. For this reason we selected DoGSiteScorer to compute features 
for each pocket in our reference dataset. Details regarding the features used are included in 
Supplementary Information Table 5.3. 
Similar to the previous section, we used a cumulative density plot to visualize the 
correlation values. The densities are centered around zero in all metrics and tools. This suggests 
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predominantly weak correlations between the features and the quality metrics. Furthermore, 
the Pearson correlation coefficients for MCC, precision, and overlap never exceeded 0.5 in all 
tools. For GHECOM, the feature simple score (simpleScore) correlated slightly with recall 
(0.56). 
 
5.3.5 Tool Score 
To rank the tools, we defined a simple tool score (TScore) by summing MCC, precision, recall, 
overlap and normalized the sum by four. Figure 5.6 shows the TScores per protein-ligand 
complex as a heatmap. We then labelled each protein with the tool that achieved the highest 
TScore (maxTScore). DEPTH, GHECOM, Fpocket, DoGSiteScorer, PocketPicker, IsoMif, 
and ProACT2 were assigned to 65, 33, 36, 15, 0, 14, and 4 proteins, respectively. The average 
TScores across DEPTH (0.58), GHECOM (0.54), Fpocket (0.55), DoGSiteScorer (0.55), and 
IsoMif (0.53) did not differ much. Compared to this group, PocketPicker (0.40) and ProACT2 
(0.36) yielded considerably lower scores. Picking the tools randomly from the seven tools 
yielded an average TScore of 0.53. On the other hand, if one would always pick the tool with 
the highest TScore for each individual protein, the maximum possible TScore is 0.67. This 
means that an optimal choice of tools with the highest TScore for each protein may improve 
the average score by 28% over choosing tools randomly. 
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Figure 5.6 Heatmap of TScores of DEPTH, GHECOM, Fpocket, DoGSiteScorer, 
PocketPicker, IsoMif, ProACT2, and maxTScore, respectively. The column maxTScore 
contains the maximum TScores among all methods. 
 
5.3.6 Identifying an Optimal Pocket Tool for a Protein 
Since we are now in possession of a labelled dataset along with the corresponding features, we 
were able to train classifiers on this dataset. The idea behind is that such classifiers could be 
used to identify the optimal tool for an unknown protein. We trained Bayes, decision tree, 
random forest, support vector machine with radial and linear kernel on 75% of the total data 
and tested on the remaining data. As the training and testing dataset are split randomly, we 
needed to account for the variance on each split, hence, we iterated the training 100 times. We 
found that random forest yielded an accuracy of 0.60 followed by support vector machine with 
radial kernel (0.55), decision tree (0.50), support vector machine with linear kernel (0.38), and 
Bayes (0.34).  
As the TScores amongst the tools are very similar, thus, we computed the ratio of the 
TScores the predictions in our best performing classifier (random forest) and the maximum 
TScores of the reference proteins (TRatio). Such a ratio approximates the distance between the 
TScore of the random forest predictions and the corresponding maximum TScore of reference 
proteins. A ratio value near one indicates that the TScore of the random forest prediction is 
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very similar to the maximum TScore of the reference protein. We found that TRatios are 
distributed around 0.90±0.03, further indicating that the best tools have similar predictive 
capabilities. 
 As TScores are very similar across the tools we decided to output a list of tools along 
with the corresponding weights (probability values from the random forest model) for each 
protein in the prediction instead of just one optimal tool.  A higher weight indicates that the 
classifier is confident in the decision while uniform weights across the tools indicate less 
confidence in the decision.  For example, for EPSP synthase from Escherichia coli (PDB 
ID:2QFT) DEPTH has a clearly higher weight (0.4253) than the other tools (first row, Table 
2). On the other hand, in the case of 2-naphtamidine urokinase inhibitor (PDB ID:1SQA) four 
tools (DEPTH, Fpocket, DoGSiteScorer, and IsoMif) have similar weights (second row, Table 
2). Similarly, for the PTP16-inhibitor complex (PDB ID:2QBR) DEPTH and IsoMif have 
similar weights (last row, Table 2). For cases like 1SQA and 2QBR it is useful to present the 
predictions in the form of a list of tools instead of just one tool to allow users to interfere and 
make a choice based on their need or objectives. Supplementary Information Table 5.4 lists the 
weight for each tool obtained for each protein of the training and test sets. 
 
Table 5.2 Examples of weight for each tool for each protein complex obtained from the 
classifier of the random forest model. 
 
PDB ID DEPTH GHECOM Fpocket DoGSiteScorer IsoMif ProACT2 
2QFT 0.4253 0.1908 0.1888 0.0744 0.0817 0.0389 
1SQA 0.2332 0.1385 0.2138 0.1915 0.1757 0.0472 
2QBR 0.2545 0.1071 0.1713 0.1459 0.2411 0.0801 
 
5.4 Discussion 
As mentioned in the introduction section defining the correct pockets on protein surfaces is not 
an easy task. This is reflected in our results. Despite similar average TScores for five tools, we 
found clear differences in the shape and size of the predictions (Figures 5.2 and 5.4). It was 
previously reported that pockets vary in shapes and can be found buried deep within a protein 
or narrow and shallow on the protein surface [201,202]. In addition, Villar and Kauvar [218] 
noted that specific amino acids such as Arg, His, Trp, and Tyr are often enriched in protein 
binding sites compared to the entire protein. Due to these complexities, a pocket identification 
tool can be very successful for a set of proteins and less successful on other sets. 
   On the dataset studied here and using the four quality metrics defined by us, DEPTH 
yielded the highest aggregated TScore for 64 proteins. However, one should note that DEPTH 
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predicted larger pockets compared to other tools for the majority of the proteins. This is 
illustrated by the number of residues per predicted pocket. DEPTH, on average, predicted 
pockets with 77.0 residues while other tools predicted an average smaller pockets (for top five 
pockets), DoGSiteScorer (26.7), PocketPicker (26.5), IsoMif (23.6), Fpocket (17.4), and 
GHECOM (9.0). We speculate that the larger pocket sizes might have provided an advantage 
to DEPTH in terms of TScores since the score is computed based on these residues.  
Interestingly, when TScores were correlated to maxTScore, we found that GHECOM 
yielded the highest correlation (0.84) followed by DoGSiteScorer (0.78), DEPTH (0.77), and 
IsoMif (0.75). Not surprisingly PocketPicker (0.43) and ProACT2 (0.23) yielded the lowest 
correlations. Even though GHECOM did not yield the highest average TScores, the tool was 
either in the second or third position for each protein-ligand complex in the dataset.  In addition, 
GHECOM also predicted the smallest pockets (Figure 5.3). The high correlation to maxTScore 
and the relatively small pocket size indicate that GHECOM can produce quite precise 
predictions and could be a reasonable choice if one does not know what tool to choose for a 
given protein. Alternatively, the decision for a suitable tool may of course also be based on the 
random forest classifier that was trained here. 
 
5.5 Conclusions 
In this work we compared seven pocket identification tools. We found that these tools predict 
pockets of various size and shapes. For instance, DEPTH, DoGSiteScorer and PocketPicker 
tend to predict larger pockets, whereas GHECOM predicts smaller sized pockets. The tools 
also predict various numbers of pockets per protein. IsoMif identified most pockets an average 
(52.1), followed by DoGSiteScorer (18.4), and Fpocket (11.7). We introduced TScores as a 
measure of the predictive capabilities of the tools. When one applies the optimal tool for each 
protein, the average TScore increases by 28% over randomly labelled proteins. The tool 
GHECOM constructed pockets of rather compact size and its predictions were consistently 
among the top three tools. Finally, we trained a random forest classifier on this dataset. The 
classifier outputs a list of tools with a corresponding set of weights indicating the confidence 
of the decision boundaries. The classifier should be useful to prioritize a set of pocket tools for 
protein structures that are not contained in our dataset.  
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Chapter 6 
 
Conclusions and Future Works 
 
In this thesis, we presented three different projects which mainly related to the core area of 
protein interactions and gene regulations. We are aimed to understanding the role of protein-
protein interactions and protein-ligand interactions, protein interfaces, and pockets. We also 
are extending our study to gain knowledge on transcription factors targeting STIM and ORAI 
genes, the regulation and relation with breast cancer.  
First, we performed statistical analysis on the composition of overlapping protein-
protein and protein-ligand interfaces. We started from the research question to find out whether 
small molecule ligands have similar physio-chemical features as protein binding interfaces 
when they bind at overlapping protein-protein or protein-ligand binding interfaces. We are 
using five different datasets from the ABC, PIBASE and TIMBAL databases. According to the 
statistics, we found that generally, both interface types have a very similar composition. Among 
the three datasets of PL complexes, we found that the protein interfaces of the Timbal dataset 
contain more hydrophobic residues and fewer polar residues than the two other datasets. In 
addition, we found that the ligands in the PIBASE and Timbal datasets bind more flat on the 
protein surfaces or bind deeper into pockets on the protein surface than ABC ligands. To further 
explore the findings, we will apply the framework on larger datasets of protein-protein and 
protein-ligand complexes. 
For the second project, we addressed several angles about STIM and ORAI genes. We 
identified ten predictive interactions between transcription factors bound to promoter regions 
of STIM and ORAI genes based on predictions using the STRING, prePPI, and mentha 
databases. We used a set of genes of interest for co-expression and differential expression 
analysis on breast invasive carcinoma dataset which main focus on the regulation of STIM and 
ORAI genes. We found ORAI1, ORAI2, and ORAI3 genes to be up-regulated and in contrast 
STIM1 and STIM2 were down-regulated. We identified several roles of STIM and ORAI genes 
in normal and breast cancer tissues. The results presented in this study allow us to gain 
knowledge and unveiling the predicted transcription factors bound to the promoter regions of 
STIM and ORAI genes, their regulation, and relation with breast cancer. In future, we aim to 
extend this study by performing gene enrichment analysis and expand this workflow to new 
datasets of diseases which reported related to STIM and ORAI such as Alzheimers disease and 
prostate cancer. 
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In final study presented in this thesis, we evaluate performance of seven protein pocket 
identification tools on a dataset of protein-ligand complexes. We analyzed how well the 
predicted pocket-lining residues overlap with the residues that contact the ligand. We also used 
the residue overlap to define a score as a measure of the predictive capabilities of the tools. We 
found comparable performance amongst the predictions of five tools in terms of average score. 
We then trained a random forest model (classifier) to output a list of suitable tools for a given 
protein structure to assist users in a pocket prediction scenario. This classifier should be helpful 
for prioritizing the tools to be used for unknown proteins or proteins that are not contained in 
our dataset. Future work, we will present a more comprehensive evaluation of our framework 
on larger datasets of protein-ligand complexes. 
In summary, the studies presented in this thesis led to gain knowledge of protein 
interactions and regulation of STIM and ORAI genes. Overall, our future works for these three 
projects will involve and focusing on applying the frameworks either on new or larger datasets 
for better understanding and comprehensive evaluation.   
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Supplementary Information 
 
8.1 Supplementary Information for Chapter 3 
Table 3.1 Datasets of PP and PL complexes.  
 
Dataset of PP complexes from the ABC database (Table A).  
PDB ID Chain Chain          
15C8 L H 1HE8 B A 1R5T A B 2BL0 B A 
1A09 A B 1HFY A B 1R8Q A E 2BTO T A 
1A6U H L 1HJA B I 1RFX B C 2C3N A B 
1AB8 B A 1HQK E D 1RH7 C B 2CHP C D 
1AHW F A 1HWU B A 1RQ7 B A 2COG A B 
1ASL B A 1I3O B E 1S4Y B A 2CUY B A 
1AV1 B A 1I8F C B 1S7Y B A 2D26 A B 
1AVA A C 1ICF A I 1SC1 A B 2D4V B A 
1AY7 A B 1IFV A B 1SGF G B 2DSQ I G 
1AZZ A C 1IIN A B 1SGR E I 2DVG C B 
1B06 A B 1JSU B C 1SND A B 2EV4 B A 
1B99 F C 1JTH D A 1STF E I 2FHZ B A 
1BJQ C A 1JZD B C 1SUV D F 2FR6 C D 
1BMF F B 1KQD A B 1T6G C A 2G2U A B 
1BRR A C 1KQM C A 1TH7 L K 2GD4 I H 
1BVI A C 1KWS B A 1U3R A B 2GMR L M 
1BVN P T 1MCI B A 1U3W B A 2GPV D B 
1BZX E I 1MCV A I 1UGH E I 2GQD B A 
1C2O D A 1MI3 B A 1UVC A B 2GVM B A 
1CKG B A 1MSA B C 1VGQ B A 2H1L E F 
1CYY A B 1N8O C E 1VLZ B A 2HI7 A B 
1D7F B A 1N9S C D 1W0I B A 2I2R H D 
1DFJ E I 1NHG B D 1W29 C D 2IDO A B 
1DLE A B 1NMA N H 1X1U A D 2IJO A I 
1DM5 B D 1NW9 A B 1X1Z A B 2IPJ B A 
1DPJ A B 1NYS A C 1XBY B A 2IWG D E 
1E0F E J 1O6S A B 1XMZ B A 2IYG B A 
1E8U B A 1O81 B A 1XX9 B D 2J3K A B 
1EYS H M 1OBQ B A 1Y48 E I 2J96 B A 
1EZL C D 1OKT B A 1YGP A B 2NX5 A D 
1F45 A B 1OME A B 1YI5 C H 2NY7 G H 
1F46 B A 1OO9 A B 1YRQ A H 2O8A A I 
1F88 B A 1OPF B A 1ZJD A B 2OCC A B 
1FAK H I 1P0S H E 1ZRS B A 2OL1 A C 
1FI8 A C 1P4I L H 1ZUX D B 2P1L A B 
1FX9 B A 1P7L A B 2AAX A B 2PRG A C 
1G0A D B 1PA0 B A 2AGY B D 2PVO D A 
1G21 H G 1PMO D C 2AMT C B 2TNF B A 
1G3N A B 1PPF E I 2AQ3 G A 3PCD A M 
1G6V A K 1PST M H 2AY5 A B 4AKE A B 
1GIF B A 1PYG B A 2AYQ B A 6PFK C D 
1GQ3 C B 1QGE D E 2B42 B A 7TIM B A 
1GXS D C 1QPX A B 2BE6 A D     
1H6A B A 1QRN D E 2BEX C A     
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Dataset of PL complexes from the ABC database (Table B).  
 
PDB ID Chain Ligand          
1A05 B IPM 1IT6 A CYU 1TI1 A D12 2DQV A GAL 
1A0J A BEN 1IZ2 A SUM 1TR5 A THP 2FMH A TRS 
1A8J L PME 1JI5 B MPD 1TXC A 2AN 2FNW A REP 
1ANK A AMP 1JTK A THU 1U0H B ONM 2FYD A PG4 
1AR1 A LDA 1KJ1 D MAN 1U3T B CCB 2G2Z A COZ 
1BG9 A BGC 1KMH B TTX 1UBH S MPD 2G7Y A MO9 
1BIW B S80 1KYN A KTP 1USR A SIA 2GJ6 D 3IB 
1BLC A CEM 1L7Z A MYR 1UTM A PEA 2GOO C NDG 
1BMQ A MNO 1L9B L HTO 1UX0 A THU 2H0T A EPE 
1BQI A SBA 1L9H A HTO 1V3V B 5OP 2H6Y A MPD 
1BWO A LPC 1LBC A CYZ 1V84 A NAG 2HA3 A P6G 
1C50 A CHI 1LIN A TFP 1W5F B G2P 2HG8 A MLE 
1CGY A MAL 1LOJ A MPD 1WB8 A PMS 2HQU C DUP 
1CLS D DEC 1LVW D TYD 1WV0 A BN4 2HXM A 302 
1CPC A CYC 1M2Z A BOG 1WV7 T FUC 2I17 A CIT 
1CY2 A TMP 1MBQ A BEN 1X29 B PMG 2IPF A TRS 
1DBN B NAG 1MFI B FHC 1XEY A GUA 2IW6 A QQ2 
1DHK B NAG 1MPF A C8E 1XJI A D10 2IWZ A 6NA 
1EKX C PAL 1NGP L NPA 1XKD A NAP 2J6E B MPD 
1EST A TSU 1NIP B ADP 1XR8 A PG4 2J7L A XC2 
1EWY C FAD 1O4H A 772 1XXS B STE 2J8C M GGD 
1F42 A MNB 1O5D H CR9 1Y11 A 1PE 2J9C C ATP 
1FLJ A GSH 1O6T A MES 1Y2F A WAI 2JH0 D 701 
1FQ6 A 0QF 1O9T B ATP 1YRX B D9G 2NY0 A HEZ 
1G4I A MPD 1OAU J DNF 1ZL0 A TLA 2OIZ A TSR 
1G5N A SGN 1PFK A ADP 1ZOM A 339 2OL4 B JPN 
1G8I A P6G 1Q4J A GTX 1ZRK A 367 2OM9 A AJA 
1GG6 C APF 1Q6O B LG6 2A01 A AC9 2OPY A CO9 
1GKA A D12 1Q6Y A MPD 2APX A MLA 2P95 A ME5 
1GMR A 2GP 1QIW A DPD 2AY9 B 5PV 2PL7 B HTG 
1GOY A 3GP 1RE2 A NAG 2AZ5 B 307 2UUE B GVC 
1GZR B C15 1RH7 C P6G 2B0U B MPD 2YXJ A N3C 
1H1B A 151 1RHM B NA4 2B45 X EPE 35C8 L NOX 
1H48 C CDI 1RTK A GBS 2BUQ A CAQ 3LJR A GGC 
1HJ1 A PMB 1RYD A GLC 2C01 X ATP 4LIP D CCP 
1HUR A GDP 1RZH H CDL 2C4L A SIA 4VGC B SRD 
1HVV A TAR 1S57 B EPE 2C97 B MPD 6RNT A 2AM 
1HX0 A AC1 1S9Q B CHD 2CL0 X TRS 9RSA B ADU 
1I5G A TS5 1SUP A PMS 2CZ5 B CIT     
1I9B D EPE 1SVL C ADP 2DCY A TAR     
1ICR A NIO 1TB6 I MPD 2DJH A UM3     
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Dataset of PP complexes from the PIBASE database (Table C).  
 
PDB ID Chain Chain             
1YM4 A C 1CA7 A C 1EZR A B 1HAK A B 1M43 A B 
1A22 B A 1CBK A B 1EZV B A 1HG4 A D 1M48 A B 
1A2K C B 1CD1 A B 1EZV A B 1HKV A B 1M56 A B 
1A2V C D 1CD9 B A 1EZV C D 1HP0 A B 1M7N A B 
1A5A A B 1CH4 A B 1EZV D C 1HR6 D C 1M7W A B 
1A5A B A 1CKI A B 1F1J A B 1HR6 A E 1MCZ A B 
1A7K C D 1CMV A B 1F2D A B 1HXM A B 1MF8 B A 
1A8G A B 1CN4 A C 1F3T C D 1HXM B A 1MG2 O N 
1A8T A B 1CWQ A B 1F5P A B 1HYR A C 1MPY A C 
1A99 B A 1CYD A B 1F60 A B 1I0Z A B 1MRU A B 
1AB8 A B 1D0E A B 1F6B A B 1I1R A B 1MZJ A B 
1ACB E I 1D0I A C 1F6R A C 1I3R D C 1MZN A C 
1AE1 A B 1D0O A B 1F8U A B 1I41 F G 1N0H A B 
1AFS A B 1D1Z A B 1FJG E H 1I4U A B 1N0S A B 
1AG1 O T 1D4A A C 1FR1 A B 1I7I A B 1N1A A B 
1AGR A D 1D6S A B 1FRT A B 1I85 D B 1N4O A B 
1AIG P O 1D6U A B 1FSK J L 1I85 A B 1N7G A B 
1AIG L H 1D8U A B 1FTM A C 1II6 A B 1N9E A B 
1AIP A C 1DBQ A B 1FUJ A D 1IJL A B 1NBU B C 
1AJS A B 1DCL A B 1FVU B A 1IY8 B C 1NCC N H 
1AR1 B A 1DF8 A B 1FX0 B A 1IYK A B 1NF3 B D 
1AUW C D 1DIR A B 1G1A A B 1IZ1 A P 1NFD A D 
1AZS A B 1DJU A B 1G2O A C 1J7E A B 1NFQ A B 
1AZS C B 1DN0 B A 1G4A B A 1J90 A B 1NKS A B 
1AZZ C A 1DO5 A C 1G5Q A D 1JDS A C 1NTO C D 
1B3R B D 1DOF B C 1G6O A B 1JEB A D 1NW4 A B 
1B6C D C 1DOH A B 1G6Y A B 1JFF A B 1NX9 B D 
1B7G O Q 1DPJ A B 1G73 C A 1JG8 A B 1O4S A B 
1B7T Z A 1DTY A B 1G85 A B 1JKF A B 1O5D L T 
1B7T Y A 1DUG A B 1G8Y C D 1JSW A D 1O5I A B 
1B8G A B 1DVR A B 1G9M C G 1JT0 A C 1O5O A B 
1B9C A B 1DZB A B 1GEG B C 1JWH A D 1O61 A B 
1BAI A B 1E3I A B 1GH7 A B 1JWI B A 1O63 A B 
1BB3 A B 1E3U A C 1GMY A B 1K2O A B 1O6E B A 
1BCC E D 1E5E A B 1GNX A B 1K3F A D 1O9J A B 
1BCC G C 1E7W A B 1GP7 A B 1KBU A B 1OAT B C 
1BD3 A C 1E8T A B 1GPM A B 1KCZ A B 1OD2 A B 
1BEB A B 1E9S E F 1GPW A B 1KFY B C 1ODL A B 
1BGY R O 1ECE A B 1GR7 A D 1KFY D B 1OE7 A B 
1BI7 A B 1ECS A B 1GRI A B 1KFY C B 1OGA D E 
1BJF A B 1EE0 A B 1GTV A B 1KI9 A B 1OGA E D 
1BKJ A B 1EI1 A B 1GWN A C 1KOB A B 1OJ6 A B 
1BKO A B 1EK6 A B 1GYL A B 1KRU A C 1OME A B 
1BMF C D 1EKX B C 1GZ6 A B 1KSG A B 1OPL A B 
1BML A C 1EM6 A B 1GZM A B 1KXJ A B 1ORR A B 
1BQH G H 1EOC B A 1H48 A B 1L8X A B 1ORT C D 
1BUQ A B 1EP1 A B 1H4G A B 1LBH A B 1ORW B D 
1BVR A B 1EQU A B 1H5B A B 1LLU E F 1OVL A B 
1BYE C D 1EWK A B 1H5Q A B 1LRT A B 1OVM B D 
1C0T A B 1EYS M C 1H8V D E 1LW6 E I 1OYJ C D 
Continued 
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1OZF A B 1SVX B A 1W6T A B 2BVC D E 
1P0K A B 1SXG A D 1W6U A B 2C7F A D 
1P0S H E 1T2O B A 1W91 F G 2CLT A B 
1P4B L H 1T8S A B 1WC1 B C 2D1Y B C 
1P4E A D 1T91 A D 1WUE A B 2DFT A C 
1P60 A B 1T97 A B 1WYE A B 2DNS A B 
1P7C A B 1TAH A B 1WZ8 A B 2DW6 A B 
1P93 A C 1TC0 A B 1X27 A E 2DY4 D B 
1PKG A B 1TEX A B 1X9F J K 2EGH B A 
1PKQ A B 1TF7 B C 1XCA A B 2EVO A B 
1PV4 C D 1TFC A B 1XDK B A 2EW8 B D 
1PWE C D 1TPZ A B 1XED A B 2F1G A B 
1PWX B C 1TW2 A B 1XG5 A B 2F73 A B 
1PY4 A C 1TXT A B 1XGM A B 2FG6 C D 
1PYT B A 1TZ3 A B 1XI9 A B 2FM6 A B 
1Q0C A C 1U0L A C 1XKQ A B 2FYI A B 
1Q3D A B 1U1I A B 1XNX A B 2G2U A B 
1Q3G A B 1U46 A B 1XSE A B 2GF0 A B 
1Q57 A C 1U5Q A B 1XTT B C 2GIC A B 
1Q5Q C B 1UB7 A B 1XXD B C 2GJ7 E B 
1Q6T A B 1UFH B A 1XYG B C 2I6A A D 
1Q8M A B 1UI5 A B 1Y1M A B 2IFA A B 
1Q90 B D 1UIM A B 1Y1P A B 2IG2 H L 
1QA9 A B 1UIU A B 1YDE B P 2IGO C D 
1QPB A B 1UKM A B 1YO6 A B 2IJ2 B A 
1QZF C D 1UKV Y G 1YP2 C D 2J12 B A 
1R4P E A 1UMO A B 1YQ2 A B 2NUU B C 
1R5K A C 1UPA B D 1YTA A B 2O23 A B 
1R8Q E A 1URZ B C 1YTZ C I 2O2Y C D 
1RD5 A B 1USI A C 1YVB A I 2OKR A D 
1RD7 A B 1UTR A B 1YXM A B 2ONL C A 
1RE5 B C 1UU0 A B 1Z08 B D 2PD3 B C 
1RJN A B 1UVQ A B 1Z1B A B 2PMT C D 
1RKX A D 1UZM A B 1Z5A A B 2TAA A B 
1RPY A B 1V2I A B 1Z7M E A 3TAT C D 
1RQR A C 1V4J A B 1Z7X X W 7MDH D C 
1S2G A B 1VC8 A B 1ZEM E G     
1SB2 A B 1VDM B H 1ZPD B E     
1SF2 A B 1VDW A B 2A2G A C     
1SGF G Z 1VEA A B 2A7K G H     
1SL6 D A 1VF5 B A 2A9K A B     
1SN0 A C 1VHW A D 2A9K B A     
1SP8 A B 1VIQ B C 2AAW A C     
1SPG B A 1VIY A B 2AG5 A B     
1SPI A B 1VKG A B 2ANC C E     
1SQB B I 1VM6 B D 2B4G A B     
1SQI A B 1VPX C B 2BCK A D     
1SQL D E 1W0M B D 2BD0 A B     
1SQP A I 1W2Z A B 2BEX C A     
1SU2 A B 1W59 A B 2BTW A B     
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Dataset of PL complexes from the PIBASE database (Table D). 
PDB ID Chain Ligand          
1A07 A PTR 1EE2 A CHD 1LW5 C PLG 1U2R A DDE 
1A2D A PYX 1EEI D GAA 1M2Z A BOG 1U4S A BIH 
1A50 A FIP 1EFA A NPF 1MVN A PCO 1U7G A BOG 
1A54 A MDC 1EHK A BNG 1N0S A FLU 1U9V A IHE 
1A69 A FMB 1EHK B BNG 1N3I B DIH 1UAY A ADN 
1A8G A 2ZN 1ELU A PDA 1N3Z A ADN 1UTR A PCB 
1A9X B CYG 1EUP A ASD 1NBP A MHC 1UYS A H1L 
1AB8 A FOK 1EYN A 2AN 1NLP C MN8 1VAF A ARR 
1ACM A PAL 1EYS M BGL 1NX9 A AIC 1VEA A HBN 
1AHI A CHO 1EYS H BGL 1OKE A BOG 1VKG B CRI 
1AOE A GW3 1F40 A GPI 1OSV A CHC 1W9D M SEH 
1AQU B EST 1FL6 L AAH 1PKG A PTR 1X8I A BMH 
1AWB B IPD 1FP1 D HCC 1PP9 A BHG 1X8V A ESL 
1B4W A BOG 1FUP A PMA 1PP9 B BHG 1XK9 A P34 
1B59 A OVA 1G9V A RQ3 1PP9 D BHG 1YIK A MM1 
1B9C A CRO 1GG5 A E09 1PP9 F BHG 1YK3 D BOG 
1B9I A PXG 1GSE A EAA 1PPJ G BHG 1YP2 A PMB 
1B9V A RA2 1H2S A BOG 1Q0B A NAT 1Z7Y A AA5 
1BAV A BIP 1H47 A GPP 1Q3A C NGH 2A8T A ADN 
1BCC E BOG 1H4G A FXP 1QW9 A KHP 2AEO A CPT 
1BDA A 2Z0 1H61 A PDN 1QZR A CDX 2AJ8 B SC3 
1BL6 A SB6 1HAK A K21 1R4Z A RIL 2BM2 C PM2 
1BLS A IPP 1HJ1 A PMB 1R8Q A AFB 2BT4 B CA2 
1BM7 A FLF 1HNU A REO 1R8Q E AFB 2BU3 A 3GC 
1BQM A HBY 1HRK A CHD 1REJ A B1L 2BVC F P3S 
1BT5 A IM2 1HZX A BNG 1RKW A PNT 2BXE A 1FL 
1BUQ A NTH 1I53 A RTC 1RQI A DST 2CLE B F6F 
1BX4 A ADN 1I9H A BNI 1RQR B 5FD 2CVD A HQL 
1BZJ A PIC 1IDT A CB1 1RRI A A45 2D97 A IYR 
1C1P A BAI 1IEC A SEB 1S2C A FLF 2EVC A FC3 
1C50 A CHI 1IYL A R64 1S2D A AR4 2F11 A IEM 
1C9C A PP3 1J0B B 5PA 1S36 A CEI 2FAK H SA1 
1C9M A SEB 1J12 A EBG 1SA0 A CN2 2GFD A RDA 
1CGK A NAR 1JNH H ECO 1SEZ A OMN 2GIC A IUM 
1COW B AUR 1JR1 A MOA 1SHJ A NXN 2IPK A 4DP 
1COW F AUR 1JUT A LYD 1SIH A MBQ 2IPK B 4DP 
1CQE A BOG 1JVN A 143 1SJD A NPG 2IYY A S3P 
1CRX B PO4 1JYV A 145 1SQI A 869 2OOW A OX4 
1CZI E PHI 1K3T C BRZ 1SUX A BTS 2OQW A CS3 
1D3H A A26 1KDT A DOC 1SZR A PLG 2ORK B IPD 
1D4F A ADN 1KFY C BRS 1T1R B IMB 2OT1 A N3P 
1DFG A NDT 1KFY D BRS 1T3T A CYG 2VLE A DZN 
1DHT A DHT 1KIC A NOS 1T6H A PHI 3PCI A IHB 
1DX6 A GNT 1KLL A MC 1T83 A HG2 4AC9 A CMH 
1DY3 A 87Y 1KRP A PST 1T9B A 1CS 6PRC L CEB 
1E2N A RCA 1KRV B 147 1T9H A IUM 11GS A EAA 
1E7P B F3S 1KYN A KTP 1TAU A BGL     
1E81 E M91 1L0L C FMX 1TC1 A FMB     
1EBA B DBY 1LBC B CYZ 1TFQ A 998     
1ECZ B BOG 1LKD A BP6 1TXC B 2AN     
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Dataset of PL complexes from the TIMBAL database (Table E). 
PDB ID Chain Ligand       
1A6A A NAG 2LZG A 13Q 3M1I A GTP 
1A7X B FKA 2OU7 A ANP 3MDY A LDN 
1AB8 A FOK 2P1M B IHP 3NC0 A IPH 
1AGR A GDP 2P26 A NAG 3O47 A GDP 
1AZS C GSP 2TNF A TRS 3OSK A NAG 
1CS4 A MES 2VJE D FLC 3QAZ B NAG 
1D8D B FII 2VOH A CIT 3QBR X NHE 
1H2K A OGA 2W5Y A SAH 3QD6 A NAG 
1I8L A NAG 2WBE C ANP 3QTK A TFA 
1IA0 K ACP 2WKP A FMN 3SL9 A IMD 
1ICF I NAG 2XRP B GTP 3TX7 B P6L 
1L2I A ETC 2YDS A NAG 3U88 A GGB 
1O9C A FLC 2YEM A WSH 3UP0 A D7S 
1P93 A DEX 2ZKW A CU1 3V4P C TRS 
1PZN B IMD 3A9E B REA 3VNG A FUU 
1QAB E RTL 3BEJ A MUF 4A9E A 3PF 
1R6N A 434 3CLX D X22 4AY6 A 12V 
1S1J A IQZ 3DZU D PLB 4DBB A ACY 
1TCO B MYR 3DZU A REA 4DEW A LU2 
1TW6 B BTB 3F7Q A 1PE 4DSN A GCP 
1U27 A 4IP 3FCS A IMD 4E2T A EPE 
1V7P B NAG 3GBG A PAM 4G1E A NAG 
1XLS E TCD 3HOF B DHC 4G1M A NAG 
1YJD C NAG 3HQR A OGA 4GMX C K85 
1YSG A 4FC 3HVL A SRL 4GS6 A 1FM 
2BRQ A GSH 3ICI A MES 4GZ9 A NAG 
2ERJ B NAG 3IPQ A 965 4H71 A PXE 
2GXA A ADP 3IT8 D NAG 4JWL A HRC 
2H61 E PG4 3K6S A MAN 4LOO A SB4 
2HBH A XE4 3L0L A HC3     
 
 
 
 
 
 
 
 
 
 
 
105 
 
Table 3.2 Dataset of PP complexes from the ABC dataset 
List of PP complexes from the ABC dataset comprised of 94 homodimer complexes (Table A). 
 
No 
PDB 
ID 
Resolution 
(Å) 
Name of homodimer Scientific source 
Chain 
one 
Length 
Chain 
two 
Length 
1 1GIF 1.90 Human Glycosylation-Inhibiting Factor Homo sapiens B 115 A 15 
2 1A09 2.00 
Peptide Ligands Of PP60(C-SRC) SH2 
Domains 
Homo sapiens A 107 B 107 
3 1AB8 2.20 Adenylyl Cyclase Homo sapiens B 220 A 220 
4 1ASL 2.60 Aspartate Aminotransferase Escherichia coli B 396 A 396 
5 1AV1 4.00 Apolipoprotein A-I Homo sapiens B 201 A 201 
6 1B06 2.20 Protein (Superoxide Dismutase) Sulfolobus acidocaldarius DSM 639 A 210 B 210 
7 1B99 2.70 Protein (Nucleoside Diphosphate Kinase) Dictyostelium discoideum F 155 C 155 
8 1BJQ 2.65 Lectin 
Vigna unguiculata subsp. cylindrica 
(sow-pea) 
C 253 A 253 
9 1BRR 2.90 Protein (Bacteriorhodopsin) Halobacterium salinarum A 247 C 247 
10 1BVI 1.90 Protein (Ribonuclease T1) Aspergillus oryzae A 104 C 104 
11 1C2O 4.20 Acetylcholinesterase Electrophorus electricus D 539 A 539 
12 1CKG 2.20 Protein (Lysozyme) Homo sapiens B 130 A 130 
13 1CYY 2.15 DNA Topoisomerase I Escherichia coli K-12 A 264 B 264 
14 1D7F 1.90 Cyclodextrin Glucanotransferase Bacillus sp. 1011 B 686 A 686 
15 1DLE 2.10 Complement Factor B Homo sapiens A 298 B 298 
16 1DM5 1.93 Annexin XII E105k Mutant Homohexamer Hydra vulgaris B 315 D 315 
17 1E8U 2.00 Hemagglutinin-Neuraminidase Newcastle disease virus B 454 A 454 
18 1EZL 2.00 Azurin Pseudomonas aeruginosa C 128 D 128 
19 1F46 1.50 Cell Division Protein Zipa Escherichia coli B 140 A 140 
20 1F88 2.80 Rhodopsin Bos taurus B 348 A 348 
21 1FX9 2.00 Phospholipase A2, Major Isoenzyme Sus scrofa B 124 A 124 
22 1G0A 2.04 Hemoglobin Beta Chain Bos taurus D 145 B 145 
23 1G21 3.00 Nitrogenase Iron Protein Azotobacter vinelandii H 289 G 289 
Continued 
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24 1GQ3 2.01 Aspartate Carbamoyltransferase Escherichia coli K-12 C 310 B 310 
25 1H6A 2.50 
Precursor Form Of Glucose-Fructose 
Oxidoreductase 
Zymomonas mobilis B 433 A 433 
26 1HFY 2.30 Alpha-Lactalbumin Capra hircus A 123 B 123 
27 1HQK 1.60 6,7-Dimethyl-8-Ribityllumazine Synthase Aquifex aeolicus E 154 D 154 
28 1HWU 2.10 PII Protein Herbaspirillum seropedicae B 112 A 112 
29 1I8F 1.75 Putative Snrnp SM-Like Protein Pyrobaculum aerophilum C 81 B 81 
30 1IFV 2.25 Protein LLR18B Lupinus luteus A 155 B 155 
31 1IIN 2.10 
Glucose-1-Phosphate 
Thymidylyltransferase 
Salmonella enterica A 292 B 292 
32 1KQD 1.90 
Oxygen-Insensitive NAD(P)H 
Nitroreductase 
Enterobacter cloacae A 217 B 217 
33 1KWS 2.10 Beta-1,3-Glucuronyltransferase 3 Homo sapiens B 261 A 261 
34 1MCI 2.70 
Immunoglobulin Lambda Dimer MCG 
(Light Chain) 
Homo sapiens B 216 A 216 
35 1MI3 1.80 Xylose Reductase Candida tenuis B 319 A 319 
36 1MSA 2.29 Agglutinin Galanthus nivalis B 109 C 109 
37 1N9S 3.50 Small Nuclear Ribonucleoprotein F Saccharomyces cerevisiae C 93 D 93 
38 1NYS 3.05 Activin Receptor Rattus norvegicus A 105 C 105 
39 1O81 1.50 Tryparedoxin II Crithidia fasciculata B 152 A 152 
40 1OBQ 1.85 Crustacyanin C1 Subunit Homarus gammarus B 181 A 181 
41 1OKT 1.90 Glutathione S-Transferase Plasmodium falciparum B 211 A 211 
42 1OME 2.30 Beta-Lactamase Staphylococcus aureus A 258 B 258 
43 1OPF 3.20 Matrix Porin Outer Membrane Protein F Escherichia coli B 340 A 340 
44 1P7L 2.50 S-Adenosylmethionine Synthetase EScherichia coli A 383 B 383 
45 1PA0 2.20 Myotoxic Phospholipase A2-Like Bothrops pauloensis B 121 A 121 
46 1PMO 2.30 Glutamate Decarboxylase Beta Escherichia coli A D 466 C 466 
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47 1PYG 2.87 Glycogen Phosphorylase B Oryctolagus cuniculus B 842 A 842 
48 1QPX 2.40 Papd Chaperone Escherichia coli A 218 B 218 
49 1R5T 2.00 Cytidine Deaminase Saccharomyces cerevisiae A 142 B 142 
50 1RFX 2.00 Resistin Mus musculus B 94 C 94 
51 1RH7 3.11 Resistin-Like Beta Mus musculus C 81 B 81 
52 1RQ7 2.60 Cell Division Protein FTSZ Mycobacterium tuberculosis B 382 A 382 
53 1S7Y 1.75 
Glutamate Receptor, Ionotropic Kainate 2 
Precursor 
Rattus norvegicus B 259 A 259 
54 1SND 1.84 Staphylococcal Nuclease Dimer Staphylococcus aureus A 143 B 143 
55 1TH7 1.68 Small Nuclear Riboprotein Protein Sulfolobus solfataricus L 81 K 81 
56 1U3R 2.21 Estrogen Receptor Beta Homo sapiens A 241 B 241 
57 1U3W 1.45 Alcohol Dehydrogenase Gamma Chain Homo sapiens B 374 A 374 
58 1UVC 2.00 Nonspecific Lipid Transfer Protein Oryza sativa A 91 B 91 
59 1VGQ 2.13 Formyl-Coenzyme A Transferase Oxalobacter formigenes B 427 A 427 
60 1VLZ 2.05 Chey Escherichia coli B 128 A 128 
61 1W0I 2.10 3-Oxoacyl Carrier Protein Synthase Arabidopsis thaliana B 431 A 431 
62 1W29 2.30 6,7-Dimethyl-8-Ribityllumazine Synthase Mycobacterium tuberculosis C 160 D 160 
63 1X1Z 1.45 Orotidine 5'-Phosphate Decarboxylase 
Methanothermobacter 
thermautotrophicus 
A 252 B 252 
64 1XBY 1.58 
3-Keto-L-Gulonate 6-Phosphate 
Decarboxylase 
Escherichia coli B 216 A 216 
65 1XMZ 1.38 GFP-Like Chromoprotein FP595 Anemonia sulcata B 243 A 243 
66 1YGP 2.80 Yeast Glycogen Phosphorylase Saccharomyces cerevisiae A 879 B 879 
67 1ZRS 1.50 Hypothetical Protein Pseudomonas aeruginosa B 317 A 317 
68 1ZUX 1.85 
Green To Red Photoconvertible GPF-Like 
Protein EOSFP 
Lobophyllia hemprichii D 226 B 226 
69 2AAX 1.75 Mineralocorticoid Receptor Homo sapiens A 275 B 275 
70 2AMT 2.30 
2-C-Methyl-D-Erythritol 2,4-
Cyclodiphosphate Synthase 
EScherichia coli C 159 B 159 
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71 2AQ3 2.30 T-Cell Receptor Beta Chain V Mus musculus G 112 A 112 
72 2AY5 2.40 Aromatic Amino Acid Aminotransferase Paracoccus denitrificans A 394 B 394 
73 2AYQ 3.00 3-Isopropylmalate Dehydrogenase Bacillus coagulans B 366 A 366 
74 2C3N 1.50 Glutathione S-Transferase Theta 1 Homo sapiens A 247 B 247 
75 2CHP 2.00 
Metalloregulation DNA-Binding Stress 
Protein 
Bacillus subtilis subsp. subtilis str. 
168 
C 153 D 153 
76 2COG 2.10 
branched chain aminotransferase 1, 
cytosolic 
Homo sapiens A 386 B 386 
77 2CUY 2.10 
Malonyl CoA-[acyl carrier protein] 
transacylase 
Thermus thermophilus HB8 B 305 A 305 
78 2D4V 1.90 Isocitrate Dehydrogenase isocitrate dehydrogenase B 429 A 429 
79 2DVG 2.78 Galactose-Binding Lectin Arachis hypogaea C 236 B 236 
80 2EV4 2.28 Hypothetical Protein Rv1264/MT1302 Mycobacterium tuberculosis B 222 A 222 
81 2FR6 2.07 Cytidine Deaminase Mus musculus C 146 D 146 
82 2GPV 2.85 Estrogen-Related Receptor Gamma Homo sapiens D 230 B 230 
83 2GQD 2.30 3-Oxoacyl-[Acyl-Carrier-Protein] Synthase 2 Staphylococcus aureus B 437 A 437 
84 2GVM 2.30 Hydrophobin-1 Trichoderma reesei B 75 A 75 
85 2H1L 3.16 Large T Antigen Simian virus 40 E 370 F 370 
86 2IPJ 1.80 Aldo-Keto Reductase Family 1 Member C2 Homo sapiens B 321 A 321 
87 2IYG 2.30 
Appa, Antirepressor Of PPSR, Sensor Of 
Blue Light 
Rhodobacter sphaeroides B 124 A 124 
88 2J3K 2.80 NADP-Dependent Oxidoreductase P1 Arabidopsis thaliana A 345 B 345 
89 2J96 2.25 Phycoerythrocyanin Alpha Chain Mastigocladus laminosus B 162 A 162 
90 2OL1 1.80 
Deoxyuridine 5'-Triphosphate 
Nucleotidohydrolase 
Vaccinia virus A 147 C 147 
91 2TNF 1.40 Protein (Tumor Necrosis Factor Alpha) Mus musculus B 156 A 156 
92 4AKE 2.20 Adenylate Kinase Escherichia coli A 214 B 214 
93 6PFK 2.60 Phosphofructokinase Geobacillus stearothermophilus C 319 D 319 
94 7TIM 1.90 Triosephosphate Isomerase Saccharomyces cerevisiae B 247 A 247 
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List of PP complexes from the ABC dataset comprised of heterodimer complexes (Table B). 
 
 
No 
PDB 
ID 
Resolution 
(Å) 
Chain 
one 
Name of chain one Length 
Chain 
two 
Name of chain two Length 
1 15C8 2.50 L IGG 5C8 FAB (Light Chain) 213 H IGG 5C8 FAB (Heavy Chain) 217 
2 1A6U 2.10 H B1-8 Fv (Heavy Chain) 120 L B1-8 FV (Light Chain) 108 
3 1AHW 3.00 F Tissue Factor 219 A Immunoglobulin FAB 5G9 (Light Chain) 214 
4 1AVA 1.90 A Barley Alpha-Amylase 2 403 C Barley Alpha-Amylase/Subtilisin Inhibitor 181 
5 1AY7 1.70 A Guanyl-Specific Ribonuclease SA 96 B Barstar 89 
6 1AZZ 2.30 A Collagenase 226 C Ecotin 142 
7 1BMF 2.85 F Bovine Mitochondrial F1-Atpase 482 B Bovine Mitochondrial F1-Atpase 510 
8 1BVN 2.50 P Alpha-amylase 496 T Tendamistat 71 
9 1BZX 2.10 E Protein (Trypsin) 222 I Protein (Bovine Pancreatic Trypsin Inhibitor) 58 
10 1DFJ 2.50 E Ribonuclease A 124 I Ribonuclease Inhibitor 456 
11 1DPJ 1.80 A Proteinase A 329 B Proteinase Inhibitor IA3 Peptide 33 
12 1E0F 3.10 E Thrombin 259 J Haemadin 57 
13 1EYS 2.20 H Photosynthetic Reaction Center 259 M Photosynthetic Reaction Center 324 
14 1F45 2.80 A Interleukin-12 Beta Chain 306 B Interleukin-12 Alpha Chain 197 
15 1FAK 2.10 H 
Protein (Blood Coagulation Factor 
Viia) 
254 I Protein (5l15) 55 
16 1FI8 2.20 A Natural Killer Cell Protease 1 228 C Ecotin 84 
17 1G3N 2.90 A Cyclin-Dependent Kinase 6 326 B Cyclin-Dependent Kinase 6 Inhibitor 168 
18 1G6V 3.50 A Carbonic Anhydrase 260 K Antibody Heavy Chain 126 
19 1GXS 2.30 D 
P-(S)-Hydroxymandelonitrile Lyase 
Chain B 
158 C P-(S)-Hydroxymandelonitrile Lyase Chain A 270 
20 1HE8 3.00 B Transforming Protein P21/H-Ras-1 166 A 
Phosphatidylinositol 3-Kinase Catalytic 
Subunit, Gamma Isoform 
965 
21 1HJA 2.30 B Alpha-Chymotrypsin 131 I Ovomucoid Inhibitor 51 
22 1I3O 2.70 B Caspase 3 110 E Baculoviral Iap Repeat-Containing Protein 4 121 
23 1ICF 2.00 A Protein (Cathepsin L: Heavy Chain) 175 I Protein (Invariant Chain) 65 
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24 1JSU 2.30 B Cyclin A 260 C P27 84 
25 1JTH 2.00 D Syntaxin 1a 77 A SNAP25 82 
26 1JZD 2.30 B 
Thiol:Disulfide Interchange Protein 
DSBC 
220 C Thiol:Disulfide Interchange Protein dsbd 132 
27 1KQM 3.00 A Myosin Heavy Chain 835 C Myosin Essential Light Chain 156 
28 1MCV 1.80 A Elastase 1 240 I HEI-TOE I 28 
29 1N8O 2.00 C Chymotrypsin A, C Chain 97 E Ecotin 142 
30 1NHG 2.43 B Enoyl-Acyl Carrier Reductase 229 D Enoyl-Acyl Carrier Reductase 60 
31 1NMA 3.00 N N9 Neuraminidase 388 H Fab Nc10 122 
32 1NW9 2.40 B Catalytic Domain Of Caspase-9 238 A A Inhibitor Of Apoptosis Protein 3 91 
33 1O6S 1.80 A Internalin A 461 B E-Cadherin 105 
34 1OO9 X A Stromelysin-1 168 B Metalloproteinase Inhibitor 1 128 
35 1P0S 2.80 H Coagulation Factor X Precursor 254 E Ecotin Precursor 142 
36 1P4I 2.80 L Antibody Variable Light Chain 135 H Antibody Variable Light Chain 124 
37 1PPF 1.80 E Leukocyte Elastase 218 I Ovomucoid Inhibitor 56 
38 1PST 3.00 M Photosynthetic Reaction Center 296 H Photosynthetic Reaction Center 237 
39 1QGE 1.70 D Protein (Triacylglycerol Hydrolase) 222 E Protein (Triacylglycerol Hydrolase) 97 
40 1QRN 2.80 D T-Cell Receptor, Alpha Chain 200 E T-Cell Receptor, Beta Chain 243 
41 1R8Q 1.86 A ADP-Ribosylation Factor 1 181 E Arno 203 
42 1S4Y 2.30 B Inhibin Beta A Chain 116 A Activin Receptor Type IIB Precursor 98 
43 1SC1 2.60 A Interleukin-1 Beta Convertase 178 B Interleukin-1 Beta Convertase 88 
44 1SGF 3.15 G Nerve Growth Factor 237 B Nerve Growth Factor 118 
45 1SGR 1.80 E Streptomyces Griseus Proteinase B 185 I Turkey Ovomucoid Inhibitor 51 
46 1STF 2.40 E Papain 212 I Stefin B 98 
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47 1SUV 1.75 D Serotransferrin, N-Lobe 329 F Serotransferrin, C-Lobe 345 
48 1T6G 1.80 C Endo-1,4-Beta-Xylanase I 184 A Xylanase Inhibitor 381 
49 1UGH 1.90 E Protein (Uracil-Dna Glycosylase) 223 I Protein (Uracil-Dna Glycosylase Inhibitor) 82 
50 1X1U 2.30 A Ribonuclease 110 D Barstar 89 
51 1XX9 2.20 B Coagulation Factor XI 238 D Ecotin 142 
52 1Y48 1.84 E Subtilisin BPN' 281 I Chymotrypsin Inhibitor 2 64 
53 1YI5 4.20 C Acetylcholine-Binding Protein 210 H Long Neurotoxin 1 71 
54 1YRQ 2.10 A 
Periplasmic [NiFe] Hydrogenase 
Small Subunit 
264 H 
Periplasmic [Nife] Hydrogenase Large 
Subunit 
549 
55 1ZJD 2.60 A 
Catalytic Domain of Coagulation 
Factor XI 
237 B 
Kunitz Protease Inhibitory Domain of 
Protease Nexin II 
57 
56 2AGY 1.10 B Aromatic Amine Dehydrogenase 361 D Aromatic Amine Dehydrogenase 135 
57 2B42 2.50 B Endo-1,4-beta-xylanase A 185 A Xylanase Inhibitor-I 381 
58 2BE6 2.50 A Calmodulin 2 150 D 
Voltage-Dependent L-Type Calcium Channel 
Alpha-1C Subunit 
37 
59 2BEX 1.99 C Nonsecretory Ribonuclease 135 A Ribonuclease Inhibitor 460 
60 2BL0 1.75 B Myosin Regulatory Light Chain 145 A Major Plasmodial Myosin Heavy Chain 63 
61 2BTO 2.50 T Thioredoxin 1 108 A Tubulin Btuba 473 
62 2D26 3.20 A Alpha-1-Antitrypsin 358 B Alpha-1-Antitrypsin 36 
63 2DSQ 2.80 I Insulin-Like Growth Factor IB 70 G Insulin-Like Growth Factor-Binding Protein 1 94 
64 2FHZ 1.15 A Colicin-E5 Immunity Protein 109 B Colicin-E5 108 
65 2G2U 1.60 A Beta-lactamase SHV-1 265 B Beta-lactamase inhibitory protein 165 
66 2GD4 3.30 I Antithrombin-III 443 H 
Coagulation Factor, Stuart Factor, Stuart-
Prower Factor, Contains: Factor X Light 
Chain; Factor X Heavy Chain; Activated 
Factor Xa Heavy Chain 
241 
67 2GMR 2.50 L 
Photosynthetic Reaction Center 
Protein L Chain 
281 M 
Photosynthetic Reaction Center Protein M 
Chain 
307 
68 2HI7 3.70 A 
Thiol:Disulfide Interchange Protein 
dsbA 
189 H Disulfide Bond Formation Protein B 176 
69 2I2R 3.35 H Kv Channel-Interacting Protein 1 180 D 
Potassium Voltage-Gated Channel 
Subfamily D Member 3 
144 
70 2IDO 2.10 A DNA Polymerase III Epsilon Subunit 186 C Hot Protein 83 
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71 2IJO 2.30 A Polyprotein 58 I Pancreatic Trypsin Inhibitor 58 
72 2IWG 2.35 D IG Gamma-1 Chain C 207 E 52 Kda Ro Protein 181 
73 2NX5 2.70 A HLA-B35 276 D ELS4 TCR Alpha Chain 188 
74 2NY7 2.30 G Envelope Glycoprotein Gp120 317 H Antibody B12, Heavy Chain 230 
75 2O8A 2.61 A 
Serine/Threonine-Protein 
Phosphatase Pp1-Gamma 
Catalytic Subunit 
329 I Protein phosphatase inhibitor 2 206 
76 2OCC 2.30 A Cytochrome C Oxidase 514 B Cytochrome C Oxidase 227 
77 2P1L 2.50 A Apoptosis Regulator Bcl-X 153 B Beclin 1 31 
78 2PRG 2.30 A 
Peroxisome Proliferator Activated 
Receptor Gamma 
271 C Nuclear Receptor Coactivator SRC-1 88 
79 2PVO 3.40 D Ferredoxin-1 96 A 
Ferredoxin-thioredoxin reductase, 
catalytic chain 
110 
80 3PCD 2.10 A Protocatechuate 3,4-Dioxygenase 200 M Protocatechuate 3,4-Dioxygenase 238 
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Table 3.3 Dataset of PP complexes from the PIBASE dataset 
 List of PP complexes from the PIBASE dataset were grouped into 335 homodimer complexes (Table A). 
 
No 
PDB 
ID 
Resolution 
(Å) 
Name of homodimer Scientific source 
Chain 
one 
Length 
Chain 
two 
Length 
1 1YM4 2.25 Beta-Secretase 1 Homo sapiens A 408 C 408 
2 1A2V 2.40 Methylamine Oxidase Ogataea angusta C 655 D 655 
3 1A7K 2.80 Glyceraldehyde-3-Phosphate Dehydrogenase Leishmania mexicana C 360 D 360 
4 1A8G 2.50 HIV-1 Protease 
Human immunodefiency 
virus 
A 99 B 99 
5 1A8T 2.55 Metallo-Beta-Lactamase Bacteroides fragilis A 232 B 232 
6 1A99 2.20 Putrescine-Binding Protein Escherichia coli B 344 A 344 
7 1AB8 2.20 Adenylyl Cyclase Rattus norvegia A 220 B 220 
8 1AE1 2.40 Tropinone Reductase-1 Datura stramonium A 273 B 273 
9 1AFS 2.50 3-Alpha-Hydroxysteroid Dehydrogenase Rattus norvegia A 323 B 323 
10 1AG1 2.36 Triosephosphate Isomerase Trypanosoma brucei O 250 T 250 
11 1AGR 2.80 Guanine Nucleotide-Binding Protein G(I) Rattus norvegia A 353 D 353 
12 1AJS 1.60 Aspartate Aminotransferase Sus scrofa A 412 B 412 
13 1AUW 2.50 Delta 2 Crytallin Anas platyrhynchos C 468 D 468 
14 1B3R 2.80 Protein (S-Adenosylhomocysteine Hydrolase) Rattus norvegia B 431 D 431 
15 1B7G 2.05 
Protein (Glyceraldehyde-3-phosphate 
dehydrogenase) 
Sulfolobus solfatarius O 340 Q 340 
16 1B8G 2.37 
Protein (1-Aminocyclopropane-1 carboxylate 
synthase) 
Malus domestica A 429 B 429 
17 1B9C 2.40 Protein (Green Fluorescent Protein) Auquorea victoria A 238 B 238 
18 1BAI 2.40 Protease Rous sarcoma virus A 124 B 124 
19 1BB3 1.80 Lysozyme Homo sapiens A 130 B 130 
20 1BD3 1.93 Uracil Phosphoribosyltransferase Toxoplasma gondii A 243 C 243 
21 1BEB 1.80 Beta-Lactoglobulin Bos taurus A 162 B 162 
22 1BJF 2.40 Neurocalcin Delta Bos taurus A 193 B 193 
23 1BKJ 1.80 NADPH-Flavin Oxidoreductase Vibrio harveyi A 240 B 240 
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24 1BKO 2.75 Thymidylate Synthase A Bacillus subtilis A 278 B 278 
25 1BQH 2.80 Protein (VSV8) Mus musculus G 129 H 129 
26 1BUQ X 
Protein (3-Ketosteroid isomerase-19-
nortestosterone-hemisuccinate) 
Comamonas testosteroni A 125 B 125 
27 1BVR 2.80 
Protein (Enoyl-Acyl Carrier Protein (ACP) 
Reductase) 
Mycobacterium tuberculosis A 268 B 268 
28 1BYE 2.80 Protein (Glutathione S-transferase) Zea mays C 213 D 213 
29 1C0T 2.70 HIV-1 Reverse Transcriptase Human immunodeficiency virus 1 A 560 B 440 
30 1CA7 2.50 Protein (Macrophage Migration Inhibitory Factor) Homo sapiens A 114 C 114 
31 1CBK 2.00 Pyrophosphokinase Haemophilus influenzae A 160 B 160 
32 1CH4 2.50 
Module-Substituted Chimera Hemoglobin Beta-
Alpha 
Homo sapiens A 146 B 146 
33 1CKI 2.30 Casein Kinase I Delta Rattus norvegia A 317 B 317 
34 1CMV 2.27 Human Cytomegalovirus Protease Human herpesvirus 5 A 256 B 256 
35 1CWQ 2.25 
Bacteriorhodopsin ("M" State Intermediate In 
Combination With Ground State) 
Halobacterium salinarum A 248 B 248 
36 1CYD 1.80 Carbonyl Reductase Mus musculus A 244 B 244 
37 1D0E 3.00 Reverse Transcriptase Moloney murine leukemia virus A 259 B 259 
38 1D0I 1.80 Type II 3-Dehydroquinate Hydratase Streptomyces coelicolor A 156 C 156 
39 1D0O 1.95 Bovine Endothelial Nitric Oxide Synthase Heme Bos taurus A 444 B 444 
40 1D1Z 1.40 SAP SH2 Domain Homo sapiens A 104 B 104 
41 1D4A 1.70 Quinone Reductase Homo sapiens A 273 C 273 
42 1D6S 2.30 O-Acetylserine Sulfhydrylase 
Salmonella enterica subsp. enterica 
serovar Typhimurium 
A 322 B 322 
43 1D6U 2.40 Copper Amine Oxidase Escherichia coli A 727 B 727 
44 1D8U 2.35 Non-Symbiotic Hemoglobin Oryza sativa A 166 B 166 
45 1DBQ 2.20 Purine Repressor Escherichia coli A 289 B 289 
46 1DCL 2.30 MCG Homo sapiens A 216 B 216 
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47 1DF8 1.51 Protein (Streptavidin) Streptomyces avidinii A 127 B 127 
48 1DIR 2.60 Dihydropteridine Reductase Rattus norvegia A 241 B 241 
49 1DO5 2.75 
Human Copper Chaperone For Superoxide Dismutase Domain 
II 
Homo sapiens A 154 C 154 
50 1DOF 2.10 Adenylosuccinate Lyase Pyrobaculum aerophilum B 403 C 403 
51 1DOH 2.10 Trihydroxynaphthalene Reductase Magnaporthe grisea A 283 B 283 
52 1DTY 2.14 
Adenosylmethionine-8-Amino-7-Oxononanoate 
Aminotransferase 
Escherichia coli A 429 B 429 
53 1DUG 1.80 
Chimera Of Glutathione S-Transferase-Synthetic Linker-C-
Terminal Fibrinogen Gamma Chain 
Schistosoma japonicum A 234 B 234 
54 1DVR 2.36 Adenylate Kinase Saccharomyces cerevisiae A 220 B 220 
55 1DZB 2.00 SCFV Fragment 1F9 Mus musculus A 253 B 253 
56 1E3I 2.08 Alcohol Dehydrogenase, Class II Mus musculus A 376 B 376 
57 1E3U 1.66 Beta-Lactamase Oxa-10 Pseudomonas aeruginosa A 246 C 246 
58 1E5E 2.18 Methionine Gamma-Lyase Trichomonas vaginalis G3 A 404 B 404 
59 1E7W 1.75 Pteridine Reductase Leishmania major A 291 B 291 
60 1E8T 2.50 Hemagglutinin-Neuraminidase 
Newcastle disease virus 
(strain Kansas) 
A 454 B 454 
61 1E9S 2.50 Conjugal Transfer Protein TRWB Escherichia coli E 437 F 437 
62 1ECE 2.40 Endocellulase E1 Acidothermus cellulolyticus A 358 B 358 
63 1ECS 1.70 Bleomycin Resistance Protein Klebsiella pneumoniae A 126 B 126 
64 1EE0 2.05 2-Pyrone Synthase Gerbera hybrid cultivar A 402 B 402 
65 1EI1 2.30 DNA Gyrase B Escherichia coli A 391 B 391 
66 1EK6 1.50 UDP-Galactose 4-Epimerase Homo sapiens A 348 B 348 
67 1EKX 1.95 Aspartate Transcarbamoylase Escherichia coli B 311 C 311 
68 1EM6 2.20 Liver Glycogen Phosphorylase Homo sapiens A 847 B 847 
69 1EQU 3.00 Protein (Estradiol 17 Beta-Dehydrogenase 1) Homo sapiens A 327 B 327 
70 1EWK 2.20 Metabotropic Glutamate Receptor Subtype 1 Rattus norvegia A 490 B 490 
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71 1EZR 2.50 Nucleoside Hydrolase Leishmania major A 314 B 314 
72 1F1J 2.35 Caspase-7 Protease Homo sapiens A 305 B 305 
73 1F2D 2.00 1-Aminocyclopropane-1-Carboxylate Deaminase Cyberlindnera saturnus A 341 B 341 
74 1F3T 2.00 Ornithine Decarboxylase Trypanosoma brucei C 425 D 425 
75 1F5P 2.90 Hemoglobin V Petromyzon marinus A 149 B 149 
76 1F6B 1.70 SAR1 Cricetulus griseus A 198 B 198 
77 1F6R 2.20 Alpha-Lactalbumin Bos taurus A 123 C 123 
78 1FR1 2.00 Beta-Lactamase Citrobacter freundii A 361 B 361 
79 1FTM 1.70 Glutamate Receptor Subunit 2 Rattus norvegia A 263 C 263 
80 1FUJ 2.20 PR3 Homo sapiens A 221 D 221 
81 1G1A 2.50 
DTDP-D-glucose 4,6-Dehydratase Salmonella 
Enterica 
Salmonella enterica A 352 B 352 
82 1G2O 1.75 Purine Nucleoside Phosphorylase 
Mycobacterium 
tuberculosis 
A 268 C 268 
83 1G4A 3.00 Atp-Dependent Protease Hslv Escherichia coli B 175 A 175 
84 1G5Q 2.57 Epidermin Modifying Enzyme Epid 
Staphylococcus 
epidermidis 
A 181 D 181 
85 1G6O 2.50 CAG-Alpha Helicobacter pylori A 330 B 330 
86 1G6Y 2.80 URE2 Protein 
Saccharomyces 
cerevisiae 
A 261 B 261 
87 1G85 1.80 Odorant-Binding Protein Bos taurus A 159 B 159 
88 1G8Y 2.40 Regulatory Protein REPA Escherichia coli C 279 D 279 
89 1GEG 1.70 Acetoin Reductase Klebsiella pneumoniae B 256 C 256 
90 1GH7 3.00 Cytokine Receptor Common Beta Chain Homo sapiens A 419 B 419 
91 1GMY 1.90 Cathepsin B Homo sapiens A 261 B 261 
92 1GNX 1.68 Beta-Glucosidase Streptomyces sp. A 479 B 479 
93 1GP7 2.60 Phospholipase A2 Ophiophagus hannah A 151 B 151 
94 1GPM 2.20 GMP Synthetase Escherichia coli K12 A 525 B 525 
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95 1GR7 1.80 Azurin Pseudomonas aeruginosa A 128 D 128 
96 1GRI 3.10 Growth Factor Bound Protein 2 Homo sapiens A 217 B 217 
97 1GTV 1.55 Thymidylate Kinase 
Mycobacterium 
tuberculosis 
A 214 B 214 
98 1GWN 2.10 RHO-Related GTP-Binding Protein Rhoe Mus musculus A 205 C 205 
99 1GYL 3.00 Glycolate Oxidase Spinacia oleracea A 369 B 369 
100 1GZ6 2.38 Estradiol 17 Beta-Dehydrogenase 4 Rattus norvegia A 319 B 319 
101 1GZM 2.65 Rhodopsin Bos taurus A 349 B 349 
102 1H48 2.30 
2C-Methyl-D-Erythritol-2,4-Cyclodiphosphate 
Synthase 
Escherichia coli BL21 A 161 B 161 
103 1H4G 1.10 Xylanase (Bacillus) agaradhaerens A 207 B 207 
104 1H5B 1.85 Murine T Cell Receptor (TCR) Valpha Domain Mus musculus A 113 B 113 
105 1H5Q 1.50 NADP-Dependent Mannitol Dehydrogenase Agaricus bisporus A 265 B 265 
106 1H8V 1.90 Endo-Beta-1,4-Glucanase Trichoderma reesei D 218 E 218 
107 1HAK 3.00 Annexin V Homo sapiens A 320 B 320 
108 1HG4 2.40 Ultraspiracle Drosophila melanogaster A 279 D 279 
109 1HKV 2.60 Diaminopimelate Decarboxylase 
Mycobacterium 
tuberculosis H37RV 
A 453 B 453 
110 1HP0 2.10 
Inosine-Adenosine-Guanosine-Preferring Nucleoside 
Hydrolase 
Trypanosoma vivax A 339 B 339 
111 1HR6 2.50 Mitochondrial Processing Peptidase Alpha Subunit Saccharomyces cerevisiae A 475 E 475 
112 1I0Z 2.10 L-Lactate Dehydrogenase H Chain Homo sapiens A 333 B 333 
113 1I41 3.20 Cystathionine Gamma-Synthase Nicotiana tabacum F 445 G 445 
114 1I4U 1.15 Crustacyanin Homarus gammanus A 181 B 181 
115 1I7I 2.35 Peroxisome Proliferator Activated Receptor Gamma Homo sapiens A 292 B 292 
116 1I85 3.20 T Lymphocyte Activation Antigen CD86 Homo sapiens A 110 B 110 
117 1II6 2.10 Kinesin-Related Motor Protein EG5 Homo sapiens A 368 B 368 
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118 1IJL 2.60 Phospholipase A2 Deinagkistrodon acutus A 123 B 123 
119 1IY8 1.60 Levodione Reductase Leifsonia aquatica B 267 C 267 
120 1IYK 2.30 Myristoyl-COA:Protein N-Myristoyltransferase Candida albicans A 392 B 392 
121 1IZ1 2.50 LYSR-Type Regulatory Protein Cupriavidus necator A 294 P 294 
122 1J7E 2.55 Vitamin D Binding Protein Homo sapiens A 458 B 458 
123 1J90 2.56 Deoxyribonucleoside Kinase Drosophila melanogaster A 230 B 230 
124 1JDS 1.80 5'-Methylthioadenosine Phosphorylase Sulfolobus solfatarius A 236 C 236 
125 1JG8 1.80 L-Allo-Threonine Aldolase Thermotoga maritima A 347 B 347 
126 1JKF 2.40 Myo-Inositol-1-Phosphate Synthase Saccharomyces cerevisiae A 533 B 533 
127 1JSW 2.70 L-Aspartate Ammonia-Lyase Escherichia coli A 478 D 478 
128 1JT0 2.90 
Hypothetical Transcriptional Regulator In Qaca 
5'Region 
Staphylococcus aureus A 194 C 194 
129 1K2O 1.65 Cytochrome P450CAM Pseudomonas putida A 414 B 414 
130 1K3F 2.50 Uridine Phosphorylase Escherichia coli A 253 D 253 
131 1KBU 2.20 Cre Recombinase Enterobacteria phage P1 A 349 B 349 
132 1KCZ 1.90 Beta-Methylaspartase Clostridium tetanomorphum A 419 B 419 
133 1KI9 2.76 Adenylate Kinase 
Methanothermococcus 
thermolithotrophicus 
A 192 B 192 
134 1KOB 2.30 Twitchin Aplysia californica A 387 B 387 
135 1KRU 2.80 Galactoside O-Acetyltransferase EScherichia coli A 203 C 203 
136 1KXJ 2.80 Amidotransferase HISH Thermotoga maritima A 205 B 205 
137 1L8X 2.70 Ferrochelatase Saccharomyces cerevisiae A 362 B 362 
138 1LBH 3.20 
Intact Lactose Operon Repressor With Gratuitous 
Inducer IPTG 
EScherichia coli A 360 B 360 
139 1LLU 2.30 Alcohol Dehydrogenase Pseudomonas aeruginosa E 342 F 342 
140 1LRT 2.20 Inosine-5'-Monophosphate Dehydrogenase Tritrichomonas suis A 376 B 376 
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141 1M43 2.40 Plasmepsin II Plasmodium falciparum A 331 B 331 
142 1M48 1.95 Interleukin-2 Homo sapiens A 133 B 133 
143 1M7N 2.70 Insulin-Like Growth Factor I Receptor Homo sapiens A 322 B 322 
144 1M7W 2.80 Hepatocyte Nuclear Factor 4-Alpha Rattus rattus A 250 B 250 
145 1MCZ 2.80 Benzoylformate Decarboxylase Pseudomonas putida A 582 B 582 
146 1MPY 2.80 Catechol 2,3-Dioxygenase Pseudomonas putida A 307 C 307 
147 1MRU 3.00 Probable Serine/Threonine-Protein Kinase Pknb 
Mycobacterium 
tuberculosis 
A 311 B 311 
148 1MZJ 2.10 Beta-Ketoacylsynthase III Streptomyces sp. R1128 A 339 B 339 
149 1MZN 1.90 RXR Retinoid X Receptor Homo sapiens A 240 C 240 
150 1N0H 2.80 Acetolactate Synthase 
Saccharomyces 
cerevisiae 
A 677 B 677 
151 1N0S 2.00 Bilin-Binding Protein Pieris brassicae A 184 B 184 
152 1N1A 2.40 FKBP52 Homo sapiens A 140 B 140 
153 1N4O 1.85 L2 beta-lactamase 
Stenotrophomonas 
maltophilia 
A 276 B 276 
154 1N7G 2.20 GDP-D-Mannose-4,6-Dehydratase Homo sapiens A 381 B 381 
155 1N9E 1.65 Lysyl Oxidase Komagataella pastoris A 787 B 787 
156 1NBU 1.60 Probable Dihydroneopterin Aldolase 
Mycobacterium 
tuberculosis 
B 119 C 119 
157 1NFQ 2.40 Putative Oxidoreductase Rv2002 
Mycobacterium 
tuberculosis 
A 260 B 260 
158 1NKS 2.57 Adenylate Kinase Sulfolobus acidocaldarius A 194 B 194 
159 1NTO 1.94 NAD-Dependent Alcohol Dehydrogenase Sulfolobus solfataricus C 347 D 347 
160 1NW4 2.20 Uridine Phosphorylase, Putative 
Plasmodium falciparum 
3D7 
A 276 B 276 
161 1NX9 2.20 Alpha-Amino Acid Ester Hydrolase Acetobacter pasteurianus B 652 D 652 
162 1O4S 1.90 Aspartate Aminotransferase Thermotoga maritima A 389 B 389 
163 1O5I 2.50 3-Oxoacyl-(Acyl Carrier Protein) Reductase Thermotoga maritima A 249 D 249 
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164 1O5O 2.30 Uracil Phosphoribosyltransferase Thermotoga maritima A 221 B 221 
165 1O61 1.90 Aminotransferase Campylobacter jejuni A 394 B 394 
166 1O63 2.00 ATP Phosphoribosyltransferase THermotoga maritima A 219 B 219 
167 1O6E 2.30 Capsid Protein P40 Human herpesvirus 4 A 235 B 235 
168 1O9J 2.40 Aldehyde Dehydrogenase, Cytosolic 1 Elephantulus edwardii A 501 B 501 
169 1OAT 2.50 Ornithine Aminotransferase Homo sapiens B 439 C 439 
170 1OD2 2.70 Acetyl-Coenzyme A Carboxylase Saccharomyces cerevisiae A 805 B 805 
171 1ODL 2.10 Purine Nucleoside Phosphorylase Thermus thermophilus HB8 A 235 B 235 
172 1OE7 1.80 Glutathione S-Transferase Schistosoma haematobium A 211 B 211 
173 1OJ6 1.95 Neuroglobin Homo sapiens A 151 B 151 
174 1OME 2.30 Beta-Lactamase Staphylococcus aureus A 258 B 258 
175 1OPL 3.42 Proto-Oncogene Tyrosine-Protein Kinase Homo sapiens A 537 B 537 
176 1ORR 1.50 CDP-Tyvelose-2-Epimerase 
Salmonella enterica subsp. 
enterica serovar Typhi 
A 347 B 347 
177 1ORT 3.00 Ornithine Transcarbamoylase Pseudomonas aeruginosa C 335 D 335 
178 1ORW 2.84 Dipeptidyl Peptidase IV Sus scrofa B 728 D 728 
179 1OVL 2.20 
Orphan Nuclear Receptor NURR1 (MSE 414, 
496, 511) 
Homo sapiens A 271 B 271 
180 1OVM 2.65 Indole-3-Pyruvate Decarboxylase Enterobacter cloacae B 552 D 552 
181 1OYJ 1.95 Glutathione S-Transferase Oryza sativa C 231 D 231 
182 1OZF 2.30 Acetolactate Synthase, Catabolic Klebsiella pneumoniae A 566 B 566 
183 1P0K 1.90 Isopentenyl-Diphosphate Delta-Isomerase Bacillus subtilis A 349 B 349 
184 1P4E 2.70 Recombinase FLP Protein Saccharomyces cerevisiae A 429 D 429 
185 1P60 1.96 Deoxycytidine Kinase Homo sapiens A 263 B 263 
186 1P7C 2.10 Thymidine Kinase 
Herpes simplex virus (type 1 / 
strain 17) 
A 343 B 343 
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187 1P93 2.70 Glucocorticoid Receptor Homo sapiens A 280 C 280 
188 1PKG 2.90 C-Kit Protein Homo sapiens A 329 B 329 
189 1PV4 3.00 Transcription Termination Factor Rho EScherichia coli C 419 D 419 
190 1PWE 2.80 L-Serine Dehydratase Rattus norvegia C 327 D 327 
191 1PWX 1.80 Halohydrin Dehalogenase Agrobacterium tumefaciens B 254 C 254 
192 1PY4 2.90 Beta-2-Microglobulin Precursor Homo sapiens A 100 C 100 
193 1Q0C 2.10 Homoprotocatechuate 2,3-Dioxygenase Brevibacterium fuscum A 365 C 365 
194 1Q3D 2.20 Glycogen Synthase Kinase-3 Beta Homo sapiens A 424 B 424 
195 1Q3G 2.65 
UDP-N-Acetylglucosamine 1-
Carboxyvinyltransferase 
Enterobacter cloacae A 419 B 419 
196 1Q57 3.45 DNA Primase/Helicase Enterobacteria phage T7 A 503 C 503 
197 1Q5Q 2.60 Proteasome Alpha-Type Subunit 1 Rhodococcus erythropolis C 259 B 259 
198 1Q6T 2.30 
Protein-Tyrosine Phosphatase, Non-Receptor 
Type 1 
Homo sapiens A 310 B 310 
199 1Q8M 2.60 
Triggering Receptor Expressed On Myeloid Cells 
1 
Homo sapiens A 127 B 127 
200 1QPB 2.40 Pyruvate Decarboxylase (Form B) 
Saccharomyces pastorianus 
Weihenstephan 34/70 
A 563 B 563 
201 1QZF 2.80 
Bifunctional Dihydrofolate Reductase-Thymidylate 
Synthase 
Cryptosporidium hominis C 521 D 521 
202 1R5K 2.70 Estrogen Receptor Homo sapiens A 261 C 261 
203 1RD5 2.02 Tryptophan Synthase Alpha Chain, Chloroplast Zea mays A 262 B 262 
204 1RD7 2.60 Dihydrofolate Reductase EScherichia coli A 159 B 159 
205 1RE5 2.60 3-Carboxy-Cis,Cis-Muconate Cycloisomerase Pseudomonas putida KT2440 B 450 C 450 
206 1RJN 2.30 menB Mycobacterium tuberculosis A 339 B 339 
207 1RKX 1.80 CDP-Glucose-4,6-Dehydratase Yersinia pseudotuberculosis A 357 D 357 
208 1RPY 2.30 Adaptor Protein APS Rattus norvegia A 114 B 114 
209 1RQR 2.67 5'-Fluoro-5'-Deoxyadenosine Synthase Streptomyces cattleya A 299 C 299 
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210 1S2G 2.10 Purine Trans Deoxyribosylase Lactobacillus helveticus A 167 B 167 
211 1SF2 2.40 4-Aminobutyrate Aminotransferase EScherichia coli A 426 B 426 
212 1SGF 3.15 Nerve Growth Factor Mus musculus G 237 Z 237 
213 1SL6 2.25 C-Type Lectin DC-Signr Homo sapiens D 184 A 184 
214 1SN0 1.90 Transthyretin Sparus aurata A 130 C 130 
215 1SP8 2.00 4-Hydroxyphenylpyruvate Dioxygenase Zea mays A 418 B 418 
216 1SPI 2.80 Fructose 1,6-Bisphosphatase Spinacia oleracea A 358 B 358 
217 1SQI 2.15 4-Hydroxyphenylpyruvic Acid Dioxygenase Rattus norvegia A 393 B 393 
218 1SQL 2.20 Dihydroneopterin Aldolase Arabidopsis thaliana D 146 E 146 
219 1SU2 2.70 Mutt/Nudix Family Protein Deinococcus radiodurans A 159 B 159 
220 1SXG 2.75 Glucose-Resistance Amylase Regulator Bacillus megaterium A 280 D 280 
221 1T2O 2.30 Sortase Staphylococcus aureus B 146 A 146 
222 1T8S 2.60 Amp Nucleosidase EScherichia coli A 484 B 484 
223 1T91 1.90 Ras-Related Protein Rab-7 Homo sapiens A 207 D 207 
224 1T97 2.70 Lysozyme Enterobacteria phage T4 A 175 B 175 
225 1TAH 3.00 Lipase Burkholderia glumae A 318 B 318 
226 1TC0 2.20 Endoplasmin Canis lupus familiaris A 236 B 236 
227 1TEX 2.60 Stf0 Sulfotransferase Mycobacterium smegmatis A 287 B 287 
228 1TF7 2.80 KaiC Synechococcus sp. B 525 C 525 
229 1TFC 2.40 Estrogen-Related Receptor Gamma Homo sapiens A 251 B 251 
230 1TPZ 2.00 Interferon-Inducible GTPase Mus musculus A 422 B 422 
231 1TW2 2.50 Carminomycin 4-O-Methyltransferase Streptomyces peucetius A 360 B 360 
232 1TXT 2.50 3-Hydroxy-3-Methylglutaryl-CoA Synthase Staphylococcus aureus A 388 B 388 
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233 1TZ3 2.90 Putative Sugar Kinase 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. LT2 
A 339 B 339 
234 1U0L 2.80 Probable GTPase engC Thermotoga maritima A 301 C 301 
235 1U1I 1.90 Myo-Inositol-1-Phosphate Synthase Archaeoglobus fulgidus DSM 4304 A 392 B 392 
236 1U46 2.00 Activated CDC42 Kinase 1 Homo sapiens A 291 B 291 
237 1U5Q 2.10 Serine/Threonine Protein Kinase TAO2 Rattus norvegia A 348 B 348 
238 1UB7 2.30 3-Oxoacyl-[Acyl-Carrier Protein] Synthase Thermus thermophilus HB8 A 322 B 322 
239 1UFH 2.20 YYCN Protein 
Bacillus subtilis subsp. subtilis str. 
168 
B 180 A 180 
240 1UI5 2.40 A-Factor Receptor Homolog Streptomyces coelicolor A3(2) A 215 B 215 
241 1UIM 2.15 Threonine Synthase Thermus thermophilus A 351 B 351 
242 1UIU 1.85 Nickel-Binding Periplasmic Protein EScherichia coli A 502 B 502 
243 1UMO 2.59 Cytoglobin Homo sapiens A 190 B 190 
244 1UPA 2.35 Carboxyethylarginine Synthase Streptomyces clavuligerus B 573 D 573 
245 1URZ 2.70 Envelope Protein 
Tick-borne encephalitis virus 
(WESTERN SUBTYPE) 
B 401 C 401 
246 1USI 1.80 Leucine-Specific Binding Protein Escherichia coli A 346 C 346 
247 1UTR X Uteroglobin Rattus norvegia A 96 B 96 
248 1UU0 2.85 Histidinol-Phosphate Aminotransferase Thermotoga maritima A 335 B 335 
249 1UZM 1.49 3-Oxoacyl-[Acyl-Carrier Protein] Reductase Mycobacterium tuberculosis H37Rv A 247 B 247 
250 1V2I 2.20 Hemagglutinin-Neuraminidase Glycoprotein Human parainfluenza virus 3 A 431 B 431 
251 1V4J 2.85 Octoprenyl-Diphosphate Synthase Thermotoga maritima A 299 B 299 
252 1VC8 2.00 NDX1 Thermus thermophilus HB8 A 126 B 126 
253 1VDM 2.50 Purine Phosphoribosyltransferase Pyrococcus horikoshii B 153 H 153 
254 1VDW 1.30 Hypothetical Protein PH1897 Pyrococcus horikoshii A 254 B 254 
255 1VEA 2.80 Hut Operon Positive Regulatory Protein Bacillus subtilis A 148 B 148 
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256 1VHW 1.54 Purine Nucleoside Phosphorylase Vibrio cholerae A 253 D 253 
257 1VIQ 2.40 ADP-Ribose Pyrophosphatase Escherichia coli B 220 C 220 
258 1VIY 1.89 Dephospho-CoA Kinase Escherichia coli A 218 B 218 
259 1VKG 2.20 Histone Deacetylase 8 Homo sapiens A 377 B 377 
260 1VM6 2.27 Dihydrodipicolinate Reductase THermotoga maritima B 228 D 228 
261 1VPX 2.40 Protein (Transaldolase (EC 2.2.1.2)) THermotoga maritima B 230 C 230 
262 1W0M 2.50 Triosephosphate Isomerase Thermoproteus tenax B 226 D 226 
263 1W2Z 2.24 Amine Oxidase, Copper Containing Pisum sativum A 649 B 649 
264 1W59 2.70 Cell Division Protein FTSZ Homolog 1 
Methanocaldococcus 
jannaschii 
A 364 B 364 
265 1W6T 2.10 Enolase 
Streptococcus 
pneumoniae TIGR4 
A 444 B 444 
266 1W6U 1.75 2,4-Dienoyl-Coa Reductase, Mitochondrial Precursor Homo sapiens A 302 B 302 
267 1W91 2.20 Beta-Xylosidase 
Geobacillus 
stearothermophilus 
F 503 G 503 
268 1WC1 1.93 Adenylate Cyclase Arthrospira platensis B 226 C 226 
269 1WUE 2.10 
Mandelate Racemase/Muconate Lactonizing Enzyme 
Family Protein 
Enterococcus faecalis 
V583 
A 386 B 386 
270 1WYE 2.80 2-Keto-3-Deoxygluconate Kinase Sulfolobus tokodaii str. 7 A 311 B 311 
271 1WZ8 1.80 Enoyl-CoA Hydratase 
Thermus thermophilus 
HB8 
A 264 B 264 
272 1X27 2.70 Proto-Oncogene Tyrosine-Protein Kinase LCK Homo sapiens A 167 E 167 
273 1XCA 2.30 Cellular Retinoic Acid Binding Protein Type II Homo sapiens A 137 B 137 
274 1XED 1.90 Polymeric-Immunoglobulin Receptor Homo sapiens A 117 B 117 
275 1XG5 1.53 ARPG836 Homo sapiens A 279 B 279 
276 1XGM 2.80 Methionine Aminopeptidase Pyrococcus furiosus A 295 B 295 
277 1XI9 2.33 Putative Transaminase 
Pyrococcus furiosus DSM 
3638 
A 406 B 406 
278 1XKQ 2.10 Short-Chain Reductase Family Member (5D234) Caenorhabditis elegans A 280 B 280 
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279 1XNX 2.90 Constitutive Androstane Receptor Mus musculus A 256 B 256 
280 1XSE 2.90 11beta-Hydroxysteroid Dehydrogenase Type 1 Cavia porcellus A 295 B 295 
281 1XTT 1.80 Probable Uracil Phosphoribosyltransferase Sulfolobus solfataricus B 216 C 216 
282 1XYG 2.19 
Putative N-Acetyl-Gamma-Glutamyl-Phosphate 
Reductase 
Arabidopsis thaliana B 359 C 359 
283 1Y1M 1.80 Glutamate [NMDA] Receptor Subunit Zeta 1 Rattus norvegia A 292 B 292 
284 1Y1P 1.60 Aldehyde Reductase II 
Sporidiobolus 
salmonicolor 
A 342 B 342 
285 1YDE 2.40 Retinal Dehydrogenase/Reductase 3 Homo sapiens B 270 P 270 
286 1YO6 2.60 Putative Carbonyl Reductase Sniffer Caenorhabditis elegans A 250 B 250 
287 1YP2 2.11 
Glucose-1-Phosphate Adenylyltransferase Small 
Subunit 
Solanum tuberosum C 451 D 451 
288 1YQ2 1.90 Beta-Galactosidase Arthrobacter sp. C2-2 A 1024 B 1024 
289 1YTA 2.20 Oligoribonuclease Escherichia coli A 180 B 180 
290 1YXM 1.90 Peroxisomal Trans 2-Enoyl Coa Reductase Homo sapiens A 303 B 303 
291 1Z08 1.80 Ras-Related Protein Rab-21 Homo sapiens B 170 D 170 
292 1Z1B 3.80 Integrase 
Enterobacteria phage 
lambda 
A 356 B 356 
293 1Z5A 2.20 Type II DNA Topoisomerase VI Subunit B Sulfolobus shibatae A 469 B 469 
294 1ZEM 1.90 Xylitol Dehydrogenase Gluconobacter oxydans E 262 G 262 
295 1ZPD 1.86 Pyruvate Decarboxylase Zymomonas mobilis B 568 E 568 
296 2A2G 2.90 Protein (Alpha-2u-Globulin) Rattus norvegia A 181 C 181 
297 2A7K 2.24 CarB 
Pectobacterium 
carotovorum 
G 250 H 250 
298 2AAW 2.40 Glutathione S-Transferase Plasmodium falciparum A 222 C 222 
299 2AG5 1.84 Dehydrogenase/Reductase (SDR Family) Member 6 Homo sapiens A 246 B 246 
300 2ANC 3.20 Guanylate Kinase Escherichia coli C 207 E 207 
301 2B4G 1.95 Dihydroorotate Dehydrogenase Trypanosoma brucei A 317 B 317 
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302 2BCK 2.80 
HLA Class I Histocompatibility Antigen, A-24 Alpha 
Chain 
Homo sapiens A 294 D 294 
303 2BD0 1.70 Sepiapterin Reductase Chlorobium tepidum TLS A 244 B 244 
304 2BTW 2.00 ALR0975 Protein Nostoc sp. PCC 7120 A 254 B 254 
305 2BVC 2.10 Glutamine Synthetase 1 
Mycobacterium tuberculosis 
H37Rv 
D 486 E 486 
306 2C7F 2.70 Alpha-L-Arabinofuranosidase 
Ruminiclostridium 
thermocellum 
A 513 D 513 
307 2CLT 2.67 Interstitial Collagenase Homo sapiens A 367 B 367 
308 2D1Y 1.65 Hypothetical Protein TT0321 Thermus thermophilus B 256 C 256 
309 2DFT 2.80 Shikimate Kinase Mycobacterium tuberculosis A 176 C 176 
310 2DNS 2.40 D-Amino Acid Amidase Ochrobactrum anthropi A 363 B 363 
311 2DW6 2.30 Bll6730 Protein Bradyrhizobium japonicum A 389 B 389 
312 2DY4 2.65 DNA Polymerase Enterobacteria phage RB69 D 903 B 903 
313 2EGH 2.20 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase 
Escherichia coli str. K-12 
substr. W3110 
B 424 A 424 
314 2EVO 1.70 Methionine Aminopeptidase Escherichia coli A 264 B 264 
315 2EW8 2.10 (S)-1-Phenylethanol Dehydrogenase 
Aromatoleum aromaticum 
EbN1 
B 249 D 249 
316 2F1G 1.90 Cathepsin S Homo sapiens A 220 B 220 
317 2F73 2.50 Fatty Acid-Binding Protein, Liver Homo sapiens A 149 B 149 
318 2FG6 2.80 Putative Ornithine Carbamoyltransferase 
Bacteroides fragilis NCTC 
9343 
C 338 D 338 
319 2FM6 1.75 Metallo-Beta-Lactamase L1 Stenotrophomonas maltophilia A 269 B 269 
320 2FYI 2.80 Hth-Type Transcriptional Regulator CBL Escherichia coli K-12 A 228 B 228 
321 2GF0 1.90 GTP-Binding Protein DI-RAS1 Homo sapiens A 199 B 199 
322 2GIC 2.92 Nucleocapsid Protein 
Vesicular stomatitis Indiana 
virus 
A 422 B 422 
323 2I6A 2.20 Adenosine Kinase Homo sapiens A 345 D 345 
324 2IFA 2.30 Hypothetical Protein SMU.260 Streptococcus mutans UA159 A 208 B 208 
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325 2IGO 1.95 Pyranose Oxidase Trametes ochracea C 623 D 623 
326 2IJ2 1.20 Cytochrome P450 BM3 Bacillus megaterium B 470 A 470 
327 2NUU 2.50 Ammonia Channel Escherichia coli B 415 C 415 
328 2O23 1.20 HADH2 Protein Homo sapiens A 265 B 265 
329 2O2Y 2.20 Enoyl-Acyl Carrier Reductase 
Plasmodium falciparum 
3D7 
C 349 D 349 
330 2OKR 2.00 Mitogen-Activated Protein Kinase 14 Homo sapiens A 366 D 366 
331 2PD3 2.50 Enoyl-[Acyl-Carrier-Protein] Reductase [NADH] Helicobacter pylori B 275 C 275 
332 2PMT 2.70 Glutathione Transferase Proteus mirabilis C 203 D 203 
333 2TAA 3.00 TAKA-Amylase A Aspergillus oryzae A 478 B 478 
334 3TAT 3.50 Tyrosine Aminotransferase Escherichia coli C 397 D 397 
335 7MDH 2.40 Protein (Malate Dehydrogenase) Sorghum bicolor D 375 C 375 
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List of PP complexes from the PIBASE dataset were grouped into 101 heterodimer complexes (Table B). 
No PDB ID 
Resolution 
(Å) 
Chain 
one Name of chain one Length 
Chain 
two Name of chain two Length 
1 1A22 2.60 B Growth Hormone Receptor 238 A Growth Hormone 191 
2 1A2K 2.50 C RAN 216 B Nuclear Transport Factor 2 127 
3 1A5A 1.90 A Tryptophan Synthase Alpha chain 268 B Tryptophan Synthase Beta Chain 397 
4 1A5A 1.90 B Tryptophan Synthase Beta chain 397 A Tryptophan Synthase Alpha Chain 268 
5 1ACB 2.00 E Alpha-Chymotrypsin 241 I Eglin C 63 
6 1AIG 2.60 P 
Photosynthetic Reaction Center (H 
Subunit) 
260 O 
Photosynthetic Reaction Center (M 
Subunit) 
307 
7 1AIG 2.60 L 
Photosynthetic Reaction Center (L 
Subunit) 
281 H 
Photosynthetic Reaction Center (H 
Subunit) 
260 
8 1AIP 3.00 A Elongation Factor TU 405 C Elongation Factor TS 196 
9 1AR1 2.70 B Cytochrome Oxidase 298 A Cytochrome Oxidase 558 
10 1AZS 2.30 A VC1 220 B IIC2 212 
11 1AZS 2.30 C GS-ALPHA 402 B IIC2 212 
12 1AZZ 2.30 C Ecotin 142 A Collogenase 226 
13 1B6C 2.60 D TGF-B Superfamily Receptor Type 1 342 C FK506-Binding Protein 107 
14 1B7T 2.50 Y Myosin Regulatory Light Chain 156 A Myosin Heavy Chain 835 
15 1B7T 2.50 Z Myosin Essential Light Chain 156 A Myosin Heavy Chain 835 
16 1BCC 3.16 E 
Ubiquinol Cytochrome C 
Oxidoreductase 
196 D 
Ubiquinol Cytochrome C 
Oxidoreductase 
241 
17 1BCC 3.16 G 
Ubiquinol Cytochrome C 
Oxidoreductase 
81 C 
Ubiquinol Cytochrome C 
Oxidoreductase 
380 
18 1BGY 3.00 R Cytochrome BC1 Complex 110 O Cytochrome BC1 Complex 379 
19 1BI7 3.40 A Cyclin-Dependent Kinase 6 326 B Multiple Tumor Supressor 156 
20 1BMF 2.85 C Bovine Mitochondrial F1-Atpase 510 D Bovine Mitochondrial F1-Atpase 482 
21 1BML 2.90 A Plasmin 250 C Streptokinase 362 
22 1CD1 2.67 A CD1 315 B CD1 99 
23 1CD9 2.80 B Protein (G-CSF Receptor) 215 A 
Protein (Granulocyte Colony-
Stimulating Factor) 
175 
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24 1CN4 2.80 A Protein (Erythroprotein Receptor) 228 C Protein (Erythroprotein) 166 
25 1DN0 2.28 B 
IGM-Kappa Cold Agglutinin (Heavy 
Chain) 
232 A 
IGM-Kappa Cold Agglutinin (Light 
Chain) 
215 
26 1DN0 2.10 B 
IGM-Kappa Cold Agglutinin (Heavy 
Chain) 
232 A 
IGM-Kappa Cold Agglutinin (Light 
Chain) 
215 
27 1DPJ 1.80 A Proteinase A 329 B Proteinase Inhibitor IA3 Peptide 33 
28 1EOC 2.25 B 
Protocatechuate 3,4-Dioxygenase 
Beta Chain 
241 A 
Protocatechuate 3,4-Dioxygenase 
Alpha Chain 
209 
29 1EP1 2.20 A 
Dihydroorotate Dehydrogenase B 
(Pyrd Subunit) 
311 B 
Dihydroorotate Dehydrogenase B (Pyrk 
Subunit) 
261 
30 1EYS 2.20 M Photosynthetic Reaction Center 324 C Photosynthetic Reaction Center 382 
31 1EZV 2.30 A 
Ubiquinol-Cytochrome C Reductase 
Complex Core Protein I 
430 B 
Ubiquinol-Cytochrome C Reductase 
Complex Core Protein 2 
352 
32 1EZV 2.30 B 
Ubiquinol-Cytochrome C Reductase 
Complex Core Protein 2 
352 A 
Ubiquinol-Cytochrome C Reductase 
Complex Core Protein I 
430 
33 1EZV 2.30 C Cytochrome B 385 D Cytochrome C1 245 
34 1EZV 2.30 D Cytochrome C1 245 C Cytochrome B 385 
35 1F60 1.67 A Elongation Factor EEF1A 458 B Elongation Factor EEF1BA 94 
36 1F8U 2.90 A Acetylcholinesterase 583 B Fasciculin II 61 
37 1FJG 3.00 E 30s Ribosomal Protein S5 162 H 30s Ribosomal Protein S8 138 
38 1FRT 4.50 A Neonatal FC Receptor 269 B Beta 2-Microglobulin 99 
39 1FSK 2.90 J Major Pollen Allergen Bet V 1-A 159 L Immunoglobulin Kappa Light Chain 214 
40 1FVU 1.80 B Botrocetin Beta Chain 125 A Botrocetin Alpha Chain 133 
41 1FX0 3.20 B ATP Synthase Beta Chain 498 A Atp Synthase Alpha Chain 507 
42 1G73 2.00 C Inhibitors Of Apoptosis-Like Protein Ilp 121 A 
Second Mitochondria-Derived Activator 
Of Caspases 
162 
43 1G9M 2.20 C T-Cell Surface Glycoprotein Cd4 185 G Envelope Glycoprotein GP120 321 
44 1GPW 2.40 A Hisf Protein 253 B Amidotransferase HISH 201 
45 1HR6 2.50 D 
Mitochondrial Processing Peptidase 
Beta Subunit 
443 C 
Mitochondrial Processing Peptidase 
Alpha Subunit 
475 
Continued 
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46 1HXM 3.12 A Gamma-Delta T-Cell Receptor 229 B Gamma-Delta T-Cell Receptor 242 
47 1HXM 3.12 B Gamma-Delta T-Cell Receptor 242 A Gamma-Delta T-Cell Receptor 229 
48 1HYR 2.70 A 
NKG2-D Type Ii Integral Membrane 
Protein 
137 C MHC Class I Chain-Related Protein A 275 
49 1I1R 2.40 A Interleukin-6 Receptor Beta Chain 301 B Viral IL-6 167 
50 1I3R 2.40 D 
Fusion Protein Consisting Of Mhc E-
Beta-K Precursor, Glycine Rich 
Linker, And Hemoglobin Beta-2 Chain 
228 C 
H-2 Class II Histocompatibility Antigen, 
E-K Alpha Chain 
192 
51 1I85 3.20 D 
Cytotoxic T-Lymphocyte-Associated 
Protein 4 
110 B T Lymphocyte Activation Antigen CD86 126 
52 1JEB 2.10 A Hemoglobin Zeta Chain 142 D Hemoglobin Beta-Single Chain 146 
53 1JFF X A Tubulin Alpha Chain 451 B Tubulin Beta Chain 445 
54 1JWH 3.10 A Casein Kinase II, Alpha Chain 337 D Casein Kinase II Beta Chain 215 
55 1JWI 2.00 B Platelet Aggregation Inducer 125 A Bitiscetin 131 
56 1KFY 3.60 B 
Fumarate Reductase Iron-Sulfur 
Protein 
243 C 
Fumarate Reductase 15 Kda 
Hydrophobic Protein 
130 
57 1KFY 3.60 C 
Fumarate Reductase 15 Kda 
Hydrophobic Protein 
130 B 
Fumarate Reductase Iron-Sulfur 
Protein 
243 
58 1KFY 3.60 D 
Fumarate Reductase 13 Kda 
Hydrophobic Protein 
119 B 
Fumarate Reductase Iron-Sulfur 
Protein 
243 
59 1KSG 2.30 A Arf-Like Protein 2 186 B 
Retinal Rod Rhodopsin-Sensitive 
Cgmp 3',5'-Cyclic Phosphodiesterase 
Delta-Subunit 
152 
60 1LW6 1.50 E Subtilisin BPN 281 I Ubtilisin-Chymotrypsin Inhibitor-2A 63 
61 1M56 2.30 A Cytochrome C Oxidase 566 B Cytochrome C Oxidase 264 
62 1MF8 3.10 B Calcineurin B Subunit Isoform 1 170 A 
Calmodulin-Dependent Calcineurin A 
Subunit, Alpha Isoform 
373 
63 1MG2 2.25 O Amicyanin 105 N 
Methylamine Dehydrogenase, Light 
Chain 
131 
64 1NCC 2.50 N 
Influenza A Subtype N9 
Neuraminidase 
389 H 
IGG2A-Kappa NC41 FAB (Heavy 
Chain) 
221 
65 1NF3 2.10 B 
G25K GTP-Binding Protein, Placental 
Isoform 
195 D PAR-6B 128 
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66 1NFD 2.80 A N15 Alpha-Beta T-Cell Receptor 203 D N15 Alpha-Beta T-Cell Receptor 239 
67 1O5D 2.05 L Coagulation Factor VII 152 T Tissue factor 218 
68 1OGA 1.40 D 
T-Cell Receptor Alpha Chain V 
Region 
215 E T-Cell Receptor Beta Chain C Region 252 
69 1OGA 1.40 E T-Cell Receptor Beta Chain C Region 252 D T-Cell Receptor Alpha Chain V Region 215 
70 1P0S 2.80 E Ecotin Precursor 142 H Coagulation Factor X Precursor 254 
71 1P4B 2.35 L Antibody Variable Light Chain 135 H Antibody Variable Heavy Chain 124 
72 1PKQ 3.00 A (8-18C5) Chimeric Fab, Light Chain 241 B (8-18C5) Chimeric Fab, Heavy Chain 252 
73 1PYT 2.35 B Procarboxypeptidase A 309 A Procarboxypeptidase A 94 
74 1Q90 3.10 B Cytochrome B6 215 D Cytochrome B6-F Complex Subunit 4 159 
75 1QA9 3.20 A Human Cd2 Protein 102 D Human CD58 Protein 95 
76 1R4P 1.77 E Shiga-Like Toxin Type II B Subunit 70 A Shiga-Like Toxin Type II A Subunit 297 
77 1R8Q 1.86 E Arno 203 A ADP-Ribosylation Factor 1 181 
78 1SB2 1.90 A Rhodocetin Alpha Subunit 133 B Rhodocetin Beta Subunit 129 
79 1SPG 1.95 B Hemoglobin 147 A Hemoglobin 144 
80 1SQB 2.69 B 
Ubiquinol-Cytochrome C Reductase 
Complex Core Protein 2, 
Mitochondrial 
453 I 
Ubiquinol-Cytochrome C Reductase 8 
Kda Protein 
78 
81 1SQP 2.70 A 
Ubiquinol-Cytochrome-C Reductase 
Complex Core Protein I, Mitochondrial 
Precursor 
480 I 
Ubiquinol-Cytochrome C Reductase 
Iron-Sulfur Subunit, Mitochondrial 
Precursor (EC 1.10.2.2) (Rieske Iron-
Sulfur Protein) (RISP) [Contains: 
Ubiquinol-Cytochrome C Reductase 8 
Kda Protein (Complex III Subunit IX)] 
78 
82 1SVX 2.24 B Maltose-Binding Periplasmic Protein 395 A Ankyrin Repeat Protein Off7 169 
83 1UKM 1.90 A EMS16 A Chain 134 B EMS16 B Chain 128 
Continued 
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84 1UKV 1.50 G 
Secretory Pathway GDP Dissociation 
Inhibitor 
453 Y GTP-Binding Protein YPT1 206 
85 1UVQ 1.80 A 
HLA Class II Histocompatibility 
Antigen 
197 B Hla Class II Histocompatibility Antigen 198 
86 1VF5 3.00 A Cytochrome B6 215 B Subunit IV 160 
87 1X9F 2.60 J Globin II, Extracellular 145 K Globin III, Extracellular 153 
88 1XDK 2.90 B Retinoic Acid Receptor, Beta 303 A Retinoic Acid Receptor RXR-Alpha 238 
89 1XXD 2.91 B Coagulation Factor XI 238 C Ecotin 142 
90 1YTZ 3.00 C Troponin C 162 I Troponin I 182 
91 1YVB 2.70 A Falcipain 2 241 I Cystatin 111 
92 1Z7M 2.90 E ATP Phosphoribosyltransferase 208 A 
ATP Phosphoribosyltransferase 
Regulatory Subunit 
344 
93 1Z7X 1.95 X Ribonuclease I 129 W Ribonuclease Inhibitor 461 
94 2A9K 1.73 A Ras-Related Protein Ral-A 187 B Mono-ADP-Ribosyltransferase C3 223 
95 2A9K 1.73 B Mono-ADP-Ribosyltransferase C3 223 A Ras-Related Protein Ral-A 187 
96 2BEX 1.99 C Nonsecretory Ribonuclease 135 A Ribonuclease Inhibitor 460 
97 2G2U 1.60 A Beta-lactamase SHV-1 265 B Beta-Lactamase Inhibitory Protein 165 
98 2GJ7 5.00 E Glycoprotein E 401 B IG Gamma-1 Chain C Region 227 
99 2IG2 3.00 H 
IGG1-Lambda Kol FAB  (Heavy 
Chain) 
455 L IGG1-Lambda KOL FAB (Light Chain) 216 
100 2J12 1.50 B 
Coxsackievirus And Adenovirus 
Receptor 
128 A Fiber Protein 194 
101 2ONL 4.00 C 
MAP Kinase-Activated Protein Kinase 
2 
406 A Mitogen-Activated Protein Kinase 14 366 
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8.2 Supplementary Information for Chapter 4 
Table 4.1 List of the transcription factors targeted to STIM and ORAI genes with Pubmed ID 
(PMID), technique of experiments and cell types obtained from the CheA database.  
 
Gene TF 
PMID 
(Pubmed) Technique Cell Type 
STIM1 AR 20517297 CHIP-SEQ VCAP 
 E2F4 21247883 CHIP-SEQ LYMPHOBLASTOID 
 EGR1 20690147 CHIP-SEQ ERYTHROLEUKEMIA 
 ELK3 25401928 CHIP-SEQ HUVEC 
 FLI1 21571218 CHIP-SEQ MEGAKARYOCYTES 
 FOXA2 19822575 CHIP-SEQ HepG2 
 FOXP1 21924763 CHIP-SEQ HESC 
 GATA1 21571218 CHIP-SEQ MEGAKARYOCYTES 
 GATA1 19941826 CHIP-SEQ K562 
 GATA2 19941826 CHIP-SEQ K562 
 GATA2 21666600 CHIP-SEQ HMVEC 
 HNF4A 19822575 CHIP-SEQ HepG2 
 MITF 21258399 CHIP-SEQ MELANOMA 
 MYC 19915707 CHIP-SEQ AK7 
 NCOR1 26117541 CHIP-SEQ K562 
 PHF8 20622854 CHIP-SEQ HELA 
 RUNX1 17652178 CHIP-SEQ JURKAT 
 SCL 21571218 CHIP-SEQ MEGAKARYOCYTES 
 SOX2 21211035 CHIP-SEQ LN229_GBM 
 SPI1 20517297 CHIP-SEQ HL60 
 TP63 22573176 CHIP-SEQ HFKS 
 TRIM28 17542650 CHIP-SEQ NTERA2 
 TTF2 22483619 CHIP-SEQ HELA 
STIM2 AR 22383394 CHIP-SEQ PROSTATE_CANCER 
 AR 19668381 CHIP-SEQ PC3 
 AR 25329375 CHIP-SEQ VCAP 
 
CUX1 19635798 CHIP-SEQ MULTIPLE HUMAN CANCER CELL 
TYPES 
 E2F1 21310950 CHIP-SEQ MCF7 
 E2F4 17652178 CHIP-SEQ JURKAT 
 EGR1 20690147 CHIP-SEQ ERYTHROLEUKEMIA 
 ELK3 25401928 CHIP-SEQ HUVEC 
 FOXP1 21924763 CHIP-SEQ HESC 
 GABP 19822575 CHIP-SEQ HepG2 
 GATA1 21571218 CHIP-SEQ MEGAKARYOCYTES 
 GATA2 19941826 CHIP-SEQ K562 
 HOXB7 26014856 CHIP-SEQ BT474 
 MYCN 21190229 CHIP-SEQ SHEP-21N 
 
PAX3-
FKHR 20663909 CHIP-SEQ RHABDOMYOSARCOMA 
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 POU3F2 20337985 CHIP-SEQ 501MEL 
 PPARD 21283829 CHIP-SEQ MYOFIBROBLAST 
 RUNX1 17652178 CHIP-SEQ JURKAT 
 RUNX2 22187159 CHIP-SEQ PCA 
 SCL 21571218 CHIP-SEQ MEGAKARYOCYTES 
 SMAD4 21799915 CHIP-SEQ A2780 
 SOX11 23321250 CHIP-SEQ Z138-A519-JVM2 
 SOX2 21211035 CHIP-SEQ LN229_GBM 
 TOP2B 26459242 CHIP-SEQ MCF7 
 TP63 23658742 CHIP-SEQ EP156T 
 TTF2 22483619 CHIP-SEQ HELA 
 VDR 23849224 CHIP-SEQ CD4+ 
 WT1 25993318 CHIP-SEQ PODOCYTE 
 ZNF217 24962896 CHIP-SEQ MCF7 
ORAI1 BCL6 25482012 CHIP-SEQ CML/JURL-MK1 
 E2F4 21247883 CHIP-SEQ LYMPHOBLASTOID 
 ELK3 25401928 CHIP-SEQ HUVEC 
 FLI1 21571218 CHIP-SEQ MEGAKARYOCYTES 
 FOXA2 19822575 CHIP-SEQ HepG2 
 FOXP1 21924763 CHIP-SEQ HESC 
 FOXP2 23625967 CHIP-SEQ PFSK-1 AND SK-N-MC 
 GATA6 25053715 CHIP-SEQ YYC3 
 KLF5 25053715 CHIP-SEQ YYC3 
 MITF 21258399 CHIP-SEQ MELANOMA 
 MYC 22102868 CHIP-SEQ BL 
 PPARD 21283829 CHIP-SEQ MYOFIBROBLAST 
 RUNX1 21571218 CHIP-SEQ MEGAKARYOCYTES 
 SMAD4 21741376 CHIP-SEQ HESC 
 TFEB 21752829 CHIP-SEQ HELA 
ORAI2 EBNA2 21746931 CHIP-SEQ IB4-LCL 
 ELK3 25401928 CHIP-SEQ HUVEC 
 GATA1 19941826 CHIP-SEQ K562 
 GATA2 19941826 CHIP-SEQ K562 
 MITF 21258399 CHIP-SEQ MELANOMA 
 MYC 22102868 CHIP-SEQ BL 
 PPARD 21283829 CHIP-SEQ MYOFIBROBLAST 
 RBPJ 21746931 CHIP-SEQ IB4-LCL 
 RUNX1 21571218 CHIP-SEQ MEGAKARYOCYTES 
 TP63 22573176 CHIP-SEQ HFKS 
 VDR 24763502 CHIP-SEQ THP-1 
ORAI3 BCL6 25482012 CHIP-SEQ CML/JURL-MK1 
 ELF1 20517297 CHIP-SEQ JURKAT 
 ELK3 25401928 CHIP-SEQ HUVEC 
 FOXA1 25552417 CHIP-SEQ VCAP 
 GATA2 19941826 CHIP-SEQ K562 
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 GATA2 21666600 CHIP-SEQ HMVEC 
 GATA3 24758297 CHIP-SEQ MCF7 
 GATA4 25053715 CHIP-SEQ YYC3 
 HNF4A 19822575 CHIP-SEQ HepG2 
 MITF 21258399 CHIP-SEQ MELANOMA 
 NCOR1 26117541 CHIP-SEQ K562 
 PPARD 21283829 CHIP-SEQ MYOFIBROBLAST 
 SPI1 23547873 CHIP-SEQ NB4 
 SPI1 23127762 CHIP-SEQ K562 
  TFAP2C 20629094 CHIP-SEQ MCF7 
TF, transcription factor. 
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Table 4.2 List of the promoter sequences of STIM and ORAI genes obtained from the EPDnew 
database. 
Promoter 
Name Promoter Sequence 
STIM1_1 TTGGGGGCTGGGAGCTCGCCCCCGGGCCGAGCCGGGTCAGGCTGTTGTCGCCTCAGGCAG 
  CTCCTGGGAGGCTAACGTCGTGTCCTGGGCCTCTGTTTAGACAGCTCTAGAACTGAGGCG 
  AGTGGAGCAGCACCAAGGCCCGGAGATCGGGGCAGGGCAGCTGCTGTCGCCGCCGCCGCA 
  GGCCTGAGTTACCTGAGTAACTGCGGGTCAGGGACCCGCCCGACGGCCCGCGGTTGGCGC 
  TGGAGACTCTCGGTGGGGAAAGGGAAGCTGGGACTTGATCCTTTGCGCGGGATCCTGGCA 
  AAGACTAGCGCGGGCCGGGGGTCCGGGAGAGCCCGCTAGGGGCGGGGATTCCGGGGAGCC 
  GTCTTCACCGGTTATTCCGGGATCCAGCTGGGCGCTGGGGCTGGCCCGGGCTTCGCTGGG 
  GACCGGGCGGCGCGGGGCGGGCGCGGAGACGCACGCCCCCGCCCGCCCCGGGCCCGCCCC 
  GCGCCGCCCGCCCGCCTGGAAGCCGCTGTCCTGGGCCTGGCCGGTGTGCGTCCGCCTGCT 
  GGACCTGGGCACCGCCAGCCGCCTGGGCACGGGACTGGGCGGGGGCGCTGACCTCGGCCT 
STIM1_2 CTCATTTCTTTCATTGCTTACAAGTAGATAGCATTCCAGTTCATAGGTTTCTTTGAGAAA 
  TAGACTGTAGAAAAGACGACAATGTTTATTCTCATTAGTCAGACGAACTGCAGCACAAGT 
  GTTTCAAAGAGGAACCCCAAGAACTCCCAGGCTTGTAGGAAGCATCTGATTTTACATAAG 
  TTTGCACAGTAGGAAACTGAGGTCCTCGGGGAGGAACAAAGCAACTTATGATCAGACAAA 
  TGAGTCACTAGTAGAGCTGAAATGAGAAGCCAGATCTCCTAACCACTCCCACACCCCATC 
  ACAGTGCCTCACTGCGTCTCTTACTGGTGGGCTTGATTGCTTTCCAAGGCCAGAGAAGGA 
  AGTAGCTGTTCCTGTATGCTCAGACAGGAGTATAAATCACACTGTGATGTCAGAAGCTTC 
  TTTTCTAGCTGGAGAAATAAAGCTATGCATCAGAAAAGAGCACCAATCTTATAGAGTAGT 
  ATAGAATTAAGTGCTTACTTGTGGGACCTAGACCAGTGGTTTTCAACCTTTCATATCTTT 
  TACCCCCCTCCTCTTATATCCACTGTGTTCCAGCAGAAGAGAAACAAAGTTCCATTTTTC 
STIM2_1 AAAACGCTAAGCTATGCTAACCGCGTCTAAACAGCCAGCCACTTGTAAGCCCCACCTATA 
  TTGAAATTACGGGGACGCTGCTGTTTTCCGATTGCAAGATTTTCCTGATCCATGCAATTA 
  CTTTCGCTGCCCTCTACGAGGCTGAAACTCGCCCTCAGGATGTGGGACGTCTGGACTCTT 
  CTCTCCGTCCCCTTGTAGCCCCCCACTCCCCCTCGCGGTGGTACCGTGAATGAGGGAGAG 
  GTACACGTCCCCCTTCTTCCCCGCCTCCTATCTTCGCGGCTCGCTAAAGCGTTATCAGCC 
  GCCCCACGGTACTACCGTCCGTCTAGGAACGCCTCCGGGGCGGGGCTGGGATGCCGCGCA 
  CGCGCAGTACAGCAGCGCCGCGCCTGCGCCGTGGAGAGCCTGAGGGAGGCGGGGGATTGG 
  TATGCGAGCGAATGTGCGAGGGGAGGGAGGCGTCCCGGCGGAGCGTGGTACTACGACCAG 
  CGCGGGCCGGAGGGGGCGGGGGGATGCGCCGCGGCGGCGGCGGCGCGGGAGCTGGGGTTG 
  GTGTTTGGCGGCGCCAGAGCAGCGGATCCCGGTCTCGCCGCAGCAGCAGCGCGGGTGTCG 
STIM2_2 TACAGATTTATTATAAATGTGTATACTTGAGAATAAATGAGTAGAAGAACAGTGGAGGTA 
  AGTCAAATATAGTGGAATTAGATGTGTAGTTAAATTTTATTTTTAACTTGATTTAAATAA 
  TTAGGAATTTTTGAAAAGCTTTTTGCGGAAGAGTATTTCCCTGCTTTCCCTGTCATTTGA 
  ACCCAGGATAACCAAAATAGCTGTATAGTAAGTTGCCTGATATTTGTATTAACCAAACTT 
  AAGGCTAATGAAAAATGCTATGATTTCTGATTGAAATATGTATTTAATCGCTTGACCCAG 
  TATTCATTATTTTGTAAAAAAAAATAAAACTGGAAATTTTTGTGAGGAATTTTTATTTTT 
  ATTGTTCTATAAGGCTTGAAAAGGCACAGGAAGAAAACAGAAATGTTGCTGTAGAAAAGC 
  AAAATTTAGAGCGCAAAATGATGGATGAAATCAATTATGCAAAGGAGGAGGCTTGTCGGC 
  TGAGAGAGCTAAGGGAGGGAGCTGAATGTGAATTGAGTAGACGTCAGTATGCAGAACAGG 
  AATTGGAACAGGTATTTACATTAAAAAAAAAATCACTTGTAAAGATGTTAACATTGCCAC 
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ORAI1 GACAGGTTTTGTCCATCTCGTTCACCACCCTACCCAGCCTCAGCACCTAGACCAGTGTTG 
  GCACCCAGTGGGCGCCAAATAAACACTGCTTGAACTCCAGACGTCAGCCGCTCTTTTTCC 
  TACAGACCTTGAGCCACCTTGTTCCAAAGGGGATATGGGCCTCAGGAGGCGCCCAGAGGT 
  GACCTCAGGCGGCCCGACCCAGGAGTCCAAGCTCCAGGAGCAGGGCCACGGGAGCAGCTG 
  CGGAGAGGGGCGGCGCCAGGAGCCGGAGCGGGCAGCCGGGCGCTTCCAGGAAAAGTGGCG 
  GGCGGCGGCGCGCCAGGGACCGTGGGCGGTGCCGTCGGAGCGGGCGGGTCACGTGACGCC 
  CACAACAACGCCCACTTCTTGGTGGGCGGGGCACAGGTGGGCGGGGAGCATGCAAAACAG 
  CCCAGGGCGGCGGCCAATCGCGGCGCGCGCCGGGGGTCCAGGCCCCGGGGATCCGAGGCG 
  CCGCCCGCGCGCAGTCTCTGGTCACTGCCGCCCGGGGGCTTTTGCCAGCGGCGCCGCGGG 
  CCTGCGTGCTGGGGCAGCGGGCACTTCTTCGACCTCGTCCTCCTCGTCCTGTGCGGCCGG 
ORAI2 ACTCCCCGCCCCTCTACGCAGCCAGCGTCCAATGCTGGGCACCCCCCGAGGCTCACCCTG 
  CCAAGCCTGGGGCTCCCCTTTTGCGCCCGGACCCAGGGGCAGGGAAAGCCCAGCTCGTGG 
  TCTGTGGGTAGCCGGACCCCCGATGGGGCGGTGGGGGGCCTCGCCTTGACTCCCAGAGCT 
  GGGGCCGGGGACAGGAGCTGGGGCAGGAGGGATGCGCGCGGGTCGGGGTCTTCCCACCTC 
  CCCTGCTCCTCTCCCTCGCGCGATCCCGGGGTGGTTCCAGGTGAGGCGGGGACCCCCACC 
  CCCCCACTCTCCGAGGAGGCGCCGCCAGCCCCGCCCCTCCCGGCCCGGCGGGTGACGTGG 
  CCGCGGCTCTCCCGCGGGTGGGTCACGTGTTGGCGGCGCCTGGTTGCCTTGGCAGCGGCT 
  GCGGCGGCCGCGGGGGCGGGGTGGAGGCGGGGCCGGGGGACCCCGCGCGACCGGCGGAAG 
  GAGGGAGGGGGCCGCGCTCGGCGCCCCGGCCGGGCCACTGGGCCACAGGCCACGCGGCCA 
  CGCAGTCCGAGCGGGAGCCGAGCCGGGCGGGGCGAGGGCAGCTCCGGTGAGTGTGGCGGC 
ORAI3 GTAACAGGGAGGTGCGCGGGTGGGGGGAGGGCTGGGCGGACCAAAGGCCGGAGGGGTGGG 
  GCCTGGGGATAGCGAGAGGCTTGAGAATGGGGCCGCTTGGGGGAGGGAAGAGGCAGCCCG 
  GCGAGGGGCAAGCGGGGGACCCAGCCGGGCTGGGCCCCTGGGCCCCGGGTCTGTACAATA 
  CGGTTTGCTATAAAACTCAAAATCTTCCAGCCGGGGCTGCGGAGTTCGTGTGTGTATCTG 
  CGGGGTCCCTACCTACAGATGAGTGGGCTCACCTCTCCTGGACTCATTTTGGGAGGGATT 
  TGGAAGTGTGGACACCTGGGGTGTCCAGCTGTACCTTGGAGGGGGCTGGGGTTGGCGTGC 
  ACCTCGGTGGGGTCCGGGCGCTTGGATAACGTTCTTGGTGGGTAGGGGTCGCGGGGAATC 
  TCTGCGGGCCCGGGACTGCGGGGACTTGGTCCCCGGCTCCACCCCATCATGTGGCTAGCC 
  CCGGCTCCGCCTCTGTCCCAGTTCCTGTTTTGGCCTCCGCTGTCCCGCTCCGGCTCCTGG 
  GGCTCCCCGCAGACGCTGCTTTTCTTGCTCCACTGGGGGTGCCTCTTCCTGGGCGCCCGC 
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Table 4.3 List of the predicted interactions between transcription factors, name of bridge proteins and score obtained from the STRING database. 
Promoter 
name 
Potential 
Interactions 
Type of 
interaction 
Bridge 
Proteins 
Interactions node1 node2 Score node1 node2 Score node1 node2 Score 
STIM2_1 E2F1:E2F4 Direct     E2F1 E2F4 0.966             
  E2F1:E2F4 
Bridge 
protein 
MYC E2F1>MYC>E2F4 E2F1 MYC 0.982 MYC E2F4 0.982       
STIM2_1 E2F1:EGR1 
Bridge 
protein 
SPI1 E2F1>SPI1>EGR1 E2F1 SPI1 0.905 SPI1 EGR1 0.501     
  E2F1:EGR1 
Bridge 
protein 
E2F4 E2F1>E2F4>EGR1 E2F1 E2F4 0.966 E2F4 EGR1 0.846     
  E2F1:EGR1 
Bridge 
protein 
MYC E2F1>MYC>EGR1 E2F1 MYC 0.982 MYC EGR1 0.928     
STIM2_1 E2F1:GATA1 
Bridge 
protein 
ELF1 E2F1>ELF1>GATA1 E2F1 ELF1 0.902 ELF1 GATA1 0.893       
  E2F1:GATA1 
Bridge 
protein 
SPI1 E2F1>SPI1>GATA1 E2F1 SPI1 0.905 SPI1 GATA1 0.995     
  E2F1:GATA1 
Bridge 
protein 
MYC E2F1>MYC>GATA1 E2F1 MYC 0.982 MYC GATA1 0.961       
STIM2_1 E2F4:GATA1 Direct     E2F4 GATA1 0.727             
  E2F4:GATA1 
Bridge 
protein 
MYC E2F4>MYC>GATA1 E2F4 MYC 0.96 MYC  GATA1 0.961     
  E2F4:GATA1 
Bridge 
protein 
EGR1 E2F4>EGR1>GATA1 E2F4 EGR1 0.846 EGR1 GATA1 0.584     
ORAI1 PPARD:E2F4 
Bridge 
protein 
EGR1 PPARD>EGR1>E2F4 PPARD EGR1 0.691 EGR1 E2F4 0.846      
ORAI2 NFKB1:RUNX1 
Bridge 
protein 
EGR1 NFKB1>EGR1>RUNX1 NFKB1 EGR1 0.671 EGR1 RUNX1 0.676       
  NFKB1:RUNX1 
Bridge 
protein 
MYC NFKB1>MYC>RUNX1 NFKB1 MYC 0.993 MYC RUNX1 0.61      
  NFKB1:RUNX1 
Bridge 
protein 
SPI1 NFKB1>SPI1>RUNX1 NFKB1 SPI1 0.781 SPI1 RUNX1 0.991      
  PPARD:MYC 
Bridge 
protein 
EGR1 PPARD>EGR1>MYC PPARD EGR1 0.691 EGR1 MYC 0.928      
  PPARD:MYC 
Bridge 
protein 
HNF4A PPARD>HNF4A>MYC PPARD HNF4A 0.916 HNF4A MYC 0.942       
ORAI3 MITF:ELF1 
Bridge 
proteins 
SPI1, E2F1 MITF>SPI1>E2F1>ELF1 MITF SPI1 0.951 SPI1 E2F1 0.905 E2F1 ELF1 0.902 
  MITF:ELF1 
Bridge 
proteins 
SPI1, 
GATA1 
MITF>SPI1>GATA1>ELF1 MITF SPI1 0.951 SPI1 GATA1 0.995 GATA1 ELF1 0.893 
  MITF:SPI1 Direct    MITF SPI1 0.951          
  SPI1:ELF1 
Bridge 
protein 
GATA1 SPI1>GATA1>ELF11 SPI1 GATA1 0.995 GATA1 ELF1 0.893      
  SPI1:ELF1 
Bridge 
protein 
E2F1 SPI1>E2F1>ELF1 SPI1 E2F1 0.905 E2F1 ELF1 0.902       
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Table 4.4 List of differential interactions in (normal-tumor) and (tumor-normal) samples. 
Node 1 Node 2 Weight Node 1 Node 2 Weight 
Normal-tumor Tumor-normal 
EP300 CREBBP 0.2822 FOXP2 ELK3 0.1546 
NCOR1 EP300 0.2343 MITF RUNX2 0.1528 
SP1 EP300 0.2093 FOXA1 GATA3 0.1112 
NCOR1 CREBBP 0.1903 FLI1 ELK3 0.1095 
MITF ELK3 0.1636 SPI1 FLI1 0.1049 
NCOR1 AR 0.1624 AR EP300 0.0869 
SMAD4 SP1 0.1448 SPI1 TFEB 0.0749 
MITF FLI1 0.1331 FOXP2 FLI1 0.0737 
SP1 CREBBP 0.1330 SP1 EP300 0.0673 
TOP2B SP1 0.1270 FOXP2 RUNX2 0.0625 
FLI1 ELK3 0.1135 FOXP2 MITF 0.0623 
FOXA1 GATA3 0.0985 TOP2B SP1 0.0623 
NCOR2 TRIM28 0.0976 STIM2 FLI1 0.0604 
MITF TRIM28 0.0963 ZNF217 TFEB 0.0584 
NCOR1 SP1 0.0929 MITF ELK3 0.0579 
AR EP300 0.0915 SP1 AR 0.0552 
TTF2 EP300 0.0881 FOXA1 FLI1 0.0552 
TRIM28 ELK3 0.0829 FLI1 TFEB 0.0536 
FLI1 HOXB7 0.0820 TOP2B EP300 0.0532 
KDM1A HOXB7 0.0807 NCOR1 SP1 0.0487 
SMAD4 TOP2B 0.0805 AR CREBBP 0.0484 
KDM1A HDAC2 0.0803 ELF1 TOP2B 0.0474 
KDM1A FLI1 0.0743 TP63 KLF5 0.0470 
TTF2 SP1 0.0698 EP300 ELK3 0.0440 
RBPJ TRIM28 0.0688 RUNX2 ELK3 0.0431 
KLF5 TFAP2C 0.0686 E2F1 RUNX1 0.0424 
HOXB7 TFAP2C 0.0670 ELF1 SP1 0.0410 
HDAC3 KDM1A 0.0647 FOXP2 EGR1 0.0387 
KDM1A MITF 0.0624 TOP2B AR 0.0378 
TOP2B EP300 0.0603 FLI1 GATA3 0.0378 
FOXP1 TP63 0.0587 TP63 EGR1 0.0369 
FOXP2 HDAC1 0.0549 EGR1 ELK3 0.0363 
AR CREBBP 0.0548 EGR1 FLI1 0.0360 
MITF VDR 0.0544 NCOR1 EP300 0.0349 
TRIM28 FLI1 0.0539 SP1 CREBBP 0.0324 
MITF RBPJ 0.0539 STIM2 ELK3 0.0313 
FOXP2 MITF 0.0536 FOXA1 E2F4 0.0310 
HOXB7 VDR 0.0525 NFKB1 ELK3 0.0307 
MITF HOXB7 0.0522 NCOR1 AR 0.0306 
FLI1 VDR 0.0516 ELF1 ELK3 0.0300 
NCOR1 PHF8 0.0496 FOXA1 SPI1 0.0295 
Continued 
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SMAD4 ORAI2 0.0491 MITF TRIM28 0.0294 
KDM1A TFAP2C 0.0486 SP1 ELK3 0.0283 
TP63 TFAP2C 0.0478 MITF FLI1 0.0277 
SMAD4 CUX1 0.0457 PHF8 CREBBP 0.0262 
TTF2 TOP2B 0.0424 SPI1 E2F4 0.0258 
SMAD4 EP300 0.0417 FOXA1 TFEB 0.0257 
FOXA1 PHF8 0.0404 AR ELK3 0.0248 
KLF5 CUX1 0.0398 ELF1 AR 0.0247 
FOXA1 AR 0.0392 ELF1 EP300 0.0244 
ORAI2 SP1 0.0383 SP1 CDKN2A 0.0240 
PHF8 AR 0.0379 PHF8 AR 0.0239 
FLI1 TFAP2C 0.0378 FOXP2 STIM2 0.0235 
HOXB7 GATA2 0.0370 RUNX2 RUNX1 0.0231 
KDM1A ELK3 0.0363 NCOR1 TOP2B 0.0225 
GATA6 ELK3 0.0360 NCOR1 CREBBP 0.0216 
RBPJ FLI1 0.0351 NFKB1 AR 0.0212 
FOXP2 TRIM28 0.0331 FOXP2 RUNX1 0.0211 
TTF2 CREBBP 0.0328 ELK3 RUNX1 0.0205 
FOXP2 ELK3 0.0306 ELF1 NFKB1 0.0203 
TTF2 NCOR1 0.0302 FLI1 GATA6 0.0201 
KDM1A VDR 0.0293     
NCOR2 RBPJ 0.0286     
RBPJ ELK3 0.0282     
NCOR1 TOP2B 0.0278     
TRIM28 VDR 0.0277     
MITF TFAP2C 0.0264     
FLI1 GATA2 0.0257     
TOP2B CREBBP 0.0257     
SP1 AR 0.0251     
MITF GATA6 0.0248     
TP63 CREBBP 0.0247     
KDM1A TRIM28 0.0245     
PHF8 EP300 0.0238     
VDR ELK3 0.0237     
NCOR2 FLI1 0.0236     
MITF NCOR2 0.0225     
TP63 HOXB7 0.0222     
FOXP1 SMAD4 0.0217     
HDAC3 HDAC2 0.0211     
SP1 CDKN2A 0.0207     
PHF8 CREBBP 0.0201     
TOP2B HOXB7 0.0201       
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8.3 Supplementary Information for Chapter 5 
Table 5.1 Dataset of 167 protein-ligand complexes. 
1Q8T 1Q8U 1XD0 2YKI 3JVS 2J62 2W66 4DEW 
1VSO 2WBG 3B3W 1W3K 2CBJ 3OZT 3GCS 2X97 
3OE5 1LOR 2QBP 3F3E 3I3B 3UO4 3ZSX 2V7A 
3L4W 2QBR 3PXF 2YFE 3OV1 3HUC 2WTV 3F3C 
2ZXD 2VVN 3F3A 2D3U 1H23 2ZWZ 3SU2 3BFU 
2P4Y 1YC1 2J78 2X8Z 3GBB 2VW5 3GE7 1R5Y 
4DE2 3UDH 3G2Z 3EBP 2GSS 2XHM 3MSS 1U33 
1SLN 3F17 2X00 2BRB 3AO4 4DE1 4GID 3D4Z 
2ZCR 3IMC 10GS 1GPK 1PS3 3PE2 3ACW 3FCQ 
3CYX 2CET 3K5V 2V00 1OS0 1Z95 3BKK 3MFV 
2ZJW 3DD0 3N86 3EHY 3E93 1LOQ 3F80 1U1B 
3NW9 3IVG 3N7A 1NVQ 2OBF 3G0W 1N2V 3VH9 
1LBK 3AG9 4G8M 2G70 3SU5 2VO5 3S8O 3B68 
3PWW 2XY9 3ZSO 2FVD 1KEL 3UEX 2ZCQ 2YGE 
3SU3 1SQA 2D1O 2VOT 2WEG 2XNB 3B3S 3CJ2 
3FK1 4TMN 4DJR 1P1Q 2XDL 4GQQ 3GNW 3DXG 
2X0Y 3MUZ 1HNN 3EJR 2QFT 2YMD 2QMJ 2XYS 
3VD4 2HB1 1HFS 3L3N 3OWJ 3L7B 1W3L 3COY 
3NQ3 3NOX 2ZX6 3LKA 3FV1 3MYG 2PQ9 3KV2 
2OLE 1LOL 1JYQ 2IWX 3L4U 2VL4 3KWA 4DJV 
3U9Q 3UEU 2WCA 1E66 2XB8 3G2N 1QI0  
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Table 5.2 Names, URLs, year of creation and respective limitations of the 18 pocket identification tools. 
Program URL Year Limitation 
APROPOS http://www.csb.yale.edu/poststructure/apropos/apropos.html 1996 Need CSB core 
BetaCavityWeb http://voronoi.hanyang.ac.kr/betacavityweb/ 2015 Available only as webserver 
CASTp http://sts.bioe.uic.edu/castp/calculation.php 2003/2006 Available only as webserver 
CAVER Analyst http://www.caver.cz 2014 No output file, not run automatically 
ConCavity http://compbio.cs.princeton.edu/concavity/  2009 Not compatible with Debian 16.0-4-amd64 
Epock http://epock.bitbucket.org 2014 Need VMD 
HotPatch http://hotpatch.mbi.ucla.edu/ 2007 Incomplete documentation 
LIGSITEcs http://projects.biotec.tu-dresden.de/pocket/ 1997 Need BALL algorithm 
McVol http://www.bisb.uni-bayreuth.de/index.php?page=data/mcvol/mcvol  2010 Does not take PDB as input 
Metapocket2.0 http://projects.biotec.tu-dresden.de/metapocket/ 2011 Available only as webserver 
MolSite http://presto.protein.osaka-u.ac.jp/myPresto4/index.php?lang=en 2011 Incomplete documentation 
PASS http://www.ccl.net/cca/software/UNIX/pass/overview.shtml 2000 Not compatible with Debian 16.0-4-amd64 
POCASA http://altair.sci.hokudai.ac.jp/g6/service/pocasa/ 2010 Available only as webserver 
PocketAnalyzer http://sourceforge.net/projects/papca/ or http://cpclab.uni-duesseldorf.de/downloads 2011 Not compatible with Debian 16.0-4-amd64 
QSiteFinder http://www.bioinformatics.leeds.ac.uk/qsitefinder 2005 Not compatible with Debian 16.0-4-amd64 
Rate4Site bioinfo.tau.ac.il/ConSurf 2002 Only available in Windows OS 
SITEHOUND http://scbx.mssm.edu/sitehound/sitehound-web/Input.html 2009 Not compatible with Debian 16.0-4-amd64 
SURFNET http://www.ebi.ac.uk/thornton-srv/software/SURFNET/ 1995 Not compatible with Debian 16.0-4-amd64 
VMD,Visual Molecular Dynamics; PDB, protein data bank and OS, operating system. 
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Table 5.3 List of the descriptors obtained from the DoGSiteScorer tool. 
Group Label Description 
Ligand descriptors lig_cov Percentage of ligand covered by the predicted pocket 
poc_cov Percentage of the pocket covered by the co-crystallized ligand 
Size and shape 
descriptors 
volume Pocket volume in A^3 calculated via grid points 
surface Pocket surface in A^2 calculated via grid points 
lipo_surf  solvent accessible lipophilic surface; 
depth Depth of the pocket in A 
ellips c/a or b/a Ellipsoid main axes ratios, with a > b > c 
enclosure Rratio of number of surface to hull grid points 
Functional group 
descriptors 
H-don Number of hydrogen bond donors 
H-acc Number of hydrogen bond acceptors 
Met Number of metals 
Hphob Number of hydrophobic contacts 
siac ratio Relative number of hydrophobic site interaction centers (SIACs, from 
flex) 
Element descriptors nof_dif_atms Number of surface atoms lining the pocket 
elem_x Number of elements of specific type in active site; types: C, N, O, S 
or other (X) 
Amino acid 
composition 
aa_apol, aa_pol and aa_neg Relative number of amino acids apolar, polar, positive, and negative) 
Amino acid 
descriptors 
ALA, ARG, ASN, ASP, CYS, GLN, 
GLU, GLY, HIS, ILE, LEU, LYS, 
MET, PHE, PRO, SER, THR, TRP, 
TYR and VAL 
Number of amino acids in pocket, 3-letter code of 20 amino acid 
types 
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Table 5.4 List of the weight of each tool for each protein.  
PDB ID DEPTH GHECOM Fpocket DoGSiteScorer IsoMif ProACT2 
1Q8T 0.4133 0.1937 0.2018 0.0677 0.0871 0.0363 
1Q8U 0.4149 0.2008 0.1893 0.0711 0.0875 0.0363 
1XD0 0.3998 0.1663 0.1428 0.0929 0.1599 0.0383 
2YKI 0.3981 0.2065 0.1720 0.0887 0.1021 0.0327 
3JVS 0.2649 0.0929 0.1151 0.1324 0.3245 0.0701 
2J62 0.2634 0.1428 0.2079 0.1629 0.1664 0.0567 
2W66 0.2709 0.1183 0.1988 0.1527 0.1975 0.0618 
4DEW 0.2799 0.1049 0.1460 0.1810 0.2037 0.0845 
1VSO 0.2675 0.1421 0.2116 0.1451 0.1718 0.0619 
2WBG 0.3796 0.2107 0.1432 0.0787 0.1425 0.0453 
3B3W 0.3621 0.1279 0.1229 0.1004 0.2305 0.0563 
1W3K 0.2837 0.1284 0.2061 0.1617 0.1569 0.0632 
2CBJ 0.3433 0.1332 0.1343 0.1027 0.2234 0.0631 
3OZT 0.2524 0.1665 0.2263 0.1449 0.1583 0.0515 
3GCS 0.3593 0.2084 0.1833 0.0800 0.1359 0.0331 
2X97 0.3794 0.1841 0.2701 0.0657 0.0743 0.0263 
3OE5 0.3443 0.2091 0.1697 0.0897 0.1499 0.0373 
1LOR 0.2656 0.1598 0.1891 0.1647 0.1675 0.0533 
2QBP 0.2676 0.1080 0.1657 0.1399 0.2425 0.0763 
3F3E 0.3170 0.0885 0.1060 0.1394 0.2675 0.0816 
3I3B 0.2605 0.1602 0.2600 0.1412 0.1333 0.0448 
3UO4 0.3595 0.1491 0.1715 0.0998 0.1794 0.0407 
3ZSX 0.3797 0.1957 0.1857 0.0835 0.1116 0.0439 
2V7A 0.3591 0.1501 0.1335 0.0890 0.2123 0.0561 
3L4W 0.2539 0.1482 0.2218 0.1698 0.1647 0.0416 
2QBR 0.2545 0.1071 0.1713 0.1459 0.2411 0.0801 
3PXF 0.3847 0.1979 0.1989 0.0812 0.1083 0.0290 
2YFE 0.4139 0.2012 0.1885 0.0714 0.0963 0.0287 
3OV1 0.2798 0.1208 0.1715 0.1646 0.2176 0.0457 
3HUC 0.3762 0.2115 0.1956 0.0845 0.0991 0.0331 
2WTV 0.3581 0.1694 0.1975 0.0967 0.1398 0.0385 
3F3C 0.2674 0.1753 0.2301 0.1415 0.1372 0.0485 
2ZXD 0.3690 0.2211 0.1714 0.0840 0.1248 0.0297 
2VVN 0.2577 0.1213 0.2214 0.1546 0.1911 0.0539 
3F3A 0.3711 0.1865 0.1614 0.0977 0.1388 0.0445 
2D3U 0.3539 0.1333 0.1462 0.0964 0.2297 0.0405 
1H23 0.3562 0.2298 0.1538 0.0793 0.1429 0.0381 
2ZWZ 0.3785 0.1522 0.1206 0.0819 0.2225 0.0442 
3SU2 0.3553 0.1255 0.1467 0.1062 0.2203 0.0460 
3BFU 0.2563 0.1304 0.2397 0.1555 0.1566 0.0615 
2P4Y 0.4201 0.1800 0.2041 0.0750 0.0897 0.0311 
1YC1 0.3806 0.1821 0.1683 0.0905 0.1289 0.0496 
Continued 
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2J78 0.3884 0.2140 0.1579 0.0844 0.1135 0.0418 
2X8Z 0.3873 0.1739 0.2635 0.0687 0.0769 0.0297 
3GBB 0.4069 0.1970 0.1688 0.0785 0.1123 0.0365 
2VW5 0.3799 0.1929 0.1595 0.0866 0.1300 0.0511 
3GE7 0.3484 0.1782 0.2081 0.0867 0.1327 0.0458 
1R5Y 0.2391 0.1301 0.2643 0.1558 0.1491 0.0617 
4DE2 0.2651 0.1292 0.2076 0.1613 0.1668 0.0701 
3UDH 0.4061 0.1951 0.2027 0.0788 0.0873 0.0299 
3G2Z 0.2581 0.1122 0.2129 0.1620 0.1860 0.0688 
3EBP 0.3483 0.1386 0.1527 0.1007 0.2143 0.0453 
2GSS 0.2590 0.1345 0.2499 0.1361 0.1651 0.0553 
2XHM 0.3878 0.1977 0.2380 0.0734 0.0809 0.0222 
3MSS 0.3987 0.2165 0.1761 0.0735 0.1015 0.0337 
1U33 0.3343 0.1734 0.1813 0.1213 0.1471 0.0427 
1SLN 0.3597 0.1971 0.1919 0.0851 0.1304 0.0359 
3F17 0.3821 0.1596 0.1650 0.1002 0.1493 0.0439 
2X00 0.2487 0.1189 0.1581 0.1612 0.2579 0.0551 
2BRB 0.3511 0.2136 0.1689 0.0864 0.1398 0.0402 
3AO4 0.2528 0.1397 0.3007 0.1416 0.1215 0.0437 
4DE1 0.2556 0.1245 0.2134 0.1675 0.1739 0.0652 
4GID 0.4089 0.1918 0.2181 0.0707 0.0828 0.0277 
3D4Z 0.2929 0.0859 0.1403 0.1359 0.2788 0.0662 
2ZCR 0.4160 0.1872 0.1901 0.0751 0.0962 0.0354 
3IMC 0.3658 0.1946 0.1752 0.0920 0.1290 0.0434 
10GS 0.2425 0.1485 0.2463 0.1468 0.1689 0.0470 
1GPK 0.3622 0.2275 0.1535 0.0772 0.1415 0.0381 
1PS3 0.3089 0.0839 0.1357 0.1309 0.2764 0.0643 
3PE2 0.3659 0.1701 0.1457 0.0823 0.1911 0.0449 
3ACW 0.4033 0.1907 0.2083 0.0743 0.0889 0.0345 
3FCQ 0.2641 0.1451 0.2276 0.1387 0.1711 0.0535 
3CYX 0.3889 0.1417 0.1471 0.0891 0.1770 0.0563 
2CET 0.3820 0.2205 0.1569 0.0859 0.1138 0.0409 
3K5V 0.3689 0.2124 0.1660 0.0861 0.1275 0.0392 
2V00 0.3695 0.1891 0.1833 0.0811 0.1287 0.0483 
1OS0 0.3317 0.1728 0.1963 0.0973 0.1623 0.0397 
1Z95 0.4029 0.1514 0.1545 0.0835 0.1675 0.0403 
3BKK 0.3863 0.1892 0.2387 0.0697 0.0835 0.0327 
3MFV 0.3560 0.1737 0.1672 0.0955 0.1601 0.0474 
2ZJW 0.3655 0.2112 0.1799 0.0777 0.1320 0.0337 
3DD0 0.2764 0.1277 0.1889 0.1473 0.2013 0.0585 
3N86 0.2669 0.1487 0.2331 0.1452 0.1492 0.0569 
3EHY 0.3535 0.1721 0.1775 0.1085 0.1447 0.0436 
3E93 0.3951 0.2141 0.1760 0.0691 0.1096 0.0361 
Continued 
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1LOQ 0.3578 0.2029 0.1504 0.1009 0.1505 0.0375 
3F80 0.3698 0.1705 0.1628 0.0973 0.1491 0.0506 
1U1B 0.2616 0.1033 0.2079 0.1703 0.2027 0.0541 
3NW9 0.2511 0.1711 0.2099 0.1463 0.1625 0.0591 
3IVG 0.4155 0.1983 0.1835 0.0734 0.0945 0.0347 
3N7A 0.2713 0.1502 0.2387 0.1393 0.1464 0.0541 
1NVQ 0.3624 0.1580 0.1569 0.0853 0.1903 0.0472 
2OBF 0.3819 0.1906 0.1879 0.0873 0.1146 0.0377 
3G0W 0.3903 0.1891 0.1840 0.0842 0.1185 0.0339 
1N2V 0.3244 0.1948 0.1935 0.0965 0.1465 0.0443 
3VH9 0.2863 0.1119 0.1313 0.1361 0.2704 0.0639 
1LBK 0.3877 0.2125 0.1763 0.0713 0.1189 0.0332 
3AG9 0.3723 0.1294 0.1280 0.1019 0.2185 0.0499 
4G8M 0.3749 0.1991 0.1951 0.0865 0.1081 0.0361 
2G70 0.3613 0.1873 0.1955 0.0948 0.1221 0.0390 
3SU5 0.3655 0.1380 0.1343 0.1049 0.2136 0.0437 
2VO5 0.2533 0.1543 0.2135 0.1504 0.1642 0.0643 
3S8O 0.2515 0.1237 0.1910 0.1645 0.2228 0.0465 
3B68 0.3807 0.1694 0.1623 0.0819 0.1648 0.0410 
3PWW 0.3497 0.1793 0.1529 0.1021 0.1746 0.0414 
2XY9 0.3882 0.1905 0.2272 0.0776 0.0839 0.0325 
3ZSO 0.3119 0.1780 0.2135 0.1119 0.1237 0.0609 
2FVD 0.3752 0.2055 0.2073 0.0765 0.1058 0.0297 
1KEL 0.3009 0.1216 0.2132 0.1412 0.1685 0.0545 
3UEX 0.3623 0.1668 0.1639 0.0943 0.1785 0.0342 
2ZCQ 0.4172 0.1855 0.1895 0.0747 0.1019 0.0311 
2YGE 0.3661 0.1964 0.1641 0.0809 0.1414 0.0511 
3SU3 0.3632 0.1373 0.1341 0.1067 0.2134 0.0453 
1SQA 0.2332 0.1385 0.2138 0.1915 0.1757 0.0472 
2D1O 0.3658 0.1863 0.1786 0.0900 0.1384 0.0409 
2VOT 0.4032 0.1359 0.1175 0.0817 0.2115 0.0503 
2WEG 0.4151 0.1397 0.1293 0.0887 0.1809 0.0463 
2XNB 0.3553 0.1969 0.1881 0.0851 0.1378 0.0368 
3B3S 0.2495 0.0982 0.1517 0.1665 0.2637 0.0704 
3CJ2 0.2575 0.0997 0.1736 0.1493 0.2597 0.0602 
3FK1 0.2670 0.1479 0.2725 0.1439 0.1109 0.0578 
4TMN 0.2402 0.1521 0.2409 0.1543 0.1514 0.0610 
4DJR 0.3558 0.1428 0.1231 0.1099 0.2175 0.0509 
1P1Q 0.4020 0.1787 0.2029 0.0812 0.0987 0.0365 
2XDL 0.3686 0.1537 0.1479 0.0972 0.1790 0.0537 
4GQQ 0.2517 0.0979 0.1211 0.1647 0.2953 0.0695 
3GNW 0.3769 0.2130 0.1803 0.0793 0.1181 0.0324 
3DXG 0.2593 0.1136 0.2285 0.1737 0.1713 0.0535 
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2X0Y 0.2764 0.1535 0.2337 0.1458 0.1389 0.0516 
3MUZ 0.2579 0.1597 0.2509 0.1475 0.1367 0.0473 
1HNN 0.3899 0.1849 0.1960 0.0812 0.1089 0.0391 
3EJR 0.2715 0.0863 0.1446 0.1441 0.2895 0.0640 
2QFT 0.4253 0.1908 0.1888 0.0744 0.0817 0.0389 
2YMD 0.2671 0.1069 0.1763 0.1738 0.2201 0.0557 
2QMJ 0.3813 0.1194 0.1027 0.0948 0.2598 0.0420 
2XYS 0.3611 0.1461 0.1326 0.0991 0.2165 0.0446 
3VD4 0.2621 0.1286 0.1520 0.1450 0.2527 0.0596 
2HB1 0.2612 0.1244 0.2735 0.1507 0.1431 0.0471 
1HFS 0.2732 0.1491 0.2359 0.1328 0.1661 0.0430 
3L3N 0.3594 0.2314 0.1736 0.0763 0.1234 0.0359 
3OWJ 0.3834 0.1963 0.1951 0.0727 0.1128 0.0397 
3L7B 0.3913 0.1925 0.2401 0.0686 0.0771 0.0304 
1W3L 0.2803 0.1223 0.1995 0.1619 0.1733 0.0627 
3COY 0.4210 0.1946 0.1849 0.0743 0.0918 0.0333 
3NQ3 0.3653 0.1797 0.1717 0.0968 0.1520 0.0345 
3NOX 0.2513 0.0961 0.1297 0.1398 0.3114 0.0717 
2ZX6 0.3739 0.1797 0.1630 0.0853 0.1582 0.0399 
3LKA 0.3635 0.1766 0.1665 0.1055 0.1439 0.0441 
3FV1 0.3933 0.2019 0.1709 0.0787 0.1163 0.0388 
3MYG 0.3527 0.2009 0.1989 0.0861 0.1263 0.0351 
2PQ9 0.4107 0.1839 0.2146 0.0721 0.0837 0.0351 
3KV2 0.3541 0.1728 0.1762 0.0965 0.1539 0.0464 
2OLE 0.2768 0.1041 0.1787 0.1509 0.2360 0.0535 
1LOL 0.3349 0.1709 0.1585 0.1129 0.1865 0.0363 
1JYQ 0.2774 0.0991 0.1475 0.1526 0.2646 0.0589 
2IWX 0.4143 0.2165 0.1744 0.0714 0.0933 0.0301 
3L4U 0.2695 0.0859 0.1381 0.1432 0.3048 0.0585 
2VL4 0.2695 0.1279 0.1900 0.1509 0.1963 0.0653 
3KWA 0.2726 0.1229 0.1911 0.1413 0.2076 0.0645 
4DJV 0.2601 0.1085 0.1834 0.1655 0.2207 0.0617 
3U9Q 0.4046 0.2014 0.2074 0.0717 0.0879 0.0270 
3UEU 0.3611 0.1628 0.1580 0.0961 0.1789 0.0430 
2WCA 0.3901 0.1985 0.1615 0.0863 0.1305 0.0331 
1E66 0.3604 0.2369 0.1500 0.0743 0.1390 0.0394 
2XB8 0.2739 0.1603 0.2293 0.1365 0.1443 0.0557 
3G2N 0.3911 0.1987 0.2305 0.0737 0.0744 0.0317 
1QI0 0.2703 0.1301 0.2058 0.1737 0.1650 0.0551 
 
 
 
 
